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During the last 2 decades, the public and private sectors have
made substantial international research progress toward improv-
ing the nutritional value of a wide range of food and feed crops.
Nevertheless, significant numbers of people still suffer from the
effects of undernutrition. In addition, the nutritional quality of
feed is often a limiting factor in livestock production systems,
particularly those in developing countries. As newly developed
crops with nutritionally improved traits come closer to being
available to producers and consumers, we must ensure that sci-
entifically sound and efficient processes are used to assess the
safety and nutritional quality of these crops. Such processes will
facilitate deploying these crops to those world areas with large
numbers of people who need them. This document describes 5
case studies of crops with improved nutritional value. These
case studies examine the principles and recommendations pub-
lished by the Intl. Life Sciences Ins. (ILSI) in 2004 for the safety
and nutritional assessment of foods and feeds derived from
nutritionally improved crops (ILSI 2004). One overarching con-
clusion that spans all 5 case studies is that the comparative safe-
ty assessment process is a valid approach. Such a process has
been endorsed by many publications and organizations, includ-
ing the 2004 ILSI publication. The type and extent of data that
are appropriate for a scientifically sound comparative safety
assessment are presented on a case-by-case basis in a manner
that takes into account scientific results published since the
2004 ILSI report.
Background on the Importance of Nutritionally
Improved Foods and Feeds
The United Nations (UN) charter declared that freedom from
hunger is a fundamental human right. Diets that are deficient in
essential nutrients can be a pervasive cause of hunger and
undernutrition. The UN Millennium Project recognized that the
number of undernourished people in the world had fallen from
approximately 1.5 billion in the early 1970s to around 850 mil-
lion by the 1990s, and targeted to reduce this number by half by
2015. However, it is sobering to note that even the achievement
of this goal will leave the world with over 400 million under-
nourished humans.
More than 200 million of the world’s hungry are children, and
at least 5 million of them die each year from undernutrition.
Dietary deficiencies take a staggering toll on physical and men-
tal development, which has implications for educational
achievement, work performance, and, consequently, economic
prospects. Inadequate nutrition also contributes to death from a
wide variety of infectious diseases, many of which would not be
fatal in well-nourished children.
Insufficient food intake results in many forms of macro- and
micronutrient undernutrition. Micronutrient deficiencies are
widespread in developing countries. The World Health
Organization (WHO) has recognized that such nutrient defi-
ciencies have a catastrophic effect on the health and quality of
life of at least 2 billion people. Deficiencies in micronutrients
such as iron, vitamin A, iodine, zinc, and folic acid affect large
numbers of people, especially children, resulting in significant
morbidity and mortality. In many situations, deficiencies in
energy and multiple nutrients occur, and these are thought to
exert synergistically negative effects. One example is protein-
energy malnutrition (PEM), a macronutrient deficiency that is
often associated with micronutrient deficiencies. For this reason,
most nutritional scientists believe that the long-term solution to
under- and malnutrition will be achieved only when all people
have access to a balanced, varied, and plentiful diet that meets
the known nutritional requirements.
There is no single solution to the complex problem of under-
nutrition and malnutrition. One approach, undertaken by plant
scientists, has been to improve the macro- and micronutrient
content of staple crops consumed in developing countries. In
addition to using the natural variation present in crop
germplasm, modern biotechnology tools are also being used to
develop these more nutritious crops. Crops that have been nutri-
tionally enhanced through either modern biotechnology or con-
ventional plant breeding can be thought of as being biofortified.
They have inherent fortification in which the level of a nutrient
in the crop is enhanced above that normally present. The new
varieties developed through modern biotechnology have been
described with various terms, including genetically modified
(GM or GMO), genetically engineered (GE or GEO), transgenic,
biotech, bioengineered, recombinant, and plants with novel
traits (PNT). For the present discussion, the term “GM” will be
used because of its simplicity and broad recognition.
Research Developments since Publication of the ILSI
Document “Safety and Nutritional Assessment of
Nutritionally Improved Foods and Feeds”
In 2002, a task force of international scientific experts, con-
vened by the ILSI Intl. Food Biotechnology Committee (IFBiC),
addressed the topic of the safety and nutritional assessments of
foods and feeds that are nutritionally improved through modern
biotechnology. In 2004, the task force’s work culminated in the
publication of a report that included a series of recommenda-
tions for the nutritional and safety assessments of such foods and
feeds. This document has gained global recognition from organ-
izations such as the European Food Safety Agency and has been
cited by Japan and Australia in 2005 in their comments to Codex
Alimentarius. The substantial equivalence paradigm, called the
comparative safety assessment process in the 2004 ILSI publica-
tion, is a basic principle in the document. This paradigm is one
of the topics discussed within the present publication to demon-
strate how it can be implemented in the safety assessment
process of specific nutritionally improved crops. The comparative
safety assessment process is the starting point, not the conclu-
sion, of the analysis. Significant differences in composition are
expected to be observed in the case of nutritionally enhanced
crops. These differences are intended and should not be consid-
ered negative findings because altered composition was the
objective of the development process. Instead, the nutritional
and safety implications of any potentially significant differences
must be assessed on a case-by-case basis.
Executive Summary
ILSI: Assessments of foods and feeds . . .
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Since the publication of the 2004 ILSI report, research has
progressed on several topics central to the type of data needed
to complete a scientifically sound comparative safety assess-
ment of a nutritionally improved food or feed crop. Those topics
are presented in the specific case studies in this publication.
However, the purpose of reviewing these developments is to
present new information that might impact the appropriate form
or amount of data for a scientifically sound comparative safety
assessment process, while clearly reinforcing the underlying
principle of the comparative assessment process that is consis-
tent with the 2004 publication.
One topic that has benefited from new insights is the analysis
of genetic changes in GM crops compared to the genetic
changes that occurred historically during plant evolution, crop
domestication, and the many forms of “conventional breeding.”
It is relevant to the discussion of the present case studies of nutri-
tionally improved crops because 1 crop was developed through
conventional breeding practices, while the other 4 were devel-
oped using modern biotechnology. Conventional breeding also
provides a baseline that is required for the comparative
approach. Conventional crops (that is, crops produced as a con-
sequence of traditional breeding, natural selection) might be
casually described as “natural” or characterized as unchanged
over time, while GM crops are typically described as products of
human intervention. However, human intervention has been as
critical to agronomically viable, nutritious, safe, and palatable
food and feed crops developed through conventional crop
domestication and breeding practices as it has been for GM
crops. The goal of domestication is to produce crops with unifor-
mity and desirable agronomic traits, and not necessarily to have
plants with increased fitness. In fact, recent evidence on the
nature of the changes that occur during conventional plant
breeding challenges this perception. The nature of the genetic
changes to a plant species brought about by domestication and
breeding can be larger in scale and less well defined than the
genetic changes to a species that arise from the application of
modern biotechnology. For example, it has been stated that “the
occurrence of unintended effects is not unique to the application
of recDNA techniques, but also occurs frequently in convention-
al breeding” (Kuiper and others 2001) and that “in fact, conven-
tional breeding programs generally evaluate populations with
much wider ranges of phenotypic variation than is observed in
transgenic programs“ (Bradford and others 2005b). The plants
used as major food crops today that were produced by conven-
tional breeding have changed more quickly (for example, over
the past few hundred years) than would have been possible
through “natural” evolution without human intervention.
Furthermore, the changes are commonly in the opposite direc-
tion of Darwinian “survival of the fittest.” Natural selection cre-
ates resilient biological systems with properties that adapt to a
variety of environmental conditions and ensures continuation of
the species. Unlike natural selection, conventional plant breed-
ing and domestication of many crops often create gene combina-
tions that would not survive without ongoing human interven-
tion.
In addition, it has become clear that major domesticated
crops have a wide genetic diversity that reflects the various glob-
al environments in which they are grown, and that such diversi-
ty is possible because breeding often takes advantage of the
hypermutable, genetically fluid characteristics of plant
genomes. Extensive variation in DNA content (both amount and
makeup) is normal within a species so that members of the same
species may possess a slightly different complement of genes or
display heterogeneity within specific genes. DNA rearrange-
ments and mutations are common, natural phenomena, and can
result in the loss of some proteins, the modification of others,
and the creation of novel proteins. Scientific experts sponsored
by organizations such as the Food and Agriculture Organization
of the United Nations (FAO), the European Commission (EC),
and the U.S. Natl. Academy of Sciences (NAS) have frequently
studied variations due to breeding and modern biotechnology
application. In each case, they concluded that modern biotech-
nology is no more likely to produce unintended effects than
conventional breeding is. Indeed, many expert reviews conclud-
ed that the more defined nature of the changes introduced into
crops via modern biotechnology may actually be safer than
changes produced by conventional plant breeding.
For example, it has been demonstrated that insertion of an
entire high-flux pathway into GM Arabidopsis plants was
achievable without pleiotropic side effects when assessed by
combined analyses of the morphological phenotypes or through
metabolic and transcript profiling (Kristensen and others 2005).
Similarly, extensive analytical comparison of conventional
wheat to GM wheat expressing a high molecular weight subunit
of the HMW subunit of gluten proteins showed that the expres-
sion of the transgene in the GM lines was as that of the corre-
sponding endogenous genes, the GM and control lines showed
similar stability in agronomic performance and grain functional
properties when grown at multiple sites and years, the gene
expression profiles in developing grains of GM and control lines
are much more similar to those of the parental lines than are the
profiles of lines produced by conventional plant breeding, and
the metabolite profiles of control and GM lines usually fell with-
in the range of variation that is observed between genotypes of
the species or samples of the same genotype grown under vary-
ing environmental conditions (Shewry and others 2007).
The data currently used for the safety assessment of GM crops
have focused on the potential perceived risks associated with
modern biotechnology. There are now worldwide data from
more than 10 y of commercial use of GM crops and over 
2 decades of research experience, and no verified adverse con-
sequences have been reported (James 1996). These results
allayed the concerns of many and resulted in greater acceptance
of GM foods. Indeed, some scientists have begun to question the
painstaking premarket safety assessment of GM crops as prac-
ticed in some countries, and recommend that the extent and
type of data that are part of a current safety assessment be updat-
ed to reflect this extensive safe experience with GM crops, cou-
pled with new information about plant genome plasticity. They
suggest that refinements to the process could include incorpo-
rating factors such as “familiarity” (for example, for commonly
used proteins such as CP4 EPSPS, Cry1Ab, and PAT) and the
gene source (for example, when the gene is from the same crop
species or is one with a history of safe use) into the overall safe-
ty assessment, influencing the extent to which event-specific
data are needed.
Recent reports have demonstrated that GM crops are often
more closely related to the isogenic parental strain used in their
CRFSFS: Comprehensive Reviews in Food Science and Food Safety
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development than to other members of the same genus and
species. For example, metabolomic studies in Solanum tubero-
sum have shown that conventional plant breeding produces
both intended and unintended effects and that insertion of trans-
genes can occur with little apparent effect on composition, even
when the GM variety produces significant quantities of a new
metabolite (for example, inulin) (Catchpole and others 2005).
Indeed, when the metabolites (DP2-3 fructans) that accumulate
because of the presence of the introduced gene and its
expressed product were removed from the analysis parameters,
multivariate statistical analysis showed no significant variation
in the metabolic phenotype, including harmful glycoalkaloids,
between the GM crop and the progenitor lines; whereas con-
ventionally bred cultivars showed clearly separated metabolic
phenotypes. Similar results have been observed at the level of
the proteome (for example, the set of proteins expressed by an
organism’s genome) for other plant species.
In the 2004 ILSI report, it was suggested that it is unwise to set
a fixed numeric limit to the variation permitted for a metabolite
as a trigger for further safety assessment. It was instead recom-
mended that limits should depend on the specific metabolite, its
role in safety and nutrition, and the dietary pattern of consump-
tion in the target population, thus making an arbitrary limit
across all composition analytes of little value. Nonetheless,
there continues to be misunderstanding about the comparative
safety assessment process. Substantial equivalence is not a con-
clusion to be reached, but rather the starting point for compar-
ing a novel product to something with a history of safe use, in
which the identified differences are subjected to additional
assessment. Attempting to demonstrate the absence of any sta-
tistically significant differences between the new crop and its
conventional counterpart will clearly be futile for crops whose
compositions have been deliberately altered. For the major
commodity crops (for example, maize, soy), the content of nutri-
ents, antinutrients, and toxicants is well known and has a long
history. This enabled the Organisation for Economic Co-opera-
tion and Development (OECD) to establish a well-defined list of
constituents that should be assessed for several of these major
crops, even if some of these constituents are not nutritionally or
toxicologically important. Major crops are frequently, but not
always, chosen as the target for nutritional enhancement, and
these OECD composition guidelines are appropriate for
improved nutrition varieties of these major crops. It is important
to regard nutritional changes in the context of that food’s con-
sumption by various groups in the population and its contribu-
tion relative to specific nutrients—obviously few foods are good
sources of all, or even many, nutrients. Similarly, targeted analy-
sis of the well-understood antinutrients and natural toxicants in
the major crops humans and animals consume will reveal
whether unacceptable changes have occurred that would war-
rant safety concerns.
Several case studies in this document involve introduction of
a protein not currently present in the crop. Therefore, it is impor-
tant to note that another ILSI IFBiC task force is developing the
scientific basis and recommendation for a framework for the
safety assessment of proteins. The report from this Protein Safety
Task Force, which is expected to be published in 2008, 
will describe the characteristics of proteins and how such char-
acteristics should drive the safety assessment. It will include 
recommendations for a tiered, weight-of-evidence approach to
the safety assessment of proteins.
Within the 2004 ILSI publication, comprehensive, untargeted
compositional analysis techniques, such as metabolomics, pro-
teomics, and transcriptomics, were suggested as potentially use-
ful tools to screen for unintended changes in food and feed
crops. Efforts continue in these areas to standardize the report-
ing structure of such “–omics” data and to recommend current
best practices. These are important steps to harmonize work-
flows and to enable queries of the metabolomes, proteomes, or
transcriptomes of novel foods against databases in order to find
meaningful unintended and unexpected events. However, to
date, public repositories on baseline metabolomes, proteomes,
and transcriptomes of crops (such as is available for composition
data at www.cropcomposition.org) are just becoming available,
and it will require substantial time and financial commitment to
establish and maintain databases that are standardized, validat-
ed, and monitored. It is recommended that data from analyses
of samples from different environmental conditions be repre-
sented within crop profiling databases to enable baseline assess-
ments to which profiles of metabolites and proteins in novel
foods may be compared, if deemed necessary.
At the time of the 2004 ILSI publication, many studies were in
progress to determine if DNA or protein from GM crops could
be detected in products from animals fed these products. Two
recent reports reviewed publications of studies conducted in a
range of livestock species (Flachowsky and others 2005; Phipps
and others 2006). Fragments of DNA from multicopy endoge-
nous genes were found at trace levels in specific tissues in some
of the studies in this review, although these fragments were typ-
ically very small, and certainly too small to encode a function-
al gene. No fragments of transgenic DNA that could retain any
biological activity were detected in any animal-derived prod-
ucts. These reviews of published reports, plus other publica-
tions, demonstrate that to date there is still no scientific evi-
dence to suggest that milk, meat, and eggs derived from animals
consuming GM crops are anything other than as safe as those
derived from animals fed conventional crops.
Application of Risk Analysis 
to Improved Nutrition Crops
In the Codex Alimentarius model, risk analysis is composed of
3 elements (that is, risk assessment, risk management, and risk
communication). During risk analysis, the risks are to be
weighed against other issues, such as the benefits, with the aim
to ensure the highest appropriate level of public health protec-
tion and to strive for risk management transparency and contin-
uous communication between assessors and managers during
the process. Implementation should be examined and reviewed
for its effectiveness in protecting public health. The case studies
of nutritionally improved crops in this document focus on rec-
ommended scientific assessments of possible risks associated
with the new nutritionally improved food or feed. However, sci-
ence-based premarket assessments, as currently performed, typ-
ically do not balance the assessment of potential risks with the
intended benefits that accrue from use. For nutritionally
enhanced crops, it is particularly important to balance the
intended nutritional benefits (for example, improved health,
ILSI: Assessments of foods and feeds . . .
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decreased incidence of disease, suffering, and/or death) against
the outcome of the risk characterization. The perceived hazards
often represent relatively small risks, whereas the potential nutri-
tional benefits are relatively large. For example, it has been 
estimated that the development of iron- and zinc-dense varieties
of rice and wheat for India and Bangladesh could prevent 44
million cases of anemia over 10 y (Bouis 2002).
Some scientists have begun to ask if the premarket safety
assessment used in many countries is attempting to achieve a
standard of absolute safety by continually adding data require-
ments as newer analytical methods come available (Bradford
and others 2005a, 2005b). These scientists suggest that, from a
scientific perspective, the cumulative experience over a few
decades of assessing GM crop safety should allow us to deter-
mine which tests need to be applied to new GM varieties to
determine if they are as safe as their traditional counterparts
with a history of safe consumption. This process is relatively sim-
ple for some crop species, while others may require more exten-
sive analysis—yet today, we subject all crop species to the same
assessment process, regardless of potential risk. The fundamen-
tal concept of the comparative risk assessment process is that it
enables a reasonable certainty that a new GM variety of a crop
is as safe as the conventional varieties currently being safely
consumed by humans and animals.
Case Studies
This publication applies the recommended principles for safe-
ty and nutritional assessments of nutritionally enhanced crops
set forth in the 2004 ILSI publication to 5 examples of nutrition-
ally enhanced foods and feeds. The case studies are used to
illustrate how the 2004 recommendations provide a strong and
robust paradigm for safety assessment for “real world” examples
of improved nutrition crops. These case studies are at different
stages of development; therefore they have differing levels of
available data. Nevertheless, the recommendations can be
drawn equally from the 2004 ILSI publication. Four of the 5 case
studies represent crops in which the nutritional improvement
was achieved through application of modern biotechnology
(that is, recombinant DNA techniques), and 1 case study
reviews a crop improved through conventional breeding. One
case study examines a crop primarily used for animal feed,
while the other four are examples of crops modified to improve
human nutrition.
Food
The 4 food case studies illustrate the variety of improved nutri-
tion crops that are currently being developed to address the
dietary insufficiency for particular nutrients in specific locales.
Nearly 70% of the world’s population relies on cereal grains
as a dietary staple (FAOSTAT 2004). Rice is recognized as the
most important cereal for human nutrition, providing over 30%
of the energy intake of the population of Asia. Maize ranks third,
after rice and wheat, as one of the world’s 3 leading food crops.
Although maize grain is primarily used for livestock feed in
developed countries, maize is a dietary staple in Latin America
and Africa. Other crops, such as sweetpotato, are also important
secondary staple foods for large numbers of people in Eastern
and Southern Africa, especially for subsistence farmers.
Sweetpotato is also an important component of animal feed in
China. Most crops, and hence the food derived from those
crops, are deficient in one or more essential nutrients, and the
diets of many in developing countries that rely on these crops
lack dietary diversity. A lack of dietary diversity directly increas-
es the risk of nutrient deficiencies.
The 1st case study of nutritionally improved food crops targets
increasing maize’s nutritional characteristics for human con-
sumption and livestock feeding systems by increasing the level
and quality of key nutrients such as protein and oil; this has
been a long-term goal of conventional plant breeding. This case
study describes "Double-Embryo Maize," a variety being devel-
oped through modern biotechnology in which the grain con-
tains 2 embryos, resulting in maize grain with higher protein
and oil contents.
The next 2 case studies describe and compare 2 different
nutritional improvements of "Sweetpotato." Sweetpotato tuber-
ous roots vary in color (white-, yellow-, orange-, red-, or purple-
fleshed), with orange-fleshed types being particularly rich in -
carotene. The 2nd case study involves conventional breeding
and selection of orange-fleshed sweetpotato as a crop bioforti-
fied with -carotene to control vitamin A deficiency (VAD). The
3rd case study is based on the recognition that both the protein
content and quality of sweetpotato are relatively low, such that
improved protein content and quality through biotechnology
could benefit animal feed and high sweetpotato-consuming
populations at risk for protein-energy malnutrition (PEM).
The 4th case study is "Golden Rice 2," in which the concen-
tration of the most important provitamin A carotenoid, -
carotene, was increased through modern biotechnology to
address VAD. It is estimated that 70 g (1/3 cup) of Golden Rice
2 may provide 2/3 of the daily recommended intake of vitamin
A for a preschool child, therefore holding great promise to
reduce VAD in developing counties.
Feed
Many nutritional limitations to livestock production are pres-
ent in both developed and developing countries. For nonrumi-
nant livestock production systems, maize grain is often the pre-
ferred energy source; however, it is low in the essential amino
acid lysine. Consequently, diets based on maize must be supple-
mented with lysine, either from crystalline lysine or from high-
protein ingredients (for example, soybean meal, fish meal). The
last case study discusses "Lysine maize," a crop in which the
lysine content of maize has been increased through biotechnol-
ogy, making it possible to simplify diet preparation by reducing
or even eliminating the addition of crystalline lysine or high-
protein supplements to some nonruminant diets.
Conclusions
The crops being developed to improve human or animal
nutrition hold great promise in helping to address global nutri-
tion needs. The present examination of 5 case studies (4 of
which are GM crops) has reinforced the conclusion that the
existing comprehensive safety and nutritional assessment
processes used to assess the safety of GM foods and feeds
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already introduced into the marketplace are appropriate to
ensure the safety and nutritional value of nutritionally improved
crops. Additional studies may be needed, on a case-by-case
basis, to assess potential safety or nutritional consequences
resulting from changed levels of the improved nutritional fac-
tor(s). For both conventional and GM crops, the precommercial
breeding and development process (for example, selecting a sin-
gle commercial variety from large numbers of crosses between
conventional lines or from hundreds to thousands of initial
transformation events for GM crops) eliminates the vast majori-
ty of conventionally bred varieties and GM events that contain
unintended changes, winnowing down to a single commercial-
ized variety or GM event. In addition, the selected commercial
product candidate typically undergoes detailed phenotypic,
agronomic, morphological, and compositional analyses to fur-
ther screen for unintended effects that would limit commercial
acceptance or product safety.
Recommendations
The current comparative safety assessment process provides
assurance of safety and nutritional quality by identifying similar-
ities and differences between the new food or feed crop and a
conventional counterpart with a history of safe use. The similar-
ities noted through this process are not subject to further assess-
ment. The identified differences then become the focus of addi-
tional scientific assessment. A number of recommendations
resulting from the safety and nutritional assessment of the 5 case
studies presented in this document are consistent across all case
studies. These consistently noted recommendations are listed
below and confirm that the principles set forth in this task force’s
2004 ILSI publication are sound.
Recommendation 1. The safety assessment of a nutritionally
improved food or feed begins with a comparative assessment of
the new food or feed crop with an appropriate comparator crop
that has a history of safe use (the definition history of safe use is
explored in a recent publication of the ILSI Europe Novel Foods
Task Force).
Recommendation 2. To evaluate the safety and nutritional
impact of nutritionally improved food and feed crops, it is nec-
essary to develop data on a case-by-case basis in the context of
the proposed use of the product in the diet and consequent
dietary exposure.
Recommendation 3. The safety of any novel protein(s) intro-
duced into a crop needs to be assessed. It is noted that another
ILSI IFBiC publication recommends a tiered, weight-of-evidence
approach for the safety assessment of transgenic proteins.
Recommendation 4. Compositional analysis of crops with
known toxicants and antinutrient compounds should include
analysis of those specific analytes. If warranted, an evaluation of
the targeted metabolic pathway should also be conducted to
identify specific metabolites for inclusion in the compositional
analysis due to safety and/or nutritional considerations.
Recommendation 5. The appropriate phenotypic properties of
the nutritionally improved crop need to be assessed when grown
in representative production locations as part of the overall 
comparative safety assessment process. Further study is warranted
if significant unintended and unexplainable differences between
the improved crop and an appropriate comparator are identified.
Recommendation 6. Studies with laboratory animals can con-
firm observations from other components of the safety assess-
ment, thereby providing a sense of added safety assurance,
although they may lack the sensitivity to reveal unintended
minor changes.
Recommendation 7. While feeding studies with target live-
stock species are not part of the safety assessment, they are
important to demonstrate the expected nutritional benefit of
nutritionally enhanced feed crops.
Recommendation 8. Premarket studies in humans might be
appropriate on a case-by-case basis to assess the nutritional
effectiveness of the improved nutrition crop in those cases where
alteration by conventional breeding would trigger similar studies.
Recommendation 9. Premarket assessment regarding the
impact of the introduction of an improved nutrition crop on the
nutrient intake of consumers may often be appropriate (for
example, when changes in agricultural practices or changes in
consumer-led dietary intakes are anticipated).
Recommendation 10. The scientific assessment of the possi-
ble consequences of the adoption of improved nutrition crops
should balance not only assessing the potential risks, but also
considering the opportunity for benefits to alleviate undernutri-
tion for a potentially large number of people. In this regard, it
may be useful to think of benefits as the removal of the risk of
harm caused by nutritional deficiencies. This will provide the
relevant data required for a meaningful risk-benefit analysis.
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1.1 Background
During the last decade, the planted area of GM crops modi-
fied for agronomic input traits such as herbicide tolerance (Ht)
and insect resistance (Bt is the most common example) has
increased from 2 to 102 million ha, and these crops are now
grown by over 10 million farmers in a total of 22 developed and
developing countries (Brookes and Barfoot 2006; James 2006).
Although further expansion in the planted area of these crops is
expected, there is increasing interest in the next generation of
GM crops, which are those modified for improved nutritional
characteristics of feed and food. Table 1–1 illustrates the breadth
of international research efforts by both public and private sec-
tors toward improving the nutritional characteristics of a wide
range of crops. The reasons for this are easy to understand. In
spite of noteworthy progress during the last 2 decades, signifi-
cant numbers of people still suffer from the effects of mal- and
undernutrition. Also, feed quality is often a limiting factor in
livestock production systems, particularly those in developing
countries.
1.2 Global Undernutrition
The United Nations (UN) charter declared that freedom from
hunger is a fundamental human right, and a diet that is deficient
in essential nutrients is a pervasive form of hunger. To address
persistent and widespread undernutrition punctuated by episo-
dic famines, the First World Food Conference was held in Rome
in 1974 with the hope of developing a strategy to eliminate
hunger. UN Millennium Project recognized that the number of
undernourished people in the world had fallen from approxi-
mately 1.5 billion in the early 1970s to around 850 million by
the 1990s. With Goal 1, titled “Eradicate Extreme Poverty and
Hunger,” the Millennium Project set a target to “halve, between
1990 and 2015, the proportion of people who suffer from
hunger.” However, it is sobering that even the achievement of
this goal will still leave the world with over 400 million under-
nourished humans.
More than 200 million of the world’s hungry are children, and
at least 5 million die each year from undernutrition. Nutritional
deficiencies take a sizeable toll on physical and mental devel-
opment, which has implications for educational achievement,
work performance, and, consequently, economic prospects.
Inadequate nutrition also contributes to death from a wide vari-
ety of infectious conditions such as diarrhea and respiratory tract
infections, many of which would not be fatal in well-nourished
children (UN Millennium Project 2005).
Insufficient daily food intake can result in protein-energy mal-
nutrition (PEM, see Appendix 2), which may also be associated
with micronutrient deficiencies and disease. Iron deficiency
alone affects some 2 billion people, and vitamin A deficiency
affects at least 100 million children each year, of whom 1.3 to
2.5 million will die and over 250,000 others will suffer 
permanent damage such as blindness. Nearly 30% of the world’s
population is at risk of iodine deficiency. Approximately 800 mil-
lion people consume iodine-deficient diets, of which 50 million
people suffer from iodine deficiency-mediated brain damage.
Folic acid deficiency is associated with neural tube defects such
as spina bifida, and 250,000 babies with such defects are born
each year. Zinc deficiency often accompanies poverty and inad-
equate diet. Although not as well quantified, the number affect-
ed is estimated to be in the same order of magnitude as those
with iron deficiency, as the causes are similar. Zinc deficiency
clearly diminishes appetite and adversely affects the immune
response, both of which affect growth and development. Anemia
has also been associated with zinc deficiency. In many situations,
multiple deficiencies occur and these are thought to exert syner-
gistically deleterious nutritional effects. For this reason, most
nutritional scientists believe that the long-term solution to mal-
and undernutrition will be achieved only when all people have
access to a balanced, varied, and plentiful diet that meets or
exceeds all known human nutritional requirements.
The causes of mal- and undernutrition are complex. If
attained, the UN Millennium Project goals (focused on econom-
ic development, opportunity, education, and investment as
engines to lift people out of poverty) will undoubtedly do much
to alleviate undernutrition. Until those goals are achieved, food
aid and a variety of micronutrient fortification and pharmaceu-
tical supplementation programs seek to fill the gap in the world’s
need. Although these strategies may be appropriate for a large
number of the undernourished, approximately half of the
world’s poor are subsistence farmers or small producers who do
not buy food on a regular basis. Additionally, pharmaceutical
supplementation programs require a well-functioning health-
care system that does not always exist. Thus, fortification and
pharmaceutical supplementation programs have not proven
fully successful for these individuals, and improvements in crop
yield, distribution, and nutritional quality may be a beneficial
and appropriate solution in such instances.
In recent years, plant scientists have worked to improve the
macro- and micronutrient content of staple crops consumed in
developing countries. Besides using the natural variation present
in crop germplasm, modern biotechnology tools are also used to
construct these more nutritious crops. Crops that have been
nutritionally enhanced through either modern biotechnology or
conventional plant breeding can be thought of as being biofor-
tified (inherent fortification in which the concentration of nutri-
ent in the crop is enhanced above that normally present).
1.3 Earlier Work
In 2002, the International Intl. Food Biotechnology Committee
(IFBiC) of the International Intl. Life Sciences Institute Inst. (ILSI)
convened a task force of international scientific experts to
address the topic of safety and nutritional 
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Trait Crop (trait detail) Reference
Protein and amino acids
Protein quality and level Bahiagrass (protein↑) Luciani and others (2005)
Canola (amino acid composition) Roesler and others (1997)
Maize (amino acid composition; protein↑) 
Cromwell and others (1967, 1969), Yang 
and others (2002), O’Quinn and others (2000),
Young and others (2004)
Potato (amino acid composition; protein↑)
Chakraborty and others (2000), Li and others
(2001), Yu and Ao (1997), Atanassov 
and others (2004)
Rice (protein↑; amino acid composition) Katsube and others (1999)
Soybean (amino acid balance) Rapp (2002), Dinkins and others (2001) 
Sweetpotato (protein↑) Prakash and others (2000)
Essential amino acids Canola (lysine↑) Falco and others (1995)
Lupin (methionine↑) White and others (2001)
Maize (lysine↑; methionine↑) Agbios (2006), Lai and Messing (2002)
Potato (methionine↑) Zeh and others (2001)
Sorghum (lysine↑) Zhao and others (2003)
Soybean (lysine↑; tryptophan↑) Falco and others (1995), Galili 
and others (2002)
Oils and fatty acids
Canola (lauric acid↑; -linolenic acid↑; + -3
fatty acids; 8:0 and 10:0 fatty acids↑; lauric +
myristic acid↑; oleic acid↑)
Del Vecchio (1996), James and others (2003),
Dehesh and others (1996), Agbios (2006),
Roesler and others (1997)
Cotton (oleic acid↑; oleic acid + stearic acid↑) Chapman and others (2001), Liu 
and others (2002)
Linseed (+ -3 and- 6 fatty acids) Abbadi and others (2004)
Maize (oil↑) Young and others (2004)
Oil palm (oleic acid↑ or stearic acid↑; 
oleic acid↑ + palmitic acid↓) Parveez (2003), Jalani and others (1997)
Rapeseed (oil and fatty acyl composition) Zou and others (1997)
Rice (-linolenic acid↑) Anai and others (2003)
Soybean (oleic acid↑; -linolenic acid↑) Kinney and Knowlton (1998), Reddy and Thomas (1996)
Carbohydrates
Fructans Chicory (fructan↑; fructan modification) Smeekens (1997), Sprenger and others (1997)
Maize (fructan↑) Caimi and others (1996)
Potato (fructan↑) Hellwege and others (1997)
Sugar beet (fructan↑) Smeekens (1997)
Inulin Potato (inulin↑) Hellwege and others (2000)
Starch Rice Chiang and others (2005)
Micronutrients 
and functional metabolites
Vitamins and carotenoids Canola (vitamin E↑) Shintani and DellaPenna (1998)
Table 1-1— Examples of crops in research and/or development with nutritionally improved traits intended to provide
health benefits to consumers and animals.a
assessments of foods and feeds that are nutritionally improved
through modern biotechnology. The resultant publication (ILSI
2004a, 2004b) reported on the principles and concepts proposed
for use in this process and produced a series of recommendations
for the nutritional and safety assessments of nutritionally
improved foods and feeds developed through biotechnology.
Other publications have examined the potential costs, benefits,
and risks of biotechnology application to agriculture in the devel-
oping world, where the majority of agricultural insufficiency and
undernutrition occur (Hepple and others 2004).
1.4 Present Study
This publication applies the guidelines and principles rec-
ommended for the safety and nutritional assessments of nutri-
tionally enhanced crops in the 2004 ILSI publication to 5
examples of nutritionally enhanced feeds or foods. The case
studies are used to illustrate how the 2004 guidelines provide
a strong and robust paradigm for safety assessment of “real
world” examples of improved nutrition crops. These case stud-
ies are at different stages of development, and therefore they
have differing levels of available data; however, recommendations
ILSI: Assessments of foods and feeds . . .
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Trait Crop (trait detail) Reference
Maize (vitamin E↑; vitamin C↑) Rocheford and others (2002), Cahoon 
and others (2003), Chen and others (2003)
Mustard (+-carotene) Shewmaker and others (1999)
Potato (-carotene and lutein↑) Ducreux and others (2005)
Rice (+ -carotene) Ye and others (2000)
Strawberry (vitamin C↑) Agius and others (2003)
Tomato (folate↑; phytoene and -carotene↑;
lycopene≠; provitamin A↑)
Díaz de la Garza and others (2004), 
Enfissi and others (2005), Mehta and others
(2002), Fraser and others (2001), Rosati 
and others (2000)
Functional secondary metabolites Apple (+stilbenes) Szankowski and others (2003)
Alfalfa (+resveratrol) Hipskind and Paiva (2000)
Canola (indole glucosinolate↓) Chavadej and others (1994)
Cassava (cyanogen↓) Siritunga and Sayre (2003)
Coffee (caffeine↓) Moisyadi and others (1998), Kato 
and others (2000), Ogita and others (2003)
Kiwi (+resveratrol) Kobayashi and others (2000)
Maize (flavonoids↑) Yu and others (2000)
Potato (steroidal glycoalkaloids↓, anthocyanin
and alkaloid glycoside↓; solanin↓)
McCue and others (2003), Lukaszewicz 
and others (2004)
Rice (flavonoids↑; +resveratrol) Shin and others (2006), Stark-Lorenzen 
and others (1997)
Soybean (flavonoids↑) Yu and others (2003)
Tea (caffeine↓) Kato and others (2000)
Tomato (+resveratrol; chlorogenic acid↑;
flavonoids↑; stilbene↑)
Giovinazzo and others (2005), Niggeweg 
and others (2004), Muir and others (2001),
Rosati and others (2000)
Wheat (caffeic and ferulic acids↑; +resveratrol) UPI (2002)
Mineral availabilities Alfalfa (phytase↑) Austin-Phillips and others (1999)
Lettuce (iron↑) Goto and others (2000)
Rice (iron↑) Lucca and others (2002)
Soybean (phytase↑) Denbow and others (1998)
Wheat (phytase↑) Brinch-Pedersen and others (2000)
aThis table excludes protein functionality, starch functionality, fruit ripening/shelf life, taste/aesthetics, and fiber quality traits. It also excludes
food quality benefits that are not directly linked to nutrition, such as reduced allergenicity and reduced mycotoxins.
Table 1-1 continued.
for each case study can be drawn equally from the 2004 ILSI
publication.
1.5 Case Studies Included in This Report
1.5.1 Food
The 4 food case studies illustrate the variety of improved nutri-
tion crops that are currently being developed to address the
dietary insufficiency for specific nutrients in specific locales,
and demonstrate applying the safety assessment principles for
nutritionally enhanced foods and feeds outlined in the 2004 ILSI
publication.
Cereal grains represent a staple in the diet for nearly 70% of
the world population. Rice is recognized as the most important
cereal for human nutrition, providing over 30% of the energy
intake of the population of Asia. Maize ranks third, after wheat
and rice, as one of the world’s 3 leading food crops. Although
maize grain is primarily used for livestock feed in developed
countries, it is a dietary staple in Latin America and Africa.
Crops more limited in planted area, such as sweetpotato, are
also important secondary staple foods for large numbers of peo-
ple in Eastern and Southern Africa. Sweetpotato is also an
important component of animal feed in China. Most crops, and
hence the food derived from those crops, are deficient in one or
more essential nutrients. Consequently, a lack of dietary diversi-
ty increases the risk of nutrient deficiencies.
Case study 1: Double-embryo maize grain with in-
creased protein and oil content (biotechnology). A long-
term goal of conventional plant breeding has been to increase
the nutritional characteristics of maize for human consumption
and livestock feeding systems by increasing the level and the
quality of key nutrients such as protein and oil. The 1st improved
nutrition food crop case study describes "Double-Embryo
Maize," a variety developed through modern biotechnology in
which the grain contains 2 embryos, resulting in maize grain of
greatly increased protein and oil contents. This type of maize is
still in the relatively early stages of development.
Case studies 2 and 3: Sweetpotato with increased pro-
tein content (biotechnology) and sweetpotato with
enhanced -carotene content (conventional breeding).
The next 2 case studies describe and compare 2 different nutri-
tional improvements of "Sweetpotato." Sweetpotato tuberous
roots vary in color (white-, yellow-, orange-, red-, or purple-
fleshed), with orange-fleshed types being particularly rich in -
carotene. The 2nd case study involves conventional breeding
and selection of orange-fleshed sweetpotato as a crop bioforti-
fied with -carotene to control vitamin A deficiency (VAD). The
3rd case study is based on the recognition that both the protein
content and quality of sweetpotato are relatively low. This case
study, therefore, describes using modern biotechnology to
increase both the protein content and quality by improving the
amino acid profile of the crop to address both PEM and poor
quality animal feed.
Case study 4: Rice enriched with -carotene (biotech-
nology). Micronutrient deficiencies are widespread in develop-
ing countries, and the World Health Organization (WHO) has
recognized that such nutrient deficiencies have a catastrophic
effect on the health and quality of life of at least 2 billion 
people. VAD is a global public health challenge, especially
where rice is the staple food. It affects about 100 million chil-
dren; more than 250,000 are severely deficient and become
blind each year, and approximately 125,000 of these die within
a year (West 2002; WHO 2003). Historically, the emphasis has
been on increasing the intake of green leafy vegetables and yel-
low-orange fruits and vegetables to increase vitamin A intake
and on pharmaceutical supplementation with vitamin A, but
these strategies have been difficult to implement on a large
scale. The need to address VAD is clear and unequivocal. The
4th case study of nutritionally improved food crops is "Golden
Rice 2" in which -carotene, the most important provitamin A
carotenoid, was increased using modern biotechnology. It is
estimated that 70 g (approximately 1 serving of 1/3 cup rice) of
the Golden Rice 2 will provide approximately 2/3 of the daily
recommended intake of vitamin A for a preschool child, there-
fore holding great promise to reduce VAD in developing coun-
ties where this crop would be available.
1.5.2 Feed
Nutritional limitations to livestock production are numerous
and varied in both developed and developing countries. Animal
production is often restricted because feed resources are defi-
cient in one or more specific nutrients (for example, maize grain
is typically low in lysine content compared to other crops), have
limited nutrient bioavailability (for example, the use of crop
residues as the primary forage source in developing countries), or
are constrained by the presence of antinutritional factors or tox-
ins (for example, phytate and mycotoxins) (Table 1–1).
Case study 5: Increased lysine content in maize grain
(biotechnology). For example, in the case of nonruminant live-
stock production systems, maize grain is often the preferred
energy supplement. However, it is low in the essential amino
acid lysine and either a crystalline lysine supplement or a high-
protein supplement is required to ensure optimum animal per-
formance. The 5th case study discusses "Lysine maize," a crop in
which the lysine content has been increased through biotech-
nology, making it possible to reduce or even eliminate the addi-
tion of crystalline lysine supplements to some nonruminant
diets.
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2.1 Background
Following the publication of the 2004 ILSI report, research
has progressed on several topics central to the completion of a
scientifically sound comparative safety assessment of an
improved nutrition food or feed crop. Those topics merit review
as part of the presentation of the specific case studies in this
publication. The purpose for reviewing the topics is to present
new information that might affect the form or amount of data
appropriate to conduct a scientifically sound comparative safe-
ty assessment process, while reinforcing the underlying princi-
ple of the comparative assessment process, consistent with the
2004 publication.
2.2 New Insights into Plant Breeding 
and Unintended Effects
Some scientists have begun to question if the premarket 
safety assessment used in many countries is attempting to
achieve a standard of absolute safety by adding data require-
ments as newer analytical methods come available (Bradford
2005a, 2005b). Another example is Cellini and others (2004),
who concluded:
The safety assessment of GM crops should focus primarily
on the intended novel traits (target gene[s] and product[s]).
Unintended effects occur in both GM and non-GM crops;
however, GM crops are better characterised. It may be sug-
gested that the two should be treated the same in safety
assessments, bearing in mind that safety assessments are
not required for non-GM crops.
These scientists suggest that, from a scientific perspective, the
cumulative experience of the past 2 decades of assessing GM
crop safety should allow us to determine which tests need to be
applied to new GM varieties to determine if they are as safe as
their traditional counterparts with a history of safe consumption.
This process is relatively simple for some crop species, while
others may require more extensive analysis—yet today, we sub-
ject all crops species to the same assessment process, regardless
of risk. The fundamental concept of the comparative risk assess-
ment process is that it enables a reasonable certainty that a new
GM variety of a crop is as safe as the conventional varieties cur-
rently being safely consumed by humans and animals.
The safety assessment paradigm applied to GM crops attempts
to evaluate whether any unintended deleterious changes have
occurred (ILSI 2004). This requirement, given that conventional-
ly bred crops are not subjected to comparable premarket safety
assessments, may have contributed to the impression that GM
crops pose unique risks. Conventional crops are often described
as being “natural,” with little (if any) changes over millennia,
whereas GM crops are sometimes typically described as prod-
ucts of human intervention. Recent studies that challenge this
perception provided scientific data on the nature of the changes
that occur during plant evolution, crop domestication, and the
many forms of “conventional breeding.” Therefore, this is one
topic that has benefited from new insights and is relevant to this
publication of improved nutrition crop case studies.
Most domesticated crops have been developed during the last
5000 y, many within the last few hundred years (Gepts 2002).
The nature of the genetic changes to a plant species brought
about by domestication and breeding typically is much larger in
scale, and much less well-defined, than the genetic changes to
a species that arise from modern biotechnology applications.
For example, it has been stated that “in fact, conventional breed-
ing programs generally evaluate populations with much wider
ranges of phenotypic variation than is observed in transgenic
programs…” (Bradford and others 2005b). It is clear from these
and other studies (Baker and others 2006; Baudo and others
2006) that the plants used as major food crops have evolved
more quickly (for example, over the past few thousand years)
than would be possible solely through “natural” evolution, and
the changes are often in the opposite direction of Darwinian
“survival of the fittest” (Gepts 2002; FAO 2004). Unlike natural
selection, which creates resilient biological systems with prop-
erties that adapt to a variety of environmental conditions and
ensures continuation of the species, conventional plant breed-
ing and crop domestication have often created gene combina-
tions that would rarely survive without human intervention.
Major domesticated crops represent hundreds, or even thou-
sands, of unique varieties cultivated (that is, “cultivars”) by
humans, each adapted to specific geographic environments
used to produce food and feed around the world (Gepts 2002;
FAO 2004). This wide diversity in crop varieties is possible, in
part, because the plant breeding selection takes advantage of the
genetic fluidity of plant genomes, modern maize being an excel-
lent example (Parrott 2006). Extensive variation in DNA content
is normal within a species, especially for plants, in which DNA
rearrangements are common natural phenomena, and individu-
als within a plant species can have different numbers of genes
through natural selection processes (Cellini and others 2004;
Bradford and others 2005a, 2005b). These natural phenomena
often come about by random, sequence-independent insertions,
deletions, and/or transpositions of DNA, changes that are nei-
ther planned nor programmed. On some occasions, genes have
also been observed to be transferred between unrelated, sexual-
ly incompatible species—with the frequency being sufficient to
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say the phenomenon, though not common, is natural (Prins and
Zadoks 1994; Ashby and others 1997; Aoki and Syono 1999;
Hull and others 2002; Bergthorsson and others 2003, 2004).
Scientific experts sponsored by organizations such as the
Food and Agriculture Organization of the United Nations (FAO),
the European Commission (EC), and the U.S. Natl. Academy of
Sciences (NAS) have studied variations due to breeding and
application of modern biotechnology. In each case, their
research concluded that modern biotechnology is no more like-
ly than conventional breeding to produce unintended effects (EC
2001; FAO 2004; NRC 2004). It has been stated that “the occur-
rence of unintended effects is not unique for the application of
recDNA techniques, but also occurs frequently in conventional
breeding” (Kuiper and others 2001). Indeed, many expert
reviews concluded that the greater precision and more defined
nature of the changes introduced into crops via modern biotech-
nology may actually be safer than changes produced by conven-
tional plant breeding. For example, it has been demonstrated
that inserting an entire high-flux cyanogenic glucoside pathway
into GM Arabidopsis plants was achievable without pleiotropic
side effects when assessed by combined analyses of the mor-
phological phenotypes and through metabolic and transcript
profiling (Kristensen and others 2005).
Some scientists recommend updating the current safety
assessment paradigm to reflect nearly 2 decades of experience
with GM crops that, coupled with new knowledge about plant
genome plasticity, could lead to a more balanced and reason-
able safety assessment process (Cellini and others 2004;
Bradford and others 2005a, 2005b). Refinements to the process
could include incorporating factors such as “familiarity” (for
example, for commonly used proteins such as CP4 EPSPS,
Cry1Ab, and PAT) and the gene’s source (for example, when the
gene is from the same crop species, or a crop with a history of
safe use) into the overall safety assessment, influencing the
extent to which event-specific data are needed.
2.3 An Insight into Substantial Equivalence,
Composition, and Dietary Intake
The “substantial equivalence” paradigm, referred to as the
“comparative safety assessment process” in the 2004 ILSI publi-
cation, is a key principle in the document (ILSI 2004). However,
because of continuing misinterpretation of substantial equiva-
lence, further discussion of this principle is warranted and is a
key topic of the present publication.
The comparative safety assessment process is the starting
point, not the conclusion, of the analysis. The overall safety
assessment begins with the concept of a comparative approach
that identifies the similarities and differences between the GM
product and one or more appropriate comparators with a
known history of safe use—a model that is found in all interna-
tional crop biotechnology assessment guidelines. Consideration
is given to the history and safe use of the conventional line that
serves as the principal comparator. This ensures that identifying
similarities with the comparator provides a solid basis for con-
cluding that these aspects of the product are not likely to raise
concerns. Considering the safety of the parent crop and the gene
donor helps to eliminate the possibility of potentially undesirable
traits being introduced from those sources. Additionally, under-
standing the safety of the parent crop and gene donor facilitates
a directed search in the GM product to determine to what, if
any, extent the trait(s) may have been transferred.
If the comparison of the GM product to the comparator iden-
tifies differences that include the introduced trait, such differ-
ences are subjected to an evaluation of their potential toxic,
allergenic, or nutritional impact. Thoroughly evaluating the
identified differences from a safety perspective makes possible a
conclusion about the safety of food or feed derived from the GM
crop, as compared to its traditional counterpart with a history of
safe use/consumption. Using this approach, in total more than
100 GM crops have been approved worldwide, with the conclu-
sion reached in each case that foods and feeds derived from
these GM crops are as safe and nutritious as those derived from
their traditional counterpart crops. The lack of any demonstrable
adverse effects resulting from the production and consumption
of GM crops grown on more than 1 billion cumulative acres
over the last 10+ y supports these safety conclusions. In the case
of nutritionally enhanced crops, significant composition differ-
ences are intended; therefore they are to be expected.
Significant composition differences of nutritionally enhanced
crops should not be considered to be negative attributes since
many will be intentional and desirable improvements over the
conventional counterpart. Instead, the nutritional and safety
implications of the potentially significant observed differences
must be assessed on a case-by-case basis.
Recent reports have demonstrated that GM crops have a com-
position more similar to the isogenic parental strain used in their
development than that same strain is to other breeding cultivars
of the same genus and species. This effect has been observed at
the proteome level for Arabidopsis thaliana (Ruebelt and others
2006a, 2006b, 2006c), potato (Lehesranta and others 2005),
tomato (Corpillo and others 2004), and wheat (Shewry and oth-
ers 2007). In these studies, 2-dimensional (2-D) gel electro-
phoresis was used to compare the protein content of conven-
tional and GM varieties. In each case, GM plants were found to
be more similar to the parental isogenic variety from which they
were derived than the variety developed through conventional
breeding was to other conventional varieties of the same
species. Parallel results have been observed at the metabolomic
level for wheat (Baker and others 2006) and potato (Catchpole
and others 2005). Catchpole and coworkers concluded:
A major finding from the present study was the large varia-
tion in metabolite profile between the conventional culti-
vars…. In the context of substantial equivalence, we show
that the metabolite composition of field-grown inulin-pro-
ducing potatoes were within the natural metabolite range of
classical cultivars and were, in fact, very similar to the pro-
genitor line, Désirée, with the exception of the introduced
genes….
The results of this study highlight that conventional plant breed-
ing produces both intended and unintended effects. The study
also shows that inserting transgenes into a crop can occur with
little apparent effect on composition, even when the GM variety
produces significant quantities of a new metabolite (for exam-
ple, inulin in this potato example). Indeed, when the introduced
gene product (DP2-3 fructans) was removed from the analysis
parameters, multivariate statistical analysis showed no significant
variation in the metabolic phenotype, including harmful 
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glycoalkaloids, between the GM crop and the progenitor lines,
whereas other conventionally bred cultivars showed clearly sep-
arated metabolic phenotypes. Naturally, such conclusions can
only be reached on a case-by-case basis and cannot be general-
ized to conclude that all GM crops have the same metabolome
as their parent strain. This underscores the need for careful com-
positional analysis of key metabolites, nutrients, antinutrients,
natural toxicants, and other metabolites whose content one
might expect to be altered by the specific metabolic changes
introduced into the new product.
Very recently, a detailed analysis of conventional and GM
wheat lines was reported (Shewry and others 2007).
Transcriptomics was conducted on glasshouse-grown control
and GM wheat plants. In addition, grain samples from control
and GM wheat lines grown in replicated field trials over 4 y and
from 2 sites with contrasting climates were subjected to a range
of measurements, including dry weight, nitrogen content, pro-
tein composition by SDS-PAGE, dough mixing properties by
Mixograph, and metabolite profiles. These analyses were used to
draw conclusions about the relative stability of expression of the
endogenous and GM forms of the HMW subunit genes and their
impact on the grain composition and properties. The conclu-
sions were: (1) The expression of the transgenes in the lines stud-
ied is not intrinsically more or less stable than that of the corre-
sponding endogenous genes. (2) The GM and control lines show
similar stability in agronomic performance and grain functional
properties when grown at multiple sites and years. (3) The gene
expression profiles in developing grains of GM and control lines
are much more similar to those of the parental lines than are the
profiles of lines produced by conventional plant breeding. (4)
The metabolite profiles of control and GM lines usually fall
within the range of variation which is observed between geno-
types of the species or samples of the same genotype grown
under varying environmental conditions. These results clearly
demonstrate that it is possible to produce GM wheat lines that
are equivalent to conventional wheat at the level of analysis pro-
vided by modern ‘‘–omics’’ technologies, except for effects that
are directly attributable to the desired new GM trait.
Hothorn and Oberdoerfer (2006) described an elegant statis-
tical treatment to analyze each measured analyte, with the
authors concluding that further analysis should be undertaken
when any analyte of the GM crop is outside of a blanket thresh-
old of ± 20% range. This 20% threshold is also offered as a way
to establish substantial equivalence of a new product. For rea-
sons noted previously, substantial equivalence is not the end-
point of a safety assessment, but instead a process through
which differences are identified and subjected to additional
safety assessment. However, the concept of a blanket threshold
for all compositional analytes does not consider the crop’s rela-
tive importance for each component in terms of overall diet and
nutritional status for the population. As mentioned in the 2004
ILSI publication and elsewhere in this document, for any given
crop, it is most important to assess the nutrients for which that
crop is a significant dietary source. Therefore, the list of compo-
sitional analytes requiring close scrutiny must be determined on
a crop-by-crop basis, such as has been done by the Organisation
for Economic Co-Operation and Development (OECD) consensus
documents for major food crops. The proposal that all measured
components must fall within the ± 20% range is, therefore, not
only unnecessary, but is scientifically inappropriate since it is
not nutritionally justifiable.
Moreover, if one applies the same standards Hothorne and
Oberdoerfer (2006) suggest to traditionally bred crops, the
observed large composition variations and recently observed
unintended changes that occur during conventional breeding
(Cellini and others 2004) would trigger extensive safety testing of
these conventional crops. To note, attempting to demonstrate the
absence of any statistically significant differences between the
new crop and its conventional counterpart will be futile for crops
whose compositions have been deliberately altered. For the
major commodity crops (for example, maize, soy), the contents
of essential nutrients, antinutrients, and toxicants are well known
from a long history of study and safe consumption. This has
enabled the OECD to establish a well-defined list of constituents
that should be assessed for several of these major crops, such as
maize (OECD 2003a). Major crops are frequently, but not
always, chosen as the target for nutritional enhancement, and
these OECD composition guidelines are appropriate for
improved nutrition varieties of these major crops. It is important
to regard nutritional changes in the context of that food’s con-
sumption by various groups in the population and the food’s con-
tribution relative to specific nutrients---obviously few foods are
good sources of all, or even many, nutrients (Senti and Rizek
1974; Spiher 1974). Similarly, targeted analysis of the well-
understood antinutrients and natural toxicants in the major crops
humans and animals consume will reveal whether unacceptable
changes have occurred that would warrant safety concerns.
The 2004 ILSI report concluded that it is unwise to set a fixed
numerical limit to the variation permitted for a metabolite as a
trigger for further safety assessment. The report suggested that lim-
its depend on the specific metabolite, its role in safety and nutri-
tion, and the dietary pattern of consumption in the target popula-
tion. The objective was to avoid measuring every analyte based on
blanket criteria, even when changes in the analyte would have no
measurable impact on health and/or nutrition. This is in contrast
to an earlier approach by the U.S. Food and Drug Administration
(FDA) for new varieties of crops developed through conventional
breeding (Senti and Rizek 1974; Spiher 1974).
Changes in crop composition are unlikely to have a signifi-
cant nutritional impact unless they extensively alter the intake
and/or bioavailability of an essential nutrient (Bouis 2002; ILSI
2004). The FDA examined this concept as it considered the
nutritional and safety consequences of composition variation
that result from conventional crop breeding (Senti and Rizek
1974; Spiher 1974). The FDA set a 20% change in any nutrition-
ally important analyte as a trigger that would require further
safety studies. The list of crops and nutrients necessary to be
considered was pared down to 9 major crop plants that con-
tributed 5% or more to the average dietary intake of Americans
at that time, and to a short series of nutrients—those provided in
a meaningful quantity by that specific crop. However, a 20%
change in a specific nutrient from a food that provides only 5%
of that nutrient in the human diet results in a 1% change that is
most likely insignificant in terms of the overall dietary intake of
that nutrient. A report summarized the levels of each contributed
nutrient by each of the major foods in the diet at that time (Senti
and Rizek 1974). Since 1974, although the FDA has reserved the
authority to regulate crops produced through conventional
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breeding, they have not actively enforced the 20% change trig-
gering rule in practice because a long history of plant breeding
shows the technology is generally safe. Moreover, consumers
often exercise their freedom of food choice in a manner that
results in a far greater variability in nutrient intake and overall
dietary composition than would be possible from a 20% change
in a single nutrient from a single dietary component.
It is reasonable to expect that significant changes in composi-
tion will be observed, and it is important to regard such changes
in the context of that food’s consumption by various groups in
the population and its contribution of specific nutrients.
Similarly, targeted analysis of the well-understood antinutrients
and natural toxicants in the major crops humans and animals
consume will reveal whether unacceptable changes have
occurred that would warrant safety concerns.
2.4 Recent Developments in Food 
Protein Safety Assessments
Several of the case studies in this document involve introduc-
ing a protein not currently present in the crop. Therefore, it is
important to note that another IFBiC task force is developing the
scientific basis and recommendation for a framework for the
safety assessment of proteins. The report from this Protein Safety
Task Force, which is expected to be published in 2008, will
describe the characteristics of proteins and how such character-
istics should drive the safety assessment. It will include recom-
mendations for a tiered, weight-of-evidence approach to the
safety assessment of proteins. The publication will also include
a detailed description (including applicability, best practices for
use, and limitations) of current assessments to demonstrate pro-
tein safety, including expression level and pattern, history of safe
use, bioinformatics, mode-of-action, protein stability, and toxi-
cological testing. The definition of history of safe use is explored
in a recent publication of the ILSI Europe Novel Foods Task
Force (Constable and others, 2007).
2.4.1 Protein safety
Currently, appropriate toxicological studies are typically needed
for the introduced protein in GM crops (Codex 2003). The
assessment often includes a description of the biological func-
tion of the protein in the plant, when known, and studies such
as a bioinformatic comparison of the new protein’s amino acid
sequence with a database of all publicly available protein
sequences to determine if the protein is homologous to protein
with known toxicity (for example, protease inhibitors, lectins),
and testing the newly introduced protein’s stability to heat or
processing. Appropriate toxicity studies (such as acute toxicity
feeding studies in animals) may be needed in cases where the
protein present in the food is dissimilar to proteins that have pre-
viously been consumed safely in food.
2.4.2 Protein allergenicity
The potential allergenicity of new genetic variants of crops
theoretically presents 3 different kinds of concerns (Lehrer and
Bannon 2005):
1. that a known protein allergen might be transferred 
to a crop plant;
2. that the level of endogenous protein allergens (for example,
soy allergens) might be increased; and
3. that a novel protein with no prior history of human 
consumption might be introduced into a crop plant and become
an allergen.
A stepwise evaluation scheme, first suggested by ILSI (1996),
has been used around the world to ensure that GM crops are no
more likely than their conventional counterparts to induce food
allergies. No substantiated incidents of food allergy caused by
commercialized GM crops have been documented during the
1st decade of their commercial adoption, which is reassuring
given the broad acceptance of GM crops by farmers around the
world (James 2006). For example, claims that the Cry9C protein
caused food allergies could not be authenticated (Lehrer and
Bannon 2005). The absence of allergenicity should not be sur-
prising, however, because all GM crops introduced into the
marketplace for food and feed usage have been subjected to a
thorough premarket allergenic potential assessment.
Additionally, it is becoming clear that very few families of pro-
teins have the potential to induce food allergy when presented
in a food matrix (Jenkins and others 2005).
It is relatively straightforward to assess the allergenic potential
of an introduced protein from a plant with a known allergen, as
exemplified by the successful identification of an allergen from
Brazil nut, expressed in soybeans (Nordlee and others 1996). By
comparison, a robust set of analyses is required to determine
whether novel food proteins pose a concern for allergenicity.
Food allergies depend not only on the allergen itself, but also on
host genetics and physiological status, food use/avoidance
behavior, and environmental factors.
The molecular properties of a protein should be considered
when assessing potential allergenicity (Breiteneder and Mills
2005). Recent studies show that most food allergens fall into one
of a few specific protein superfamilies (Mills and others 2004;
Breiteneder and Mills 2005). Bioinformatic analyses can be
effective in determining the level of similarity between protein
sequences when examining allergenic potential. For example, if
a protein is not a member of the known food allergen protein
families and has a low level of sequence similarity to known
allergens, it is unlikely that it will be allergenic. Bioinformatic
analyses are recommended as part of the most recent
FAO/WHO consensus (Codex 2003). The amino acid sequences
of proteins introduced into GM crops are screened by bioinfor-
matic analysis for similarity to sequences of known allergens. A
query sequence is considered to possess an immunologically
significant sequence if it has a sequence identity with a known
or putative allergen of at least 8 linearly contiguous amino
acids, the smallest likely IgE binding epitope (Metcalfe and oth-
ers 1996; Hileman and others 2002).
However, the lack of value for sequence matches for less than
8 amino acids (for example, a 6 or 7 amino acid sliding-win-
dow) was recently demonstrated in a comprehensive analysis of
short peptide match frequencies (Silvanovich and others 2006).
The suggestion to increase bioinformatic search stringency by
examining 6 amino acid residue matches between allergens and
novel proteins (FAO 2001) has been shown to not be scientifi-
cally reasonable because of high rates of false positive, random
associations (Bannon and Ogawa 2006). In addition, no further
margin of confidence in identifying proteins with cross-reactivity
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to allergens was shown from this approach. Nevertheless, there
are opportunities to develop increasingly useful bioinformatic
strategies. These may include constructing allergen epitope
databases or using conformational protein structures to identify
potential allergens (Thomas and others 2004; Bannon and
Ogawa 2006).
Some crops, such as soya, are known to contain endogenous
allergenic proteins; therefore another potential concern is that
introducing new DNA into a crop may alter the level of one or
more of these endogenous allergenic proteins. To date, how-
ever, GM varieties of crops such as soya have shown no evi-
dence of possessing increased allergenicity due to undergoing
transformation (Park and others 2001; Batista and others 2005).
Allergy safety assessments use a panel of characteristics to
evaluate novel proteins for allergenic potential. If a novel food
protein is not similar to allergens and is not derived from aller-
genic protein families, it is unlikely to provoke allergy.
Moreover, if a protein is degraded in simulated gastric fluid, is
small in size (for example, < 10 kDa), and is not glycosylated,
the likelihood that it will be an allergen is also unlikely (Lehrer
and Bannon 2005; Sánchez-Monge and Salcedo 2005). A major
research challenge is the development of methods to predict the
allergenic potential of novel food proteins that have no relation-
ship to known allergens. Animal models offer some potential for
measuring allergenicity. The predictive capability of animals is
complicated, however, by the absence of scientifically justified
model systems (McClain and Bannon 2006). Several animal
model systems (for example, canine, murine, and porcine) are
being researched (Lehrer and Bannon 2005; Sánchez-Monge
and Salcedo 2005). Other methods of measuring allergenic
potential, such as in vitro IgE binding in the sera of allergic
patients, are currently under review for their utility in allergy
safety assessments (Thomas and others 2006).
There are many factors that may elicit food protein allergy,
including extrinsic factors such as food use and processing;
however, this is not well understood and is a continuing topic of
research and discussion (ILSI-HESI 2006). It is important to note
that many proteins possess one or more of the properties char-
acteristic of an allergen, and yet they do not cause allergy. The
likelihood that a novel biotechnology-derived protein will be an
allergen is very low for proteins without sequence similarity and
physical properties comparable to known allergens. From a safe-
ty perspective, the risk of allergy due to introduction of a novel
protein into a crop remains low, regardless of whether proteins
are introduced through conventional crop breeding or modern
biotechnology.
2.5 Developments in Nontargeted “Profiling”
Composition Analysis Techniques
Comprehensive, untargeted profiling techniques, such as
metabolomics, proteomics, and transcriptomics, were discussed
in chapter 6 of the 2004 ILSI publication as potentially useful
tools to screen for unintended changes in the edible parts of
crops (ILSI 2004). Efforts continue in these areas to standardize
the reporting structure of such “–omics” data and to recommend
current best practices. These are important steps to harmonize
workflows and to enable queries of the metabolomes, pro-
teomes, or transcriptomes of novel foods against databases in
order to find meaningful unintended and unexpected events.
However, to date, there are no public repositories on baseline
metabolomes, proteomes, and transcriptomes of crops (such as
that for composition data at www.cropcomposition.org), and it
will require substantial time and financial commitment to estab-
lish and maintain databases that are standardized, validated,
and monitored. It is recommended that data from analyses of
relevant tissue samples from different environmental conditions
be represented within crop profiling databases to provide base-
line assessments to which profiles of metabolites and proteins in
novel foods may be compared.
2.5.1 Metabolomics
Metabolomics, which shares the same etymological root as
metabolism (metabol, GK. change), seeks to understand
changes in biological systems in terms of changes in metabo-
lism. A major aspiration is the identification and semiquantifica-
tion of all metabolites (often termed metabolic profiling) in a
given biological context (Fiehn and others 2005). This represents
a demanding challenge, for which sophisticated analytical
methods such as mass spectrometry (MS) coupled to gas and liq-
uid chromatography (GC/MS and LC/MS) are generally
employed. Although the ideal metabolomics methodology
would generate, as nearly as possible, a quantitative global
analysis of metabolite content and of metabolic flux, current
metabolic profiling methods (for example, GC/MS, LC/MS)
allow identification of only a subset of previously described
metabolites. Furthermore, accurate quantitation in nontargeted
metabolic profiling is often not possible due to both coelution
and differential detector responses of metabolite analytes.
To date, studies have been restricted to single, relatively small
batches of plants produced under controlled growth conditions.
Many such studies adopt a 2-tiered, hierarchical profiling
approach. For an initial assessment of overall compositional
similarity, a rapid MS-based "fingerprinting" technique that does
not incorporate a chromatographic step is often used (Catchpole
and others 2005; Fiehn and others 2005) prior to more rigorous
analyses. Fingerprints such as flow injection electrospray ioniza-
tion (FIE)-MS can be regarded as simplified images of total sam-
ple composition in that the measured variables (m/z) depend not
only on the levels of a measured metabolite but also on the lev-
els of coeluting material that can contribute to matrix effects or
ion suppression. The low resolution adopted in fingerprinting
approaches (typically 1 atomic mass unit) also implies that a sin-
gle m/z value is compiled by integrating the levels of more than
1 metabolite (for example, members of a homologous series or
isomers).
Multivariate fingerprint analyses can be used to highlight
compositional similarities or dissimilarities. Where composi-
tional differences between a novel crop and a conventional
standard are preliminarily identified, a more rigorous compara-
tive assessment process, using validated and quantitative com-
positional analysis methods, can then be pursued in order to
determine whether additional safety assessments are needed.
Defining compositional equivalence is not easily achieved
using standard statistical methods. Unsupervised data analysis
techniques such as principal components analysis (PCA) look for
regularities in unlabeled data. Supervised techniques such as
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linear discriminant analysis (LDA) and decision tree analysis
build models that discriminate between labeled data. However,
for compositional equivalence, the interest is in data similarity
rather than the ability to discriminate between classes. It has
been suggested that if an unsupervised algorithm clusters
metabolome samples close together, they can then objectively
be considered as similar, and if classes cannot easily be discrim-
inated by supervised methods, then they are, in effect, objective-
ly similar (Catchpole and others 2005).
The comparator approach’s strength has recently been
demonstrated in a study in which field-grown tubers from con-
ventional potato cultivars were compared to GM potatoes that
contained high levels of inulin-type fructans (Catchpole and oth-
ers 2005). Two classes of experimental GM potato lines devel-
oped in the Désirée cultivar were investigated. The 1st transgene
coded for the enzyme sucrose:sucrose 1-fructosyltransferase (1-
SST), which transfers a fructosyl residue from 1 sucrose mole-
cule to another, producing the trisaccharide 1-kestose, and
oligofructans with up to 5 degrees of polymerization (DP)
(Hellwege and others 2000). The 2nd transgene was
fructose:fructose 1-fructosyltransferase (1-FFT), the product of
which utilizes 1-kestose (and other oligofructans) to build inulin
polymers (Hellwege and others 2000). The acquired data high-
lighted large variation in the metabolic profile and composition
of the conventional cultivars. In the context of the comparative
safety assessment process, it demonstrated that the metabolite
composition of field-grown inulin-producing potatoes was with-
in the natural metabolite range of classical cultivars. The GM
potatoes were, in fact, very similar to the progenitor line,
Désirée, with the exception of the intentional elevation of fruc-
tans and their expected derivatives. In the comparative assess-
ment framework, such metabolic side products would be sub-
jected to follow-up assessment.
The cultivar-based compositional heterogeneity that has been
described by Catchpole and others (2005) emphasizes the impor-
tance of comparison with a range of equivalent cultivars and not
solely the parental line. For example, although the trisaccharide
1-kestose metabolite was not found in the genetic background
line of the GM plants, a trisaccharide indistinguishable from 1-
kestose was found in the other field grown conventional tubers.
GC-TOF (time of flight) analysis highlighted similar findings and
indicated that metabolic changes observed in conventional
breeding approaches were, in these cases, comparable in magni-
tude to those resulting from modern biotechnology.
The value of targeted metabolic profiling has also been
demonstrated in a recent evaluation of chromatographic meth-
ods for the highly selective detection and quantification of the 2
major potato glycoalkaloids, -chaconine and -solanine.
High-throughput capabilities for > 1000 analytical runs were
developed for electrospray-tandem mass spectrometry in multi-
ple reaction monitoring mode coupled with either reversed-
phase (RP) or hydrophilic interaction (HILIC) columns (Zywicki
and others 2005). The RP method was more precise, more accu-
rate, and more rugged under field conditions than the HILIC
method for maintaining peak shape symmetry over 1000 analyses.
In a study on the potato peels of 6 GM lines, the glycoalkaloid
content in potato peels was found within the range of 6 
conventional cultivars (Bushway and others 1983). This is con-
sistent with the work of Catchpole and others (2005), described
previously, who also found no differences between convention-
al and GM cultivars in these metabolites.
2.5.2 Proteomics
For more than 30 y, proteomics and protein profiling have
been used as research tools to comprehensively analyze protein
abundance and diversity. Just as there are metabolic compounds
with known hazards, there are proteins known to cause aller-
genic or other toxic effects and, thus, might need to be moni-
tored. In principle, monitoring proteins can be accomplished
with selective and sensitive techniques such as western blots or
"mass westerns," which employ LC and triple quadrupole MS for
specific fragments and mass transitions of target proteins.
Unfortunately, there is no prediction tool that allows an unbiased
calculation of the likelihood that any given protein, or a specific
protein posttranslational modification (for example, glycosyla-
tion, phosphorylation, or any of the other 200 known modifica-
tions), would raise safety concerns with respect to potential toxic
or allergenic effects.
It has been suggested that nontargeted "fishing" for novel pro-
teins could provide a preliminary indication of potential con-
cern. For that information to be useful, however, validation and
statistical data analysis strategies would need to achieve the
same level of precision, repeatability, and so on as that required
for targeted metabolite analyses that are currently used for safety
and nutritional assessments of GM crops. First, the proteomic
approaches must establish that they can be used in a robust and
reliable manner, giving consistent and precise quantification
results for a wide range of proteins. In principle, 2 methods can
be applied for the nontargeted comparisons of relative protein
abundances: either classical 2-D gel electrophoresis using colori-
metric staining for detection and relative quantification, or chro-
matography-based separations followed by MS detection and
quantification (LC/MS).
The 2-D gels can be used today at comparatively low costs
and reasonably high precision; however, this technique usually
does not detect integral membrane lipophilic proteins and pro-
teins of either very high or very low masses and extreme isoelec-
tric points (pI). In addition, spot detection, gel alignments, and
automated quantification methods must be shown to work reli-
ably for standard food and feed crops before proteomic databas-
es can be set up to unambiguously determine when changes for
a specific protein in a new crop fall outside the natural range for
that protein in that species. Recently, Ruebelt and others pub-
lished a series of papers (2006a, 2006b, 2006c) demonstrating,
with 2-D gel proteomics of Arabidopsis thaliana seed samples,
that the method itself can reproducibly detect and quantify
spots, but that there was a wide range of protein abundances
when 12 different Arabidopsis varieties were compared. In fact,
the range covered the abundance range of GM Arabidopsis
lines. A similarly thorough study on potato varieties and GM
lines concluded that proteome dissimilarities between different
individual cultivar lines were far larger than dissimilarities
between a GM line and its progenitor conventional counterpart
(Lehesranta and others 2005). In principle, 2-D gel proteomics
may be used if efforts are made to ensure quality control and
there is a high enough sample throughput to cope with the 
statistical challenges.
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A 2nd proteomic approach is to utilize LC/tandem MS (LC/MS)
on fractionated or partly fractionated proteome samples (for
example, by using online cation exchange fractionation steps
before LC/MS separation of trypsin-digested proteomes). Such
approaches can be used with or without labeling with stable 
isotope intermediates that are often employed to enhance the
precision of quantification results. No reports have yet been pub-
lished on plant proteomes with the same diligence toward preci-
sion and range assessments using this method as have been
reported with the 2-D gel approach. In principle, proteome frac-
tionation with subsequent LC/MS quantifications may work, but
is still plagued by some fundamental challenges called ion sup-
pression and retention time alignments. For either of the 2 gene-
ral approaches on proteome quantifications, laboratories have to
establish that they can perform protein quantifications in a high-
throughput manner using quality control charts and precision
analyses as minimum quality checks to be able to populate range
assessments of crop proteome databases.
2.5.3 Transcriptomics
Several laboratories investigated the potential value of tran-
script profiling for the safety assessment of GM food plants
(Kuiper and others 2003; Baudo and others 2006). A study of
tomatoes showed that different stages of ripening could be iden-
tified based on reproducible differences in gene expression pat-
terns (Kuiper and others 2003). Detailed global gene expression
profiles with a series of GM and conventionally bred wheat lines
showed that differences in endosperm and leaf transcriptome
profiles between conventional and related GM lines were con-
sistently extremely small (Baudo and others 2006). Differences
in gene expression in the endosperm among conventionally
bred materials were much greater than differences between GM
and conventional lines exhibiting the same complements of
gluten subunits (Baudo and others 2006). These results suggest
that the presence of the transgenes did not significantly alter
gene expression. However, for transcriptomics to be useful, the
variability for each transcript needs to be established and knowl-
edge gained on the relevance of each new assay point regarding
safety and nutrition.
2.5.4 Conclusions and recommendations about profiling
Nontargeted methods have been established for metabolite,
protein, and transcript analyses. Although these profiling tech-
niques may prove useful to identify differences among tissues or
between a food component from a GM product and its conven-
tional counterpart, the relevance to safety assessment has yet to
be established. Hence, these methods may be useful during a
product’s developmental phase because they can help focus the
safety assessment process by identifying the specific compounds
that may need to be measured in a nutritionally improved prod-
uct. It remains important to monitor novel foods and feeds by
targeted metabolite analyses for nutritional value and antinutri-
ent and toxicant levels to detect alterations in the composition
of the nutritionally improved crop as part of a nutritional and
safety assessment of the GM crop. Targeted approaches for the
detection of specific differences between novel plant lines and
a variety of comparator lines must adequately address natural
variability and quality control measures. In addition to range
levels that are recommended for these compounds based on
health considerations, it is recommended that profiling databas-
es for crops are established that span wide environmental con-
ditions. Such databases will enable baseline assessments to
which profiles of metabolites, proteins, and transcripts in novel
foods may be compared, whether they are generated using
molecular biology techniques or otherwise. At present, the non-
targeted approaches complement existing direct approaches for
detecting specific differences. For nontargeted profiling methods
to be useful for nutritional and safety assessment purposes, the
methods must be validated and harmonized globally.
2.6 Safety of Animal-Derived Foods (Meat, Milk, and Eggs)
At the time of the ILSI (2004) publication, it was concluded
that one could assume nutritional equivalence of GM crops with
agronomic input traits if compositional equivalence was estab-
lished and that longer-term livestock feeding studies added little
to the nutritional assessment (Flachowsky and others 2001).
However, a number of hypothetical safety concerns continue
to be raised, including the potential for introduced DNA and/or
the protein encoded by the transgene to transfer to animal-
derived products intended for human consumption. This con-
cern has been addressed by the FAO, WHO, FDA, and the
OECD (FAO/WHO 1991; FDA 1992; OECD 2003b). These
organizations stated that the consumption of DNA from all
sources—including GM plants—is safe and does not produce a
risk to human health, given the long history of safe consumption
of DNA. Nevertheless, the search for fragments of transgenic
DNA in the digestive tract of livestock and their presence in
foods such as milk, meat, and eggs continues.
It has been noted that although DNA fragments from endoge-
nous multicopy genes, such as rubisco, have been detected in
animal tissues, fragments of transgenic DNA have not been
widely detected in animal-derived products (Flachowsky and
others 2005; CAST 2006). Thus, the relative frequency of a gene
in the plant affects the probability of it being found in an animal
tissue—DNA from endogenous multicopy genes is far more
abundant than that of the transgene.
A recent review reported on the detection of DNA in animal-
derived products in 15 feeding studies conducted since 2003
(Flachowsky and others 2005). These studies were conducted in
a range of livestock species, and although fragments of DNA
from multicopy endogenous genes were found in some tissues,
no fragments of transgenic DNA were detected in any animal-
derived products. These findings are supported by a recent and
detailed study with poultry (Deaville and Maddison 2005). In this
poultry study, although 23% of all animal samples contained
fragments of the multicopy rubisco gene fragments, fragments of
transgenic DNA were not detected in any animal tissues, even
though fragments of the transgene were still detectable in feed
samples traversing the upper gastrointestinal tract.
In 2006, a study using an assay with greatly enhanced analyti-
cal sensitivity identified very small fragments (106 to 146 base
pairs [bp]) of the transgenes cry1Ab and cp4 epsps in conventional
and "organic" milk samples in Italy (Agodi and others 2006).
"Organic" milk is supposed to come from animals not fed GM
crops, so the source of the fragments of these transgenes is
debatable. In addition, the fragments of transgenic DNA 
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reported in milk were so small that the results must be interpret-
ed in the context of the minimal size for a functional gene. For
example, the size of the intact cry1Ab gene is 3500 bp, and its
minimal functional unit is encoded on 1800 bp of DNA, both of
which are considerably larger than the detected 106 to 146 bp
DNA fragments.
To conclude, therefore, the detection of DNA in milk, meat,
and eggs is likely to be a function of the abundance of the gene,
the size of the DNA fragment being tested, and the sensitivity of
the analytical methods, such that detecting fragments of trans-
genic DNA would be much rarer and more difficult than detect-
ing high copy number endogenous genes. Given the long histo-
ry of safe consumption of meat, milk, and eggs from animals in
which plant gene fragments have now been shown to be
detectable, and given that the DNA of a transgene is identical to
all other types of DNA, then products from animals fed GM
crops would not differ from foods already deemed safe (Jonas
and others 2001).
2.7 Application of Risk–Benefit Analysis to Improved
Nutrition Crops
In the Codex Alimentarius model, risk analysis is composed of
3 elements, risk assessment, risk management, and risk commu-
nication (Figure 2-1). The aim is to ensure the highest appropri-
ate level of public health protection, as well as to strive for trans-
parency of risk management and continuous communication
between assessors and managers during the process. During risk
analysis, the risks have to be weighed against other issues, such
as the expected impacts, which require an understanding of
these issues within the context of the levels of health protection
that are considered appropriate. For nutritionally enhanced
crops, it is particularly important to balance the intended posi-
tive health impact such as a significant improvement in health
and a significant decrease in disease, suffering, and/or death
against the outcome of the risk characterization. The impact of
nutritionally enhanced crops may alternatively be viewed as a
reduction in harm caused by control of a preexisting risk such as
malnutrition. The case studies in this document focus on recom-
mended scientific assessments of possible risks associated with
new nutritionally improved food or feed.
The issue that science-based risk assessments, as currently
performed, do not balance the potential risks against the intend-
ed positive nutritional impact (Boobis 2006) was discussed with
experts during a workshop in preparation of this document (ILSI
2006). The workshop participants recommended that the risk
assessment of improved nutrition foods and feeds follow current
internationally harmonized food safety assessment procedures
and be completed regardless of the potential positive impact of
the improved nutrition crop. It was also recommended by the
workshop participants that, similar to current risk assessment
practices, if the positive nutritional impacts are to be assessed,
the methodologies must be similarly detailed and science-based
and should account for regional variation in factors such as pro-
cessing, consumption, and health issues.
It is likely that different groups of scientists are involved in
assessing risks from those assessing positive impacts. Those assess-
ing positive impacts may be instigated by the need to verify claims
of a positive health effect of a particular food or feed. Assessment
of the positive nutritional impact of a novel food in the target pop-
ulation(s) must also consider its projected use and intake once it
is commercially available. The workshop participants also noted
that some nonscientific issues may be linked with the assessment
of potential positive impacts of improved nutrition foods that are
not within the domain of scientific risk assessors, but may be
appropriate for consideration by risk managers (Figure 2-2).
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Figure 2-1—Risk analysis model (adapted from FAO/WHO
1997).
Figure 2-2—Risk management process (adapted from
FAO/WHO 1997).
Some scientists have begun asking if the premarket safety
assessment used in many countries is attempting to achieve a
standard of absolute safety by continually adding data require-
ments as newer analytical methods come available (Bradford
2005a, 2005b). These scientists suggest that, from a scientific
perspective, the cumulative experience over 2 decades of
assessing GM crop safety should allow us to determine which
tests need to be applied to new GM varieties to determine if they
are as safe as their traditional counterparts with a history of safe
consumption. This process is relatively simple for some crop
species, while others may require more extensive analysis—yet
today all crops species undergo the same assessment process,
regardless of risk. The fundamental concept of the comparative
risk assessment process is that it provides a reasonable degree of
certainty that a new GM variety of a crop is as safe as the con-
ventional varieties currently being safely consumed by humans
and animals.
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3.1 Demonstrated Trait Need
Cereal grains are the most important crops for humanity, rep-
resenting the staple diet for two-thirds of the world’s population
(FAOSTAT 2004). Beyond that, they are a principal staple for
animal feed and for production of valuable commodities such as
oil, protein, and starch. Today, there is great variation in nutri-
tional composition of many maize varieties (Table 3-1). Maize,
the most widely produced feed grain in the United States,
accounts for more than 90% of the total production of feed
grains in the country, with > 32 million hectares of land planted
with maize. In the United States, the majority of maize (> 50%)
is used to feed animals for meat, milk, and egg production
(NCGA 2007). Much of the remainder is exported for feeding
animals or made into maize sweeteners or fuel alcohol.
While maize may not comprise a significant component of
the human diet in North America, as described in more detail in
Appendix 2, protein-energy malnutrition (PEM) is the most
lethal form of malnutrition and affects every 4th child world-
wide according to the WHO (2006). The FAO estimates that 850
million people worldwide suffer from undernutrition, of which
insufficient protein in the diet is a significant contributing factor
(FAO 2005). For animal diets, there is interest in maize oil; as
noted, approximately 70% of all maize grown in the United
States is fed to domestic livestock in the form of ground grain
(including high-oil and high-moisture maize) and maize silage.
Researchers have tried for some time to breed high-quality
protein maize with some success. One type, called Quality
Protein Maize is a natural mutant, known as opaque2 (o2).
Weanling rats fed a diet of 90% o2 maize gained weight more
than 3 times faster than those fed a diet with standard hybrid
maize (Maffia and others 1976). In a number of regional studies,
including Guatemala, Peru, Colombia, and India, various
parameters were measured such as apparent nitrogen retention
and biological value. For children, o2 maize was generally
found to be nearly equivalent to milk protein in meeting protein
nutritional requirements and in aiding recovery from kwashior-
kor, a protein deficiency disease (Nelson 2001). However,
breeding for trait improvement has limitations that include sig-
nificant reduction in yield, slow drying kernels that are more
subject to fungal infections, soft endosperm that easily breaks
under typical harvesting and milling practices, and lysine con-
tent that was unusually susceptible to environmental fluctua-
tions, complicating efficient diet formulation.
The most extensive breeding program for developing high-
lysine maize based on the o2 mutant, but with more acceptable
agronomic and grain handling characteristics, was conducted
by the Intl. Maize and Wheat Improvement Center in Mexico
(Centro Intl. de Mejoramiento de Maiz y Trigo, CIMMYT) and
resulted in Quality Protein Maize. The center introduced modi-
fiers that increased endosperm hardness to a more desirable
phenotype, and there was continued selection for yield and
other performance aspects. This variety is now being grown in
regions such as Africa and China, but requires continual breed-
ing to ensure that the mutation is maintained in the crop.
Unlike many less-developed regions in the world, only a frac-
tion of maize grown in the United States is used for human food.
Up to 70% is used to feed livestock, 20% to make the maize
starches and oils that are key components of many foods, and
approximately 5% is milled for dry products such as maize chips.
Therefore, in a field in which increases in oil, protein, or starch
content as small as 1% are considered a significant achievement,
any technology that provides the ability to significantly increase
any one of these would be viewed as a considerable advance-
ment. Scientists at the Univ. of California, Riverside have used a
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Chapter 3: Double-Embryo, High-Protein, 
High-Oil Maize Produced Using 
a Cytokinin-Based Flower Rescue
ABSTRACT: Maize is an important staple of human diets and animal feed. Improving the nutritional profile for both
of these purposes is a desirable research focus and agricultural endpoint. Many mechanisms have been used to
improve maize protein and oil content, including selective breeding to introgress desirable traits (Quality Protein
Maize), introducing single natural or synthetic genes expressing desired traits, changing signal sequences (high
methionine maize), and modifying metabolic pathways (high-lysine maize, see Chapter 6). A novel approach was
used to indirectly increase protein and oil content (Young and others 2004). Maize produces unisexual florets.
Within the maize spikelet, the meristem gives rise to an upper and lower floret and male (tassel)- and female (ear)-
specific florets are borne on separate inflorescences. The lower floret of each ear spikelet is aborted early in its devel-
opment, leaving the upper floret to mature as the only female floret. Expression of a bacterial cytokinin-synthesiz-
ing isopentenyl transferase (IPT) enzyme, under the control of the Arabidopsis senescence-inducible promoter SAG
12 (senescence associated gene), blocked the abortion of the lower floret and resulted in 2 functional florets per
spikelet. The pistil in each floret was fertile, but the spikelet produced just 1 kernel composed of a fused endosperm
with 2 viable embryos. The 2 embryos were genetically distinct, indicating that they had arisen from independent
fertilization events. The embryo contains most of the protein and oil in the kernel and kernels that contained 2
embryos have more protein than conventional maize. The presence of 2 embryos in a normal-sized kernel leads to
displacement of endosperm growth, resulting in kernels with an increased ratio of embryo to endosperm content.
The end result is maize with more protein and oil and less carbohydrate (Young and others 2004).
peculiarity of certain plants that has evolved as a reproductive
strategy to achieve such an endpoint for two of the principal
components in maize, protein and oil content.
3.2 Experimental Procedure
To put the current work in context from a nutritional and safe-
ty assessment perspective, it is important to provide some back-
ground on kernel development in maize. Unlike the majority of
plant species, maize produces unisexual florets that have only
either male (stamen) or female (pistil) parts, but both male and
female flowers appear on the same plant (monoecious). For
monoecious species, the sex determination process by which
sexual organs form in each floret is rather complex. Within the
maize spikelet, the meristem gives rise to an upper and a lower
floret, and male (tassel)- and female (ear)-specific florets are
borne on separate inflorescences. The male stamen (tassel) is
responsible for producing pollen. The female pistil (ear) bears
the ovaries that give rise to kernels after pollination. Although
initially bisexual, floret unisexuality is established through
selective organ elimination and abortion of specific floret
organs. Female initials are eliminated from florets in the tassel
inflorescence, resulting in male florets; conversely, male initials
are eliminated from florets in the ear inflorescence, resulting in
female florets. In addition, the lower floret of each ear spikelet
is aborted early in its development, leaving the upper floret to
mature as the only female floret. Arrest of pistil development in
the lower floret is followed by degeneration, which initiates in
the pistil primordium (precursor cells).
As with many organisms, this selective loss is achieved
through apoptosis or programmed cell death (PCD), a funda-
mental process that cuts across the boundaries of many scientific
disciplines. In the context of maize reproduction, it is interesting
that the Greek term apoptosis traces its roots not to a medical
phenomenon, but rather to the process of a petal falling from a
flower or the loss of a leaf from a tree. As with other apoptotic
applications in plant development, the process results in dis-
carding tissues or organs that are no longer required, modifying
existing organs, or adapting to environmental changes.
Induction of PCD is a fine balance between the withdrawal of
positive signals; that is, signals needed for continued survival,
and the receipt of negative signals. The continued survival of
most cells requires that they receive continuous stimulation
from other cells.
There are several naturally occurring maize mutations called
tasselseed (for example, ts1 and ts2) that result in female flow-
ers developing on the male tassel. The ts2 mutation has been
cloned and encodes a short-chain alcohol dehydrogenase.
Normal expression of ts2 in the pistil primordium of male flow-
ers induces apoptosis and leads to pistil abortion and male tas-
sel development. Both genes are suppressed by silkless1 (sk1).
Loss of sk1 leads to the abortion of both upper and lower floret
pistil in ear spikelets. In contrast, loss of ts1 or ts2 function
results in the sexual maturation of pistils in all florets, tassels,
and upper and lower florets of each ear spikelet, leading to a
complete female takeover. Expression of ts2 seems to switch on
PCD because it coincides with the loss of nuclei in the pistil pri-
mordium. The presence of Sk1 basically eliminates ts2 activity
in the upper floret pistil by blocking PCD, although ts2 is
expressed in all pistil primordial cells (Calderon-Urrea and
Dellaporta 1999). Mutations at 2 other loci (pi1/pi2) differential-
ly suppress pistil abortion in the lower ear floret, but not in the
tassel spikelets (Veit and others 1993). The fact that this demon-
strates a mechanism (even if the actual process is unknown)
whereby one can rescue the lower floret pistil, while not affect-
ing pistil abortion in tassel spikelets (thus not affecting male fer-
tility), makes for a potential intervention point that was taken
advantage of with some unexpected payoffs from a nutritional
perspective (Young and others 2004). Intervention was achieved
by the judicious use of plant growth regulators (PGRs) rather
than direct manipulation of gene activity, per se.
It had already been demonstrated in tobacco leaves that
cytokinin plays a key role in regulating entry into a senescence
program. Cytokinins are adenine-derived compounds that pro-
mote cell division and have other similar functions to kinetin.
Gan and Amasino (1995) developed a system based on
cytokinins to study leaf senescence because it has important
agricultural implications. For example, senescence may limit
yield in certain crops, and it also contributes to the postharvest
loss of vegetable crops. Therefore, studying leaf senescence
could lead to ways of manipulating senescence for agricultural
applications. Gan and Amasino (1995) developed a construct to
study the effect of cytokinin by placing the Agrobacterium
cytokinin-synthesizing IPT gene under the control of the
Arabidopsis senescence-inducible promoter from the cysteine
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Dent 14 343 7.5 3.6 70.3 8.1 1.3 15 290 3 38 14 53 280 2.3 0.5
QPM 14 350 9 3.8 69.9 1.3 9 232 3.7 0.9
Sweet 76.9 81 2.6 1 18.6 0.2 9 0.8 0.03 0.01 0.7
Table 3-1—Nutritional values of corn grain.
Data extracted from Dickerson (2003), Saldana and Brown (1984), USDA (1976–1993), and Valverde and others (1981), no data available in 
empty cells.
protease gene, SAG, which induces senescence. There are about
30 different SAG-coding degradative enzymes, such as RNases,
proteinases, and lipases, and genes with products involved in
nutrient translocation processes. Interestingly, the group also
includes genes homologous to short-chain alcohol dehydroge-
nases similar to Ts2, which is a member of the short-chain alco-
hol dehydrogenase family. As also noted, Ts2 is required for
PCD during sex determination in maize (DeLong and others
1993), and the existence of 2 members of this class of genes in
different PCD programs is intriguing.
The PGRs regulating senescence and PCD can be similar,
although these processes are distinct developmentally. The former
typically occurs as the last developmental stage of an organ,
whereas the latter can initiate even at early developmental stages.
For instance, ethylene, a simple gaseous hydrocarbon PGR, pro-
motes the senescence of leaves as well as the PCD of root cortical
cells in response to hypoxia (Grbic and Bleecker 1995; He and
others 1996). To investigate whether cytokinin may affect the abor-
tion of maize floral organs, a construct, similar to that used by Gan
and Amasino (1995) with the cytokinin-synthesizing IPT enzyme
under the control of the Arabidopsis SAG12 (senescence-inducible
promoter), was introduced into maize (Young and others 2004).
The selectable marker used was bialophos resistance. The hypoth-
esis that expression of IPT would be observed in the ear during
early floral development was confirmed by experimentation.
Abortion of the lower floret pistil in the ear was suppressed, result-
ing in a spikelet with 2 florets that each contained a fertile pistil.
Neither the number nor arrangement of florets within a spikelet,
nor organ number within each floret, was altered, demonstrating
that IPT expression did not alter either spikelet or floret determina-
cy. Somewhat surprisingly, the pistil in each floret was fertile and
pollination resulted in the production of a single kernel from each
ear spikelet composed of a fused endosperm with 2 viable, normal
size, genetically distinct embryos, indicating that fusion between
the 2 pistils within a spikelet had occurred. Because the 2 embryos
were genetically distinct, this indicates that they had arisen from
independent fertilization events.
These results suggest that cytokinin can determine pistil cell
fate during maize floret development. The embryo contains most
of the protein and oil in the kernel, and kernels that contained
2 embryos have more protein than normal maize. The presence
of 2 embryos in a normal-sized kernel meant that something had
to be reduced, leading to displacement of endosperm growth.
This resulted in kernels with an increased ratio of embryo to
endosperm content. The end result is maize grain with more
protein and less carbohydrate (personal communication, Daniel
Gallie 2005, unpublished data).
3.3 Considerations for Safety and Nutritional
Assessment
The majority of products on the market to date have been
modified for agronomic “input” traits. Although the use of a PGR
induction system may at first seem to differ substantially from
the current commercialized applications, the same rigorous
assessment system in place for current assessments should suf-
fice to address all nutritional and safety concerns. A meticulous
safety testing paradigm using a systematic, stepwise, analytical,
and integrated safety assessment approach has been developed
and implemented for GM crops. The resultant science-based
process focuses on a classical evaluation of the toxic potential
of the introduced novel trait and the wholesomeness of the GM
crop. In addition, detailed consideration is given to the history
and safe use of the parent crop, as well as that of the gene
donor(s). There are some specific assessments of double-embryo
maize that are appropriate for consideration in determining food
and feed nutritional and safety appraisal.
3.3.1 Agronomic aspects
Safety issues aside, it will take many years to determine
whether double-embryo maize is suitable for commercial pro-
duction. One of the key issues is that each kernel will produce
2 plants because each contains 2 embryos. Two seedlings grow-
ing from the same kernel or seed is inefficient because they
compete for nutrients and resources. Determining how well
these plants grow and perform when they are competing for
resources will be an important field test. From an economic per-
spective, if farmers are to adopt a new variety, it must perform at
least as well as today’s commercially grown maize varieties.
Possibly, this trait could be bred into other elite strains of maize
and selected against different genetic backgrounds.
In addition, setting aside safety and nutritional considerations,
because distribution for this trait is expected to be global, espe-
cially in less developed countries, researchers must consider that
the high levels of fat and protein do not interfere with people’s
ability to mill and cook the grain. If modified cultivation, pro-
cessing, or preparation is required, then this may affect adoption.
3.3.2 Nutritional safety issues
The nutritional endpoint of higher protein and oil and lower
starch presents no known nutritional limitations or safety impli-
cations for these targeted endpoints. No change is anticipated
from present expected dietary impact and consumption levels
for maize. An increase in cytokinin-synthesis, which is part of a
well-understood pathway in maize and involves specific cells
undergoing programmed cell death, is not expected to have any
negative nutritional or safety concerns. This is especially true
considering that once sufficient cytokinin is produced to retard
senescence (or in this instance, apoptosis), the activity of the
senescence-specific promoter is attenuated.
R.E.D. FACTS (1995) reports that the plant growth regulator
cytokinin was initially registered in the United States in 1978 as
CYTEX (EPA Reg. NR 35980-1) for application to certain citrus,
fruit, and vegetable crops. During Phase Four of the accelerated
pesticide re-registration process, the database for cytokinin was
evaluated and determined to be inadequate in satisfying certain
requirements for biochemical pesticides that include plant reg-
ulators. A data call in (DCI) was issued by the U.S.
Environmental Protection Agency (U.S. EPA) in August 1993 to
fill the outstanding data gaps. Since the DCI, the initial EPA posi-
tion regarding these data gaps was reevaluated. All of these data
requirements, except a nontarget insects study, were waived
because available information indicated that cytokinin does not
cause unreasonable adverse effects in that (1) the principal
sources of cytokinin, algae and seaweed, are natural compo-
nents of fish diets, (2) cytokinin has minimal acute mammalian
toxicity, (3) cytokinin is used as a dietary supplement in animal
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feeds, and (4) cytokinin pesticide products are expected to have
no adverse effects to fish and wildlife. The report (R.E.D. FACTS
1995) further states that the acute dermal toxicity (LD > 2 g/kg),
eye irritation (slight irritation), and dermal irritation 50 (slightly
irritating) place cytokinin in Toxicity Category III (the 2nd lowest
of 4 toxicity categories). Cytokinin’s oral toxicity 50 (LD > 5
g/kg) places it in Toxicity Category IV (the lowest of 4 toxicity
categories1).
In 1998, the U.S. EPA proposed a growth regulator tolerance
exemption regulation (including cytokinin) to facilitate adding
new crops, application rates, and uses to the labels of products
containing the listed active ingredients when used as plant regu-
lators (EPA 1998). The U.S. EPA determined that tolerance
exemptions for these types of substances are usually based on the
results of subchronic feeding, developmental toxicity, and muta-
genicity studies. However, for many of the plant regulators, some
or all of these study requirements have been waived because of
negligible exposure from very low use rates. Such use rates for
these active ingredients are expected to be effective when these
substances are used as plant regulators, and these low use rates
are not expected to significantly increase dietary intake over that
anticipated from consumption of a normal diet because the sub-
ject active ingredients are naturally occurring (or are synthesized
to approximate the naturally occurring forms) in plants. The U.S.
EPA observed, parenthetically, that plants are part of a normal
human diet and all plants produce cytokinin.
The U.S. EPA noted that these substances are effective plant
regulators when applied at low rates, but are often herbicidal
when applied at high rates. The toxicological data they present-
ed demonstrate that testing at high doses yields few effects in lab-
oratory animals. Doses high enough to cause toxicity in animal
studies would represent application rates toxic to crops (high,
herbicidal rates). The EPA specifically noted that no additional
toxicity data are needed for cytokinins because they are natural-
ly occurring in numerous plant food sources and are available as
a food supplement. In studies using laboratory animals, cytokinin
has generally been shown to be of low acute toxicity. These eval-
uations all refer to topical applications of cytokinin, so its
increased expression within the plant tissue should be assessed.
As measured so far, the SAG promoter expression levels will
be low and should only occur in specific cells undergoing PCD.
The metabolism of the target nutrients, protein and oil, within
humans and animals is very well understood. From studies to
date, there are no expected or unexpected pleiotropic changes
in nutrients and antinutrients or intermediary metabolites in the
maize (personal communication, Daniel Gallie 2005, unpub-
lished data). Also, there have not been any adverse effects on
expression of other plant genes directly or indirectly through
transcription factors or mRNA stability.
3.4 Genetic Modification Details
3.4.1 Inserts
Embryogenetic maize callus from the HiII inbred line (derived
from A188 B73) was used for transformation by particle 
bombardment. One hundred sixty-eight plants were regenerat-
ed from 18 transformation events as described by Armstrong
(1994). Transgene-containing plants were crossed to B73, and
the progeny were selfed. Rescue of the lower floret was exam-
ined in T3 kernels of self-pollinated T2 plants.
3.4.2 Selectable marker: bar gene
Plasmid pAHC20 (Christensen and Quail 1996) contains the
selectable bar gene (phosphinothricin acetyl transferase) that
confers tolerance to the herbicide Basta (active ingredient glu-
fosinate ammonium) under the control of the maize ubiquitin
promoter. This plasmid was codelivered with the SAG12-IPT
construct to select for transformants on the plant selective antibi-
otic, bialaphos (the enzyme phosphinothricin acetyltransferase
inactivates phosphinothricin, the active ingredient of the herbi-
cide bialaphos, by acetylation). The biochemical and toxicolog-
ical characteristics of glufosinate have made it a popular, nons-
elective herbicide, which has been commercialized as Basta®
and Liberty® by Bayer CropScience. Some microorganisms can
detoxify glufosinate by producing an enzyme that catalyzes
acetylation of the amino group. The bar and pat genes, isolated
from different Streptomyces species, both encode a phos-
phinothricin acetyltransferase (PAT) and are widely applied in
plant genetic engineering. The gene from S. hygroscopicus has
been referred to as bar (for bialaphos resistance) and that from
S. viridochromogenes as pat. Treatment of genetically modified
plant cells carrying a bar gene with glufosinate or bialaphos pro-
vides a very efficient means of selection in transformation pro-
tocols. Although the double-embryo maize will be marketed for
the intended increase in protein and oil, the presence and
expression of the bar gene enable tolerance to commercial
applications of the herbicide glufosinate ammonium and, there-
fore, this product should also be regarded as a herbicide-
tolerant crop.
3.4.3 Active construct
Achieving floret rescue using cytokinin required a system that
avoided undesirable pleiotropic effects. In the cytokinin biosyn-
thesis pathway, the 1st committed and controlling step is cat-
alyzed by IPT. Therefore, expression of this enzyme will result in
the production of cytokinins. The native plant IPT has not been
identified, but a bacterial version (Agrobacterium) is available
(Agrobacterium infection can cause a cytokinin-induced tumor
to develop). However, having an expressed gene is not sufficient
in and of itself. Cytokinins regulate a variety of developmental
processes in addition to leaf senescence, such as rooting and api-
cal growth (McKenzie and others 1998); cell division and assim-
ilate import and partitioning (Brenner and Cheikh 1995); and
vascular tissue differentiation (Aloni 1995). To avoid direct inter-
ference with these other aspects of normal plant development,
Gan and Amasino (1995) cloned a highly senescence-specific
SAG12 promoter to target cytokinin biosynthesis to the senescing
tissues in transgenic tobacco plants. Transgenic tobacco plants
expressing this chimeric gene do not exhibit the developmental
abnormalities usually associated with IPT overexpression
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1For acute oral, dietary, mammalian/avian/aquatic toxicity: Category I = very highly or
highly toxic, Category II = moderately toxic, Category III = slightly toxic, Category IV 
= practically nontoxic.
because the system is targeted to senescing leaves and negative-
ly autoregulated, thus preventing developmental abnormalities.
Because sufficient cytokinin is produced to retard senescence,
the activity of the senescence-specific promoter is attenuated.
Senescence-retarded leaves exhibit a prolonged, photosyntheti-
cally active life span. This result demonstrates that endogenously
produced cytokinin can regulate senescence and provides a sys-
tem to specifically manipulate the senescence program without
further phenotypic developmental abnormalities (Gan and
Amasino 1997). Taking this into consideration, the construct used
is pSAG12–IPT, composed of the Agrobacterium IPT gene under
the senescence-specific Arabidopsis SAG12 promoter (Gan and
Amasino 1995). In this instance, the construct targets the female
pistils undergoing apoptosis (as opposed to senescence) and res-
cues them, resulting in a fertile floret.
3.4.4 Proof of gene insert in transgenic plants
The presence of the IPT transgene was determined by poly-
merase chain reaction (PCR) in seedling leaves using HotStarTaq
(Qiagen) in a reaction containing dNTPs (deoxynucleotide 5’-
triphosphate), MgCl2, forward primer (SAG12F2; CGTACG-
TATCCCTCTTGTCGTCTAATGA), and reverse primer (IPTR1;
CGTTCCTTTCAGTTCTTCCACTGTTGGT). The principal basic
concern is unexpected, unintended pleiotropic effects of
adverse cytokinin expression. However, given the specificity of
the SAG12 promoter, this is unlikely to occur and if it does, such
events should be easily eliminated early in the screening
process because of growth and morphological abnormalities
and, later, yield drag. However, these concerns center on com-
mercialization rather than safety.
3.5 Recommended Future Analysis
3.5.1 Molecular analysis
An appropriate analysis should include characterization of
the number of insertion sites, number of gene copies, and the
presence/absence of fragments.
3.5.2 Comparative safety assessment analysis
The product development process that selects a single com-
mercial product from hundreds to thousands of initial transfor-
mation events eliminates the vast majority of events that experi-
ence unintended changes caused by the inappropriate insertion
(or expression) of the transgene construct, or the action of its
resulting phenotype on unintended targets. In addition, the
selected commercial product candidate event undergoes
detailed phenotypic, agronomic, morphological, and composi-
tional analyses to further screen for unintended effects that
would limit commercial acceptance or product safety.
However, it is recommended that, as part of the safety assess-
ment of the lead double-embryo maize line, compositional and
nutritional analysis should be performed, using the parental line
and other elite maize hybrids as comparators. OECD (2002)
explains that such a comparison should include macro- 
and micronutrients, antinutrients, and natural toxicants, and
should identify the similarities and differences between the 
double-embryo maize and the conventional counterpart. In
addition, if this is to be adopted to meet nutritional needs, then
while not specifically relevant to safety and nutrition assess-
ment, agronomic performance and phenotypic characteristics of
double-embryo maize should be compared to parental and
other conventional maize hybrids to identify unexpected differ-
ences that might have resulted from introduction of the trait. A
normal phenotype is an indicator that there have not been
enough alterations to affect safety.
Based on the differences identified, further investigations may
be carried out to assess the safety and/or efficacy of these differ-
ences on double-embryo maize. Some of the already known dif-
ferences between double-embryo maize and conventional
maize are the introduced protein and associated metabolites,
including the changes to the cytokinin PGR levels. Besides 
the intended effects of the genetic modification, interactions of
the inserted DNA sequence (and the products thereof) with the
plant genome are also possible sources of unintended effects
that are assessed as part of this comparative process. Feeding
studies with rats and broiler chickens might also be done to
determine the nutritional feeding value of the increased protein
and oil in double-embryo maize.
The introduced IPT protein is not similar to any known aller-
gens and is not derived from any allergenic protein families;
therefore, it is unlikely to provoke an allergic response. While
the digestibility of the IPT protein has not yet been determined
due to its relatively small size (37.2 KDa) and nonextensive post-
translational modification, there is a limited likelihood that it
will be allergenic. Similarly, although acute toxicity studies with
IPT have not been reported to date, the enzyme has no relation-
ship to known toxicants and the protein as noted is likely to be
present at very low concentrations in maize. If the protein is
readily digested in simulated gastric fluid, then it is likely that




Recommendation 1. Foods and feeds from double-embryo
corn should be evaluated for the potential impact on health,
with particular focus on those components and associated
metabolites specifically altered in the crop, when they are char-
acterized.
Recommendation 2. Human dietary intake data and dietary
intake forecast models should be developed for at-risk populations.
3.6.2 Nutrition assessments
Recommendation 1. Premarket assessments should be con-
ducted to evaluate the potential impact on nutrient intakes of
consumers, paying particular attention to the expected benefits
obtained from higher protein and oil.
Recommendation 2. While feeding studies in laboratory ani-
mals and livestock species are unlikely to contribute to the
detection of unintended effects in a new crop because they 
lack adequate sensitivity, in the case of double-embryo corn,
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livestock feeding studies with target species should be conduct-
ed on a case-by-case basis to establish the nutritional benefits
that might be expected.
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4.1 Introduction
Sweetpotato is a root crop that is grown in many countries
(Woolfe 1992). It is grown predominantly for human food in
Africa, whereas it is produced primarily for animal feed in China
(Box 4-1). Sweetpotato roots vary in color, with orange-fleshed
types being particularly rich in -carotene, the most important
provitamin A carotenoid. Irrespective of their color, all sweet-
potato are low in protein quantity and quality (Egnin and Prakash
1997; Prakash and others 1997).
Some orange-fleshed varieties
are found naturally, while others




have also been developed
(Woodward and others 1999;
Wambugu 2001). In both cases,
selected orange-fleshed varieties
are being further developed
through participatory breeding
initiatives with local farmer communities to incorporate agro-
nomic traits that farmers want.
The orange-fleshed sweetpotato (Figure 4-1) is one of the bio-
fortified crops the HarvestPlus program is developing as part of
the global effort to control vitamin A deficiency (www.harvest-
plus.org; see Appendix 1 on VAD). The aim of HarvestPlus is to
make available varieties that can contribute significantly to meet-
ing the recommended daily intake of vitamin A for preschool
children. A number of food science and nutrition studies have
been carried out, showing that most of the provitamin A
carotenoid is retained after simple processing and that consump-
tion of these products can improve the vitamin A status of defi-
cient children. Beta-carotene has not been reported to be toxic at
intake levels observed for orange-fleshed sweetpotato.
The use of ASP-1 protein to increase the protein quality and
quantity in sweetpotato has been achieved by introducing the
asp-1 gene coding for the ASP-1
protein through recombinant
DNA techniques at Tuskegee
Univ. (Egnin and Prakash 1997).
The genetically modified sweet-
potato has the potential to
improve its contribution to both
the protein quantity and quality
in human and animal diets in
areas of the world where it is
grown indigenously.
Sweetpotato has a history of
safe use in humans as it is widely
consumed, especially in Eastern,
Western, and Southern Africa. This document contains case stud-
ies for the provitamin A-enriched sweetpotato lines developed by
the Intl. Potato Center “Centro Intl. de la Papa” (CIP) using con-
ventional breeding, and the protein-enriched sweetpotato devel-
oped by Tuskegee Univ. via a transgenic approach. In both cases,
the origin of the improved crop is reviewed and the possible
impact on both safety and nutrition is assessed.
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Chapter 4: Nutritionally Improved Sweetpotato
ABSTRACT: Sweetpotato is grown in many developing countries, and varieties can be white-, yellow-, orange-, red-,
or purple-fleshed. This crop is a secondary staple food crop in parts of Eastern and Southern Africa, and an impor-
tant component of animal feed in countries such as China. This case study describes and compares 2 nutritional
improvements of sweetpotato. One improvement involves selecting and breeding orange-fleshed sweetpotato as a
biofortified crop to reduce vitamin A deficiency in Africa. The 2nd improvement aims to increase both the quality
and quantity of protein in sweetpotato through the introduction of the synthetic asp-1 gene (Kim and others 1992;
Prakash and others 1997). Nutritional issues considered include the role of the sweetpotato in human nutrition,
with a focus on Africa, and its potential to combat vitamin A deficiency and undernutrition; and its role in animal
nutrition, specifically through increasing both the level and quality of protein. The protein case study concentrates
on the event TA3 developed at Tuskegee Univ. (Egnin and Prakash 1995, 1997), which has been shown to have no neg-
ative agronomic characteristics. In terms of safety, the history of sweetpotato use and the measurement of a num-
ber of antinutrient compounds in this crop, such as oxalic acid, trypsin inhibitor, and furanoterpenoid compounds,
are considered. If the orange-fleshed sweetpotato are to be used in animal feed in a way not previously done, it is rec-
ommended that additional nutritional testing, such as for performance and bioavailability, be carried out in domes-
tic animals. Four studies are recommended for the ASP-1 sweetpotato. First, testing the safety of the genetic modifi-
cation with the asp-1 gene and derived ASP-1 protein. Second, carrying out supplementary compositional studies
focused on, for example, appropriate antinutrients, such as oxalic acid, trypsin inhibitor, and others where appro-
priate. Third, documenting the phenotypic properties of the sweetpotato line and its comparator grown in represen-
tative production sites. Fourth, measuring the performance of animals fed ASP-1 sweetpotato compared with those
fed conventional sweetpotato varieties. These studies could use a suitable animal model; an ILSI task force formu-
lated guidelines for this type of study in a report titled Best Practices for the Conduct of Animal Studies to Evaluate
Genetically Modified Crops (ILSI 2003). Data on protein bioefficacy in the enhanced protein sweetpotato are avail-
able from 1 hamster study.
Box 4-1—Sweetpotato
• Grown in many countries, particularly China, for animal feed:
roots and vines.
• Human food, especially in Africa: roots consumed boiled,
baked, or fried or as processed products such as starch,
noodles, cakes, or juice.
• Rich in carbohydrate and low in protein.
• Different colored types, including white-, yellow-, orange-,
red-, or purple-fleshed, which vary in the concentration of
provitamin A carotenoids.
4.2 Sweetpotato and its Role in Nutrition
4.2.1 Origin and agricultural production
Sweetpotato (Ipomoea batatas L.) belongs to the morning
glory family (Convolvulaceae), and both the storage roots and
leaves are edible. It is thought to have originated in southern
Central America. Early trading vessels disseminated sweetpotato
throughout the world. Sweetpotato has long been an important
food crop to many peoples, particularly to the poor, and is the
6th most important food crop in the world and 4th most impor-
tant in the tropics (FAOSTAT 2004).2
Sweetpotato has a starchy and sweet taste, with different varieties
having their own unique flavor profiles. They are often grouped into
2 categories depending on texture; some are firm, dry, and mealy
when cooked, while others are soft and moist when cooked.
World annual production was > 127 million metric tons in
2004, 98.5% of which was in developing countries (FAOSTAT
2004). Asia accounts for the largest part of world sweetpotato
production, which amounted to 112.4 million tons annual pro-
duction in 2003 (FAOSTAT 2004). Production is greatest in
China, accounting for 94% of the Asian sweetpotato production.
In contrast, African farmers produced about 11.4 million met-
ric tons of sweetpotato in 2003 (FAOSTAT 2004). These data
need to be interpreted with caution because of the difficulties in
estimating production for a crop produced by small farmers on
noncontiguous plots, harvested several times a year, and neither
sold through regulated domestic marketing channels nor traded
internationally in appreciable quantities. In many developing
countries in Africa, Asia, Latin America, and the Caribbean, the
sweetpotato is a secondary staple food or an important vegetable
crop that is grown primarily by poor small farmers. Sweetpotato
is typically a small farmer crop and often grown on marginal soils
with limited yields. For example, in Kenya the average plot size
is < 0.2 hectares, and about half of the harvest is kept for home
use. Because sweetpotato is considered a “backyard crop,” there
are no reliable data on the extent to which it contributes to local
food supplies. Overall, average yield in developing countries is
low, at 15 metric tons per hectare, and there is wide variation.
For example, African yields are about one-third that of Asian
yields (CIP 2005). However, the sweetpotato is a reliable crop for
small-scale production, and because it can be left in the ground
for extended periods and harvested when needed, sweetpotato is
especially appealing to small farmers (Qaim 1999).
4.2.2 Use of sweetpotato
Both the amount of sweetpotato consumed and the manner in
which it is consumed vary widely. Average annual per capita sup-
ply of fresh roots for 2003 was estimated as Africa, 112 kg; Asia,
16 kg; Oceania, 18 kg; North and South America, 2 kg; Europe
< 0.5 kg (FAOSTAT 2004). Sweetpotato consumption also varies
within countries, by regions, by time of year, and by income
group. Green tips are used as a vegetable in some areas and can
be an important source of protein and micronutrients.
Sweetpotato is widely used by small farmers to sustain local live-
stock production systems. Almost everywhere that sweetpotato is
cultivated, some part of the plant, in some form, is used in some
type of animal production. Sweetpotato roots and vines are being
increasingly used in pig and other livestock systems in China, and
FAO estimated that 50 million tons in 2002 was used as feed (FAO-
STAT 2004). About 45% of Asia’s domestic sweetpotato supply is
used for animal feed, and nearly 50% is used for human consump-
tion, either as fresh or processed products (CIP 2005).
In contrast, 85% of Africa’s domestic sweetpotato supply is for
human consumption. For example, per capita sweetpotato con-
sumption in Rwanda is estimated as 147 kg/y; Burundi, 120 kg/y;
and Uganda, 88 kg/y, and most of this occurs in the drier sea-
sons. Sweetpotato can be used as a seasonal staple when there is
a shortage of other foodstuffs (CIP 2005). It is also an important
crop in northern regions of South Africa. In Africa, commercial
farmers use vines as fodder for livestock. Humans consume both
the roots and young leaves and tips as green vegetables.
Sweetpotato root is generally consumed boiled (and mashed) or
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Figure 4-1—Orange-fleshed sweet-
potato roots (left, photograph USDA-
ARS/K9231–1/S. Bauer), and plants
growing in pots (right, courtesy
Tuskegee University, Ala., U.S.A.).
2The book by Woolfe (1992) is an excellent source of general information on sweetpota-
to and has served as reference for many of the general considerations elaborated in the
following sections.
fried. It is also processed commercially or at home into flour that
is then often mixed with other flours to make a composite flour.
These flours are used to make porridge, which is an important
complementary food for breastfed children. Less commonly, the
flour is used to make bread and pastries. Poor households tend
to eat boiled or baked sweetpotato roots. Fresh roots are also
fried and the chips eaten as a snack food.
In China, humans mostly consume sweetpotato as a vegetable
or health food, not as a staple food, and the roots are typically
boiled or baked. Sweetpotato starch is used for making fresh or
dry starch noodles and sheets, and for fresh starch cakes. Snacks
of dry sweetpotato slices and bars are also popular. In Japan, con-
sumers use many of the deeply colored root varieties and con-
sume sweetpotato mostly as processed snacks, noodles, and can-
dies. Sweetpotato is grown and the roots are consumed in the
drier and poorer regions of India.
In Latin America, there is great diversity of varieties. Most sweet-
potato roots are again eaten boiled or baked. Use varies in the
Caribbean region. Sweetpotato is the main staple in some South
Pacific islands, especially in Papua New Guinea highlands where
many varieties are available, providing the dominant portion of the
energy and protein requirements of the population (Okuda and
others 1981; CIP 2006). In Oceania, in 2002, it was the most
important tuber and root crop after potato (FAOSTAT 2004).
For long-term storage, the roots are sliced into thin chips for
food or strips for animal feed that are sun- (usual) or shade-dried.
Chips can be stored in the dried state, rehydrated, and then
cooked. Alternatively, they can be ground into flour that can be
mixed with wheat as a composite flour; the proportions of wheat
and sweetpotato vary depending on taste. Pure or composite
flour is used to make gruels, bread, donuts, cakes, and other
products. Starch is extracted and used to make noodles, sheets,
and cakes in China.
In some countries, processed products made from sweetpota-
to, including starch, noodles, candy, desserts, and flour, are made
by farm households to extend the availability, diversify the use of,
and increase the value of the crop. In China, in particular, pro-
duction of sweetpotato starch in recent years has evolved into a
cottage industry that uses millions of tons of roots per year as raw
material inputs. The magnitude of these new uses is not easy to
quantify in a systematic way; partly for that reason, the available
statistics on processing do not always reflect their true level of
importance (CIP 2005).
Sweetpotato is also consumed in Europe and the United States
as a cooked vegetable. Sweetpotato has a low glycemic index,
indicating low digestibility of the starch despite its high carbohy-
drate content.
4.2.3 Sweetpotato as source of vitamin A
Biofortification of sweetpotato through conventional breeding,
which includes the selection of orange-fleshed varieties, is being
done with the intent of controlling vitamin A deficiency in devel-
oping countries. This is because -carotene is the most important
provitamin A carotenoid and the predominant carotenoid found
in orange-fleshed sweetpotato, and is more bioavailable than that
in carrot or green leafy vegetables for instance (for example, van
Jaarsveld and others 2005). The variation in provitamin A content
of newly harvested roots, however, can be as much as 45%.
In western Kenya, for example, where vitamin A deficiency is
a public health problem and white sweetpotato is an important
secondary staple food, orange-fleshed sweetpotato was intro-
duced and its consumption promoted along with that of other
vitamin A-rich foods (Hagenimana and others 2001). Ten
women’s groups—all of whom were farmers—grew a number of
sweetpotato varieties in on-farm, group plot, trials. Five groups
received nutrition education, individual counseling, and partici-
patory rapid appraisal techniques to promote vitamin A con-
sumption, while the other 5 served as the control groups and
received no additional promotion. Changes in the amount of
vitamin A consumed by their children under 5 y old were
assessed before and after 1 y of the program using the Helen
Keller Intl. food-frequency method (Rosen and others 1993).
Roots were analyzed for -carotene content in the form of
boiled and mashed puree, sweetpotato flour, and processed prod-
ucts. Children in the intervention group consumed vitamin A-rich
foods 93% more often than the control children, especially
orange-fleshed sweetpotato, mangoes, dark-green leafy vegeta-
bles, butter, and eggs. The yields of orange-fleshed sweetpotato
were at least twice those of white sweetpotato, as were the taste
and appearance ratings. The dry matter content exceeded 25%.
Beta-carotene values were such that 1 cup of boiled and mashed
sweetpotato fed daily to children under 2 y old would meet their
requirement for vitamin A, using the U.S. Inst. of Medicine’s
(2001) 12:1 -carotene:retinol conversion. The authors conclud-
ed that orange-fleshed sweetpotato produced and prepared by
women farmers can serve as a key food-based entry point for con-
trolling vitamin A deficiency (Hagenimana and others 2001).
The Intl. Potato Center is working with national agricultural
research institutes to breed provitamin A-rich sweetpotato in
Ethiopia, Ghana, Kenya, Mozambique, Rwanda, South Africa,
Tanzania, and Uganda. China, too, is breeding and promoting
orange-fleshed sweetpotato in Sichuan province.
Africa’s predominant sweetpotato cultivars are white- or yel-
low-fleshed varieties. The former contain no provitamin A, while
the latter contain small amounts. The orange-fleshed varieties
tend to have a high moisture content, while adults prefer varieties
with a low water content. In East and Central Africa, preference
is for varieties with > 27% dry matter, while in southern Africa
varieties with 15% are acceptable.
About 40 varieties of sweetpotato high in both provitamin A
and dry matter have been introduced to sub-Saharan Africa. Of
these, 10 to 15 varieties are being tested widely in different agro-
ecological areas in some countries (Table 4-1).
Besides -carotene, orange-flesh (and both white and yellow
flesh) sweetpotato roots are an important source of carbohydrate-
energy, vitamin C, vitamin B6, copper, potassium, iron, and fiber.
The vitamin C and -carotene may work as antioxidants to help
eliminate free radicals, which are molecules that contribute to the
damage of both cells and cell membranes and are associated with
the development of conditions such as colon cancer, atheroscle-
rosis, and heart disease (for example, Roomi and others 2005).
4.2.4 The expected dietary impact 
of vitamin A-enriched sweetpotato
To determine the expected dietary impact of consuming 
-carotene-rich sweetpotato, 3 factors have to be considered:
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retention, bioconversion, and intake levels (see Appendix 3). The
HarvestPlus project’s aim is to make available and encourage
households in vitamin A-deficient areas to substitute orange-
fleshed varieties for the white-fleshed sweetpotato currently
eaten, thereby increasing vitamin A intakes.
The carotenoids in orange-fleshed sweetpotato comprise
almost exclusively trans--carotene (Rodrigues-Amaya and
Kimura 2004). The 13-cis--carotene and a few other unidenti-
fied carotenoids are present in much smaller amounts. Cis--
carotene increases in boiled mashed sweetpotato and also in
sweetpotato chips, but the level remains very low relative to
trans--carotene. Table 4-1 shows the level of -carotene in dif-
ferent varieties of colored sweetpotato.
True retention2 of -carotene has been assessed for the Resisto
variety. Between 80% and 90% of the -carotene was retained
after boiling and mashing depending on the size of the root and
boiling conditions—time and whether a lid was used (van
Jaarsveld and others 2006).3 K’Osambo and others (1998)
observed similar results, although retention  rather than true
retention was measured. However, true retention after shade dry-
ing was 18% to 23% and after sun drying 9% to 15% (van
Jaarsveld and others 2004).
In terms of bioconversion, a stable isotope study in humans
found the relative vitamin A equivalency factors (-carotene:retinol,
wt:wt) for sweetpotato to be about 13:1 (Haskell and others
2004), which is similar to the current recommended vitamin A
equivalency factor of 12:1 for -carotene from plant foods (Inst.
of Medicine 2001).
The per capita consumption of sweetpotato in different geograph-
ic areas around the world may not undergo any significant change
in the short term. Governmental and nongovernmental promotion
to substitute nonorange varieties with orange varieties may gradual-
ly increase the consumption of the -carotene-rich varieties.
4.2.5 Sweetpotato as source of protein
As mentioned previously, sweetpotato is not a rich source of
protein, and the quality of the protein is not high, particularly the
content of tryptophan and sulfur amino acids (Ravindran and
others 1995; Egnin and Prakash 1997; Prakash and others 1997;
Shireen and Pace 2002). Consequently, human and animal diets
that contain sweetpotato as a major component of the diet
require inclusion of high-quality protein sources.
The introduction of the protein-enriched sweetpotato would
provide an additional source of protein with improved quality as
well as carbohydrates and micronutrients. The protein-enriched
sweetpotato will have an important benefit for animal nutrition,
given that sweetpotato roots are already a common constituent of
animal feed in some countries (for example, China). In addition,
the genetically modified protein-enriched ASP-1 sweetpotato was
initially developed as a potential food for astronauts on long-term
space missions. The improved protein content and high nitrogen
bioavailability will not reduce undernutrition in developing coun-
tries if energy intakes do not increase currently because the pro-
tein will be converted to energy (more on the issue of protein-
energy malnutrition can be found in Appendix 4).
Most of the proteins in sweetpotato roots are sporamin proteins
with trypsin inhibitory activity that have a role in storage, plant
protection (defense against pathogens), and regulation of
endogenous protein-degrading enzymes (Shewry 2003). Trypsin
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Variety Colora Sourcea DMb (%) Mean -carotene
mg/100 g fresh wtb
Source of roots
assayed
Ejumula Intermediate orange Local landrace from
Uganda
25 to 39 5590 to 15288 Tanzania, Uganda
Japon Intermediate orange CIP-introduced 23 to 34 2903 to 8887 Mozambique, Uganda
Jewell Intermediate orange American variety 24 14528 Tanzania
Jonathan Orange CIP-introduced 29 3634 Mozambique
Kala Deep yellow Local landrace from
Uganda
37 183 to 1592 Uganda
Karoti Dar Orange Local landrace from
Tanzania
31 to 36 2490 to 10281 Tanzania
Resisto Deep orange American variety 25 to 33 3140 to 17530 Mozambique,
Tanzania
Simama Deep yellow Improved variety from
Tanzania
42 73 Tanzania
SPK 004 –Kakamega Orange Kenyan improved vari-
ety
23 to 42 860 to 13336 Tanzania, Uganda
Tainung Deep Orange CIP-introduced 24 to 34 10570 to 17326 Mozambique,
Tanzania
Zapallo Deep orange Tanzania/Uganda 20 1526 Tanzania
Table 4-1—Sweetpotato varieties in Africa.
3[(Carotenoid content per g of cooked food x g of food before cooking)/(nutri-
ent content per g of raw food x g of food before cooking)] * 100
a CIP program reports; b DM = dry matter, values are ranges; values for -carotene are ranges; Generose Mulokosi, Tanzania Food and Nutrition Center,
personal communication, 2005.
4[Carotenoid content per g of cooked food (dry basis)/carotenoid content
per g of raw food (dry basis)] * 100.
inhibitor activity in roots impairs protein digestibility. Boiling
roots reduces the trypsin inhibitor activity and thus improves pro-
tein digestion (Dominguez 1992). In addition, some studies show
that ensiling can be an energy-efficient alternative for this pur-
pose (Peters and others 2002).
Whereas sweetpotato roots are low in protein, the green parts
(vines) are a good source, but have the drawback of being high
in fiber. Therefore, vines can only be fed in limited quantities to
nonruminants. In addition, both root and vine proteins are defi-
cient in essential amino acids, particularly tryptophan, but also
in lysine and sulfur amino acids such as methionine (Dominguez
1992; Egnin and Prakash 1997; Prakash and others 1997;
Dapeng and Xiu Qing 2004). Therefore, protein supplements are
needed in sweetpotato-containing animal diets. Given that root
protein content is inversely related to dry matter content, con-
ventional breeding for high protein is difficult (Dapeng and Xiu-
Qing 2004) and may conflict with the preference of some con-
sumers, including Africans, for high dry matter content.
Nevertheless, 2 sweetpotato lines with low trypsin inhibitor and
high protein levels in roots are being developed by conventional
means for animal feed and human food applications (Toyama
and others 2006).
Improving both the protein quantity and quality in sweetpota-
to roots would thus benefit animal nutrition and diminish or
obviate the need for supplementation with high-protein feed
ingredients.
4.2.6 Expected dietary impact 
of ASP-1 modified sweetpotato
Genetic modification for nutritional purposes has helped to
improve the nutrient content of certain foods (see other case
studies). Despite the potential benefits of this approach, such
foods are yet to be introduced into commerce and specifically in
countries where they would be most effective. The ASP-1 protein-
modified sweetpotato was engineered to improve the quality of
protein in sweetpotato, which can be of benefit to animal diets
that are high in sweetpotato and human diets.
In addition to the safety considera-
tions, 2 main factors have to be consid-
ered to determine the expected dietary
impact of using ASP-1 modified sweet-
potato—acceptability and intake levels.
Protein-energy malnutrition results
when the diet lacks energy and
macronutrients. Protein-rich sweetpota-
to could be part of a strategy against
undernutrition in the long term if total
energy intake increases. In terms of
acceptability, the dry matter content is
likely to be an important factor because
many consumers prefer a high content.
4.2.7 Antinutrients in sweetpotato
Compositional analysis is part of the
safety assessment of GM crops in gener-
al and commonly includes a range of
nutrients, antinutrients, and important secondary metabolites
that can be measured in roots and leaves. Unlike many major
crops, there is no OECD consensus document to guide the com-
position analysis for sweetpotato.
Sweetpotato contains a number of antinutrient compounds
that have been well described, including oxalic acid, trypsin
inhibitor, and furanoterpenoid compounds (Woolfe 1992;
Shireen and others 2001). Oxalic acid is an organic acid that can
complex with minerals during intestinal passage and may, there-
fore, alter their bioavailability. Stress conditions have been
reported to lead to increased levels of oxalic acid in sweetpotato
roots (Woolfe 1992). Trypsin inhibitors in sweetpotato, also des-
ignated sporamin, make up a large proportion of the soluble pro-
teins (60% to 80% depending on the variety). The number of dif-
ferent molecules and their characteristics (for example, suscepti-
bility to heat and pH) differ among sweetpotato cultivars (Scott
and Symes 1996). Heating, such as in cooking, removes some,
but not all trypsin inhibitor activity (Woolfe 1992; Sasi Kiran and
Padmaja 2003).
Testing for antinutrients is not routinely done in variety testing,
which focuses on productive traits such as yield and dry matter.
However, measurement of antinutrient levels is both common and
important in the comparative safety assessment of novel crops, such
as GM crops. Shireen and others (2001) analyzed the composition
of ASP-1 sweetpotato, specifically macronutrients, amino acids,
and trypsin inhibitor, as part of a nutritional study in hamsters.
Levels of secondary metabolites such as furanoterpenoids (for
example, ipomeamarone) may be negligible in nondiseased
sweetpotato, but elevated levels can be found in sweetpotato
plants suffering from insect or mold infestation. Ipomeamarone
and related compounds cause liver toxicity in experimental ani-
mals (Wilson and others 1970). Furthermore, molds growing on
diseases sweetpotato convert these furanoterpenoids to com-
pounds, such as ipomeanol, that exert cytochrome-P450-mediat-
ed toxicity on lungs, kidney, liver, and other organs of various
animals, and on liver of humans (Woolfe 1992; Lakhanpal and
others 2001). However, there are no reports of human adverse
reactions to sweetpotato, probably because most diseased sweet-
potato are discarded due to the bitter taste of furanoterpenoids,
and because the levels of these compounds are decreased by




4.3.1.1 Breeding and agronom-
ic performance of orange-fleshed
sweetpotato. Plant breeding is
ongoing with provitamin A–rich
orange sweetpotato varieties to
improve the sensory characteris-
tics (higher dry matter content)
and, at the same time, improve the
resistance to viruses and environ-
mental stress conditions such as
drought (Box 4-2). It should be
noted that sweetpotato is a polyploid (that is, it has more than
2n chromosomes), which makes breeding traits into sweetpota-
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Box 4-2—Orange-fleshed sweetpotato
• Rich in -carotene compared with white- and other
colored-fleshed types.
• Obtained through conventional breeding.
• Promoted by HarvestPlus to control vitamin A defi-
ciency, especially in Africa.
• Breeding program at CIP aimed at combining high
-carotene levels with high dry matter content and
disease resistance.
• Range of varieties available for further breeding by
local communities.
• History of safe use.
• Known to contain a number of antinutrient com-
pounds that have been well described, including
oxalic acid, trypsin inhibitor, and furanoterpenoid
compounds.
• Efficacy has been determined in a human study in
South African school children.
to difficult due to incompatibility, low seed setting, and 
sterility.
The Intl. Potato Center (CIP) considers any sweetpotato having
at least 100 g -carotene per gram of fresh root as being -
carotene rich. For HarvestPlus, this trait must be combined with
a high dry matter content and no loss of any agronomic traits for
the variety to be considered biofortified (Nestel and others 2006).
Efforts to develop new sweetpotato clones with high dry mat-
ter and high -carotene were initiated in 1996 at CIP’s headquar-
ters in Lima, Peru. More than 100 different sweetpotato lines
were used as parental materials. In all, more than 150000 off-
spring were developed and subjected to 5 seasons of recurrent
selection and evaluation. Of these, 100 superior clones were
selected for shipment overseas in 2002. By the breeder’s stan-
dards, all are considered to be high yielding, high in -carotene,
and to contain sufficient dry matter to meet local taste prefer-
ences. Because of significant clonal variation, farmers will have
options when selecting plants suited to local conditions. In terms
of safety, all the breeding material is based on clones that are
already consumed.
4.3.1.2 Maintaining desirable characteristics. Beta-carotene
content is inversely related to dry matter content (Manrique and
Hermann 2001). Breeding efforts have focused on increasing the
dry matter content through conventional breeding methods using
varieties with a higher dry matter content. The CIP breeders are
using recurrent selection in an attempt to break the linkage
between high dry matter and -carotene content so that these 2
traits can be combined. Parental clones are induced to flower by
grafting onto Ipomoea nil. All selected clones are thoroughly
evaluated for fresh yield, -carotene and dry matter contents,
resistance to root knot nematode (Meloidogyne incognita), and
virus diseases (www.harvestplus.org).
4.3.1.3 Synthesis pathway of -carotene. The key genes and
enzymes involved in -carotene synthesis have not been
described for sweetpotato, but the pathway seems to be similar
in plants, for example, in Arabidopsis and in bell pepper. The
biosynthesis of -carotene in plants is described in Appendix 2.
The molecular mechanism responsible for the increased and
variable levels of -carotene synthesis in the orange-fleshed
sweetpotato varieties compared with other differently colored
varieties is still unknown. This is not uncommon in that the pre-
cise molecular mechanisms underlying the desirable characteris-
tics obtained through conventional breeding are not known in
most cases.
4.3.1.4 Stage of product development—unique questions/
challenges. One variety of orange-fleshed sweetpotato has been
shown to be an efficacious source of provitamin A among South
African school children (see section 4.3.3.1). HarvestPlus is cur-
rently supporting research to assess the efficacy of daily con-
sumption of boiled or fried orange-fleshed sweetpotato to
improve the vitamin A status of nonpregnant, nonlactating
Bangladeshi women, and to estimate the relative vitamin A
equivalency of -carotene from the 2 different preparations of
orange-fleshed sweetpotato (boiled or fried).
Sweetpotato is currently a secondary crop, not the main staple
food, in the diet of people living in East and Southern Africa. To
increase orange-fleshed sweetpotato consumption, 2 criteria must
be satisfied: sufficient planting material must be available and the
material must have both the agronomic traits farmers desire and
the sensory traits (color and dry matter content) consumers want.
As stated previously, a number of sweetpotato varieties have been
selected for further optimization in collaboration with local farm-
ing communities. Improved varieties will be promoted through
national agricultural and public health nutrition programs.
4.3.2 Safety assessment (provitamin A sweetpotato)
4.3.2.1 History of safe use. Yellow- and orange-fleshed sweet-
potatoes are consumed around the world, in both developed and
developing countries.
4.3.2.2 Compositional changes. High -carotene concentra-
tion and dry matter content are the targeted selection goals for
sweetpotato programs. In changing the -carotene content, it is
possible that the carotenoid profile may also change.
The pathway leading to carotenoid biosynthesis has been well
studied in plants and microorganisms (Cunningham and Gantt
1998; Sandmann 2001; Taylor and Ramsay 2005). Data on the
pathway in sweetpotato are limited to analyses of carotenoids
and their intermediates in differently colored sweetpotato. The
results indicated that as the carotenoid level increases, the diver-
sity in the types of carotenoids decreases, with -carotene
becoming the predominant carotenoid (Woolfe 1992).
Products of conventional breeding have not traditionally been
subjected to the extensive compositional analysis, but their safe-
ty is supported by a history of safe use.
4.3.2.3 Metabolism of the target nutrient. The metabolism of
-carotene in humans and animals is considered in Appendix 3
and in section 5.5.3 of the Golden Rice 2 case study chapter.
4.3.2.4 Unintended changes. Unintended changes are not an
occurrence specific to genetic modification; they may also occur
in conventional plant breeding (Cellini and others 2004). Most of
the reported analyses of sweetpotato compare the carotenoid, 
-carotene, and dry matter contents of various sweetpotato vari-
eties. No unexpected changes have been reported during con-
ventional breeding in this species. In more general terms, unin-
tended effects may occur during breeding, and plants showing
unwanted changes are likely to be removed from the breeding
program, which in many cases will depend on the breeder’s
choice and remain nondocumented in public literature.
No metabolic pathways were intentionally changed in the
orange-fleshed sweetpotato varieties, which otherwise could
have been the target of an analysis of potential changes. Since no
foreign genes were introduced into the sweetpotato during the
traditional breeding processes, the safety assessment normally
applied to GM crops does not apply. The new varieties are
assumed to have similar metabolic pathways to those in their par-
ents, although the content or activity of certain enzymes could
have been changed in the new varieties compared with their
parental plants.
4.3.3 Nutritional assessment
4.3.3.1 Bioavailability of -carotene. An efficacy trial has
been conducted among 5- to 10-y-old South African children fed
125 g of boiled and mashed orange-fleshed sweetpotato (1031
g retinol activity equivalents per day as -carotene) or an equal
amount of boiled and mashed white-fleshed sweetpotato devoid
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of -carotene for 53 school days. Compliance was 90% in both
groups. Using the modified dose–response test, the study showed
an improvement in vitamin A liver stores of the treatment group
relative to the control group (van Jaarsveld and others 2005).
An earlier study by Jalal and others (1998) showed that serum
retinol concentrations markedly improved when dewormed
Indonesian children (5 to 10 y old) consumed meals containing
-carotene-rich sweetpotato (750 or 200 retinol equivalents per
day) and fat (27 compared with 12 g/d) for 3 wk.
A recent stable isotope study among Bangladesh men, howev-
er, found that daily supplementation with 750 g/d of RE from
sweetpotato for 60 d did not alter vitamin A stores (Haskell and
others 2004). The authors postulated that the food preparation
method (no fat) may have influenced such results because dietary
fat may influence the uptake of -carotene.
Bioavailability studies on -carotene from orange-fleshed
sweetpotato have not been carried out in domestic animals. It is
known that -carotene taken up from fortified animal feeds can
be present in edible animal products, such as chicken eggs and
dairy milk. For example, Woolfe (1992) cited several earlier stud-
ies showing that feeding dried roots of orange-fleshed sweetpota-
to led to the pigmentation of egg yolk of poultry, as well as to
increased levels of -carotene and vitamin A in cow’s milk.
Although the main focus of this chapter is on the human food
use of the orange-fleshed sweetpotato, a major part of the sweet-
potato production—including roots and vines—goes into animal
feed, particularly in China (see section 4.2.2). Bioavailability
studies with domestic animals usually measure the uptake of -
carotene from ingested feedstuffs into serum or liver (Lee and
others 1999). The efficiency with which -carotene is taken up
and mobilized into serum varies with animal species, with pre-
ruminant calves being considered efficient. However, the cost of
this animal model often precludes its use and swine or
Mongolian gerbils are used instead.
4.3.3.2 Animal performance and nutritional wholesomeness
of -carotene-rich sweetpotato. The orange-fleshed sweetpota-
to have not been intended as a nutritionally enhanced animal
feed per se, but this may change
depending on, for example, a shift
in the focus of programs promoting
the sweetpotato.
Woolfe (1992) provides an
overview of the animal feeding trials
that have been carried out with
sweetpotato. Nutritional require-
ments also vary within an animal
species, depending on the phase of
life such as lactation or weaning. For
pig feeding, sweetpotato and
derived starch commonly serve as
energy source. Performance and
digestibility feeding studies show
that maize in pig diets can be
replaced partially or wholly by
sweetpotato, while the same also
holds true for starches derived from cereals and from sweetpotato.
Feeding studies in poultry show that sweetpotato can at least par-
tially replace the maize component of chicken diets without
adversely impacting nutritional performance (for example, body
weight gain, feed efficiency) and meat or egg production. For pigs
and poultry, consideration should be given, though, to the possible
effects of trypsin inhibitors and crude starch on digestibility, which
may be prevented by appropriate processing techniques (Woolfe
1992).
Fermented sweetpotato roots and vines are reported to be used
as animal feed, as are byproducts of industrial processing of
sweetpotato, such as canning, distillation, and starch production,
which may be more common in developed countries (Woolfe
1992). Beta-carotene itself is also used as feed additive in some
species, such as horses, because of its reputed stimulating effect
on reproductive functions (Kienzle and others 2003).
4.4 ASP-1-containing Sweetpotato
4.4.1 Crop characteristics
Box 4-3 provides a summary of the characteristics of protein-
enriched sweetpotato. The engineering of sweetpotato varieties
was aimed at increasing the quality of protein for use as a food
for astronauts, but may also add value for other purposes, such as
food and animal feed, in various developing countries and some
southern U.S. states where it is grown.
4.4.1.1 Origin of the asp-1 gene. The protein ASP-1 is pro-
duced from a novel, synthetic transgenic storage protein gene
(asp-1) coding for a storage protein rich in essential amino acids
(EAA, 80%) with improved protein stability in plants. The coding
sequence of the synthetic asp-1 gene is 284 bp long (Prakash and
others 1997) The primary sequence consists of 4 repeats of an
amino acid sequence, linked by short regions (Figure 4-2) that
favor protein folding to produce a tetramer-like structure similar to
the plant storage proteins zein and phaseolin (Kim and others
1992).
4.4.1.2 Introduction of the asp-1 gene. The asp-1 gene was
linked to 35S CaMV promoter and Kozak translation enhancer
(Espinoza and others 1989; Egnin and Prakash 1995) and nos
terminator (Egnin and Prakash 1995) and inserted using
Agrobacterium tumefaciens-mediat-
ed transformation into sweetpotato
petioles. The vector DNA also
included an nptII gene (with nos
promoter and terminator) present at
the right border and a gus gene
(35S-GUS-nos) at the left border of
the transfer-DNA (Figure 4-3). A
number of different events were pro-
duced. Selection was achieved via
the nptII gene, and the resulting
transformants were screened by
polymerase chain reaction and
southern blot analyses for those that
contained asp-1 and did not include
the gus gene. The expression of the
asp-1 gene in multiple tissues,
including roots and leaves, was con-
firmed by northern and western blots (Egnin and Prakash 1997;
Prakash and others 1997). The lead event is TA3 and is the
event that is discussed in this case study. The insert in this event
has not been characterized with regard to copy number, or the
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Box 4-3—Protein-enriched sweetpotato
• Rich in protein compared with conventional types.
• Obtained through insertion of asp-1 gene.
• Aimed at improving the nutritional quality of protein
in sweetpotato.
• Known to contain a number of antinutrient com-
pounds that have been well-described, including
oxalic acid, trypsin inhibitor, and furanoterpenoid
compounds.
• Composition studies show changes in protein levels
but no other critical changes.
• Feeding studies on nutritional properties show no
adverse effects in animals compared with conven-
tional sweetpotato.
• May be useful in certain populations, but efficacy is
not yet proven on human populations.
presence or absence of additional elements from the transfor-
mation vector.
4.4.1.3 Agronomic performance and field trials. The 1st trials
were conducted at Tuskegee Univ. in 1997, using a split plot
design with 5 GM varieties, the isogenic line, and commercial
varieties. This was repeated at Tuskegee in 1999 and in the Virgin
Islands in 2000 (Egnin and others 2001a, 2001b).
Agronomic trials were also conducted at Tuskegee in row plots
in 1998, 2001, 2002, 2003, and 2004 to establish yield stability
and expression levels of ASP-1. In addition, hydroponic studies
were conducted to establish the expression pattern for ASP-1 and
the major native storage root proteins (sporamin and -amylase;
[Egnin and Prakash 1997; Egnin and others 1998, 2002, 2003]).
The yield of the TA3 sweetpotato is comparable to that of the
isogenic conventional sweetpotato (Egnin and others 1998,
2001a, 2001b). The mean yield of the TA3 was not statistically
different. In addition, the agronomic characteristics of TA3 were
equivalent to the comparator—there were no significant differ-
ences in growth pattern, photosynthetic efficiency, or other 
characteristics.
4.4.1.4 Stage of product development—unique
questions/challenges. The U.S. Natl. Aeronautics and Space
Administration at the Tuskegee Univ. Center for Plant
Biotechnology and Genomic Research supported this project as
part of a study to develop crops for use in space exploration. The
protein-enhanced sweetpotato has been grown in hydroponic
culture and tested in numerous field trails. In addition, there are
a number of studies on the protein content and composition of
the modified crop.
To increase consumption of protein-enriched sweetpotato, suf-
ficient planting material must be available. This could be
achieved by tissue culture propagation or increases from vines.
No studies of sensory traits of sweetpotato with increased protein
content have been carried out in humans.
4.4.2 Safety and nutritional assessment 
of the ASP-1-containing sweetpotato
4.4.2.1 History of safe use. Derived from the synthetic asp-1
gene, ASP-1 protein is a novel protein not previously consumed
by humans. However, ASP-1 has similarity to known crop seed
storage proteins. Bioinformatic analyses revealed no homology
to any known allergen (Egnin and Prakash 1997; Braithwaite
2001). The results show that ASP-1 protein shares the helix-turn-
helix motif with other storage proteins and is homologous to a
barley storage protein. This barley protein has transcription acti-
vator activity and such an activity could be the cause of increases
in the expression of -amylase and sporamin in the TA3 event.
ASP-1 protein has some sequence similarity to other artificial and
natural storage proteins and it is structurally similar to a trypto-
phan repressor, which blocks access to promoters by RNA poly-
merase, although the primary amino acid sequences have no sig-
nificant similarities.
In vitro digestibility data, which is a common part of regulato-
ry assessments of the potential toxicity and allergenicity of trans-
genic proteins, is not available for the ASP-1 protein. The Intl. Life
Science Inst. (ILSI) recently standardized the pepsin digestibility
assay protocol in a multilaboratory evaluation (Thomas and oth-
ers 2004), and this should be taken into account if this assay is
carried out on the ASP-1 protein.
The safety of the purified ASP-1 protein has not yet been tested
for its potential acute toxicity in laboratory animals. Given the nov-
elty of the protein, it is conceivable that, depending on the out-
comes of the in vitro and in silico studies with ASP-1, regulatory
agencies may require in vivo oral studies with purified ASP-1.
To test nutritional effects, small-scale feeding studies with stor-
age roots were carried out in hamsters, as a mammalian model.
Examination of the hamsters’ brain, liver, and kidney weights;
plasma and liver lipids; and bone calcification showed that GM
lines did not identify any adverse effects compared with animals
fed diets containing conventional sweetpotato (Shireen and Pace
2002; Shireen and others 2002).
4.4.2.2 Plant expression of the introduced genes. Analysis of
expression levels of transgene products is a common feature of
the safety assessment of GM crops. In addition, it enables estima-
tion of consumers’ exposure level to this new protein. The levels
of ASP-1 have not been determined with accuracy because of the
lack of a validated Enzyme-Linked ImmunoSorbent Assay (ELISA)
method. However, the ASP-1 protein is detectable in the storage
roots and shoots of sweetpotato containing the TA3 event and is
present in the expected tetrametric form. This size is seen in both
native and denaturing western blots.
The GM plants contain the nptII antibiotic resistance marker
gene, which was used for selection. This protein is recognized as
generally recognized as safe (GRAS) by the U.S. Food and Drug
Administration (Redenbaugh and others 1992; Fuchs and others
1993). The amount of NPTII protein has been determined in the
sweetpotato leaves (Jaynes and others 1985) but not in the roots.
A qualitative ELISA is commercially available, but there is no
commercial standard against which to quantify the results.
Because of this, the quantification of native and transgene pro-
teins was carried out through equal weight (sweetpotato storage
roots) and equal extraction volumes.
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Figure 4-2—Primary structure




















Figure 4-3—Vector used in produc-
tion of sweetpotato event TA3
(2006, personal communication
from M Egnin; unreferenced).
4.4.2.3 Compositional changes. Proximates were analyzed in
samples obtained from field trials that had been carried out on
split plots for 4 y. These analyses showed that dry matter, ash,
total carbohydrate, and crude fat were slightly increased, while
the amino acids lysine, tryptophan, methionine, threonine, and
isoleucine were significantly increased, up to manyfold for tryp-
tophan, over the control samples. In addition, 2- to 3-fold
increases in sucrose, glucose, and fructose levels were observed
(Egnin and Prakash 1997; Egnin and others 1998, 2001b, 2002;
Shireen and others 1999, 2001; Shireen and Pace 2002). In addi-
tion to ASP-1 protein being produced, quantities of sporamin
protein were also observed in storage roots grown in the field and
-amylase was increased about 2-fold; thus, total protein was
increased 3- to 5-fold. The same effects were found in sweetpota-
to roots grown in hydroponic cultures. In addition, protein levels
were increased 2- to 3-fold in the leaves. The increased total pro-
tein content of roots is thus primarily due to the enhanced levels
of native proteins, especially sporamin in the storage roots (Egnin
and others 2002), in addition to ASP-1. It is not clear what the
mechanism for this increase is, although homology of ASP-1 to a
barley storage protein with transcription activator activity might
be implicated.
4.4.2.4 Unintended changes. An unintended effect of express-
ing the asp-1 gene in sweetpotato is an increase in native protein
concentration in the storage roots, particularly the major proteins
sporamin and -amylase, and a general increase in protein con-
centration in leaves. The exact amount and nature of these
changes in leaves have not yet been determined. Sporamin is the
main protein present in sweetpotato roots and has some possible
trypsin inhibitor activity (Hattori and others 1985; Hou and oth-
ers 2001; Shireen and others 2001). Sporamin shares significant
amino acid sequence identity with some Kunitz-type trypsin
inhibitors, and has been shown to have trypsin-inhibitor type
activity (Yeh and others 1997). Heating, such as cooking, may
not remove all trypsin inhibitor activity (Woolfe 1992; Sasi Kiran
and Padmaja 2003). However, hamster feeding studies did not
show any deleterious effects of consuming raw sweetpotato flour.
As described previously, changes in dry matter and sugar content
were also observed. Chakraborty and others (2000) found similar
effects on protein concentration in potato (Solanum tuberosum)
using an amaranth protein gene. Studies of cassava expressing
ASP-1 were comparable to those in sweetpotato in terms of pro-
tein level increases (Zhang and others 2003). Thus, the observa-
tion of such increases in protein in plant storage tissues is not
restricted to this crop and protein gene, but may be a more gen-
eralized phenomenon.
The phenotypic and agronomic properties of selected cultivars
are also powerful indicators of the presence or absence of unin-
tended changes and, as stated previously, the TA3 event showed
no changes in agronomic characteristics (see section 4.4.1.3). In
addition, as with conventional breeding, plants showing unwant-
ed changes are removed from the program and remain nondoc-
umented in public literature.
Several antinutrients were not determined in this sweetpotato
event (Shireen and others 2001).
In hypothesis, the general increase in protein caused by the
modification might also have raised levels of any intrinsic aller-
gens of sweetpotato. However, sweetpotato is generally consid-
ered as being rarely allergenic or nonallergenic, and reported
cases of allergy are rare. For example, allergic reactions follow-
ing consumption of sweetpotato by a limited number of patients
were recently reported for the first time (Velloso and others
2004). In addition, there are no known accounts either of the
storage protein sporamin being an allergen.
4.4.2.5 Metabolism and nutrition of the target nutrient.
Proteins are distinct from other classes of nutrients in terms of
their size, digestibility, and metabolism. Most dietary proteins are
too large to be absorbed intact from the gastrointestinal tract and
are generally denatured by stomach acid and then digested by
exo- and endoproteases, such as those excreted into the stomach
and into the small intestine from the pancreas. The resulting
amino acids and short peptides are taken up by the mucosa, and
amino acids are translocated into the portal vein. The over-
whelming majority of dietary proteins, therefore, possess no
potential for systemic toxicity and no inherent hazard.
The expected endpoint of increased protein content and qual-
ity is improved human nutrition and health. The protein content
in TA3 is increased approximately 67% over the existing lines.
The levels of five of the most limiting essential amino acids
(lysine, tryptophan, methionine, threonine, and isoleucine)
increased, as did dry matter and sugar content.
Tryptophan is the most limiting amino acid and is almost
absent in sweetpotato. The TA3 material has about 100-fold the
amount of tryptophan than in conventional lines. To illustrate the
potential benefit, the amount of sweetpotato that would be
required to meet daily protein requirements could decrease from
5 kg to 300 g. However, one should keep in mind that sweetpota-
to is not the only food source of proteins. The appropriate com-
parator for feeding studies with the TA3 material is a diet contain-
ing another source of protein.
The results of a 28-d Syrian golden hamster feeding trial (10
animals/treatment) showed that the GM diet using freeze-dried
flour was palatable, and the increased protein and amino acids
were bioavailable to the hamsters. The animals fed TA3 sweet-
potato had no negative indicators compared with those fed con-
ventional sweetpotato (brain, liver, and kidney weights) (Shireen
2002). Hamsters fed with ASP-1 sweetpotato flour exhibited
equal total cholesterol, triglycerides, and LDL-cholesterol levels
in their plasma and liver when compared with those in the con-
ventional control group. The ASP-1 sweetpotato showed superi-
ority in true protein digestibility, net protein utilization, and bio-
logical value of the protein relative to the conventional control.
Thus the GM diet was palatable to the animals and the
increased protein and amino acids were bioavailable to the ham-
sters. However, it has not been shown that these proteins are
digested and made bioavailable to humans—a study using simu-
lated gastric and intestinal fluid could address this question.
4.5 Discussion of Differences and Similarities
These sweetpotato crop case studies demonstrate 2 types of
modifications that may be applied to a crop using different
approaches. As both these improved nutrition sweetpotatoes are
expected to offer benefits to the target populations, considering
both the risks and benefits and weighing these factors against
each other should be part of the risk analysis process for which the
safety and nutritional assessments serve as inputs (FAO/WHO
1997).
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In addition, it is important to consider the beneficial increase
in the intake of key nutrients, such as -carotene and protein,
due to the introduction of the modified varieties that substitute
for local varieties.
Compositional and nutritional data are available and show
that the orange-fleshed sweetpotato can be a good source of -
carotene in locations where the human population consumes
sweetpotato. High-protein sweetpotato has been shown to be an
excellent source of protein in hamster feeding studies.
There are a number of studies already completed on the safe-
ty and nutritional assessment of the ASP-1 protein itself and in the
GM sweetpotato. Molecular and animal studies have not identi-
fied safety concerns.
4.6 Recommendations
The preceding sections summarized the information regarding
the conventionally bred orange-fleshed sweetpotato and the
transgenic ASP-1 protein-enriched sweetpotato. It is noted that a
dichotomy exists with regard to the regulatory requirements for
both types of crops, with extensive data on molecular character-
istics, comparative compositional analysis, and the safety of
transgene products being required for the GM product. It needs
to be seen in this light that the following recommendations make
a distinction between the requirements of the orange-fleshed and
the ASP-1 sweetpotato.
For the orange-fleshed sweetpotato, the following recommen-
dation is made.
Recommendation 1. The promotion of orange-fleshed sweet-
potato described previously is not specifically geared toward ani-
mal nutrition, but to human nutrition. A number of studies test-
ing the nutrition of this sweetpotato in target human populations
have been carried out. There is no specific requirement to addi-
tionally test the nutrition of this sweetpotato in domestic animals.
However, it can be envisaged that in the future, orange-fleshed
sweetpotato might also be promoted for certain purposes in ani-
mal feed. If testing is useful, for example because of lack of expe-
rience with a new application in animal feed, the choice of the
appropriate animal model will depend upon the target animal
and the purpose of feeding this sweetpotato to these animals.
Guidance on animal trials is provided by a report authored by an
ILSI task force and entitled Best Practices for the Conduct of
Animal Studies to Evaluate Genetically Modified Crops.
For the ASP-1 sweetpotato, the following recommendations
are made.
Recommendation 1. The safety of the genetic modification with
the asp-1 gene and derived ASP-1 protein should be assessed in
the ASP-1-containing crop, including the characteristics of the
introduced and other affected proteins. This may entail studies
supplementary to those that have already been performed.
Recommendation 2. Compositional studies have been carried
out and should be examined for completeness. Supplementary
compositional analysis studies may consider, for example,
appropriate antinutrients, such as oxalic acid, trypsin inhibitor,
and others, where appropriate. It is noted that for other crops,
OECD has developed consensus documents with key parame-
ters for compositional analysis of new crop lines. However, such
a consensus document on sweetpotato has not yet been pub-
lished.
Recommendation 3. The phenotypic properties of the sweet-
potato line should be assessed when grown in representative 
production sites, as part of a comparative safety assessment.
Again, data exist for these parameters. The studies would ideally
compare the test sweetpotato with non-GM varieties. Based on
any differences identified, further studies may be needed to inves-
tigate the safety and nutritional properties of the enriched crop.
Recommendation 4. Performance of animals fed ASP-1 sweet-
potato compared with those fed conventional sweetpotato vari-
eties could be considered using a suitable animal model, for
which an ILSI task force, in a report titled Best Practices for the
Conduct of Animal Studies to Evaluate Crops Genetically
Modified for Output Traits, has formulated guidance (ILSI 2007).
For bioefficacy of the proteins in the enhanced protein sweet-
potato, a hamster study that gives some indication in this area is
available.
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5.1 Introduction
Golden Rice 1 stands as a prototype that demonstrated the fea-
sibility of using rice as a means to provide vitamin A precursors
to populations in which rice is the staple food (Ye and others
2000). However, replacing regular rice with Golden Rice 1 might
not increase -carotene intakes to the level of the total daily
requirement for vitamin A (Table 5-1, Dawe and others 2002;
Bouis and others 2003; Zimmerman and Qaim 2004). Table 5-1
assumes that the conversion of -carotene to vitamin A occurs
with a ratio of 12:1 (pessimistic) to 6:1 (optimistic). In the best-
case assumption, Golden Rice might improve vitamin A intake
by 20% to 60% of the RDA. Preliminary studies in 2 human sub-
jects showed a bioavailability/bioconversion of Golden Rice -
carotene to vitamin A in the range of 3:1 to 4:1 (2007 personal
communication from R Russell, unreferenced), which would
make Golden Rice effective in reducing or eliminating most of
the VAD’s adverse effects. This assumes that 100% of daily rice
intake is converted to Golden Rice. Economic analysis using
conservative assumptions indicates that, while not a panacea,
Golden Rice would save lives more economically than the inter-
ventions that are presently in use (Stein and others 2006). This
conclusion has recently been challenged (Krawinkel 2007) and
the researchers have responded that while Golden Rice would be
more efficacious than currently used interventions, it is intended
to supplement existing efforts rather than supplant them (Stein
and others 2007). Golden Rice 2 (Paine and others 2005), 
reported in this case study, was constructed using the same
genetic strategy applied in the construction of Golden Rice 1,
with the exception that the phytoene synthase gene from Zea
mays replaced the gene isolated from Narcissus pseudonarcissus.
Golden Rice 2 contains approximately 20-fold more carotenoids
than Golden Rice 1 and is, thus, a more promising source of vita-
min A for rice-consuming populations, which would not require
that all rice consumed be Golden Rice.
5.2 Rice in Human Nutrition
5.2.1 Host crop
Rice is the world’s most important cereal crop for human
nutrition. The earliest evidence of rice consumption dates back
approximately 5500 y in Thailand (www.therice.org/rice
/story.html), about 5000 y ago in India, and over 3000 y ago in
China. Wet paddy cultivation is the predominant production
technique, and more than half of the water used for agriculture
is devoted to rice (www.fao.org). Rice cultivation is a major agri-
cultural activity in many Asian countries. For example, more
than 50% of the population of China, Thailand, and Vietnam
engages in or directly depends on local rice agriculture. In Asia,
31% of all food energy consumed is from rice (country range =
2% to 71%); in Africa, 8% of energy intake is from rice (country
Chapter 5: Golden Rice 2
ABSTRACT: Golden Rice 1 was developed to help control vitamin A deficiency (VAD). To construct Golden Rice 2, the
phytoene synthetase gene (psy) from maize and the carotene desaturase gene (crtl) from Erwinia uredovora were
inserted into rice. Evaluation of phytoene synthase (the rate limiting step in carotenoid biosynthesis) from several
plant sources led to the identification of the psy gene from maize as the most efficacious source, resulting in the
greatest accumulation of total carotenoids and -carotene. Golden Rice 1 contains about 1.6 g of total carotenoids
per gram of dry weight of grain. Golden Rice 2 contains as much as 37 g total carotenoids per gram of dry weight of
grain, of which 31 g/g is -carotene.While the quantity of -carotene is high, its bioavailability is unknown. Golden
Rice 2 was developed with the expectation that it could make a major contribution to the vitamin A requirement. It
is conservatively estimated that a breastfed 1- to 2-y-old child could derive 60% of the of U.S. recommended dietary
allowance (RDA) from the consumption of approximately 70 g of uncooked Golden Rice 2; an average serving size
for a child this age in Thailand, for example, is 160 g. The higher level of -carotene raises the possibility that Golden
Rice 2 may help reduce many of the deaths attributed to VAD (Hess and others 2005). Biofortified rice with high lev-
els of -carotene is in an early stage of development. The published data provide a description of the DNA construct
introduced into rice and report the concentrations of both total carotenoids as well as that of the 5 major
carotenoids present in representative transgenic rice plants. The safety assessment of Golden Rice 2 follows gener-
ally accepted international guidelines. Beta-carotene biosynthesis is a peripheral biosynthetic pathway that diverts
very small amounts of biosynthetic precursors from plant metabolism and would, thus, not be expected to produce
major changes in composition. Hence, the safety assessment can be targeted to the impact of the insertion on cellu-
lar carotenoids and other metabolically related compounds. Plant phenotype, seed weight, and germination were
not affected by the presence of the genetic modification. Apart from safety concerns, there exists an urgent need for
studies to evaluate the efficacy of this product as a bioavailable source of -carotene in animals and humans. Proof
of efficacy would allow Golden Rice 2 to be widely distributed. Appropriate safety assessments are needed and
should at least include (1) characterization of the inserted DNA, (2) determination of the composition according to
OECD consensus documents, (3) analysis of the carotenoid metabolite pool, and (4) evaluation of the efficacy of this
product as a source of -carotene (although it is not related to safety). The safety of carotene desaturase gene (crtl)
and its products from E. uredovora requires characterization because it has no history of safe use in foods.
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range = 3% to 47%); in Latin America, 11% of all food energy
is from rice (country range = 1% to 30%). The contribution of
rice to energy intake in North America, Europe, and
Australia–New Zealand is negligible (<2%; IRRI 2005).
Additionally, rice consumption varies among countries and
within a single country among demographic groups; for exam-
ple, affluent urban dwellers usually consume less rice per capi-
ta than poor rural populations do (Regmi and Dyck 2001).
Although some rice is cultivated in Africa and the Americas (the
United States is the 3rd leading rice exporting nation in the
world), the majority of the rice consumed in these regions is
imported (IRRI 2005).
5.2.2 Uses and nutrient content of rice in food and feed
Rice is used primarily for human food although small amounts
of brown rice, rice bran, rice polishings, and rice hulls are used
in animal and poultry feed (OECD 2004). White (polished) rice
is not fed to animals because of its high cost. Brown rice contains
approximately 74% available carbohydrate, approximately 7.5%
protein (limiting amino acids = lysine and threonine), approxi-
mately 2% lipid, and 3% to 4% fiber. Brown rice provides signif-
icant quantities of thiamin, riboflavin, and niacin
(www.nal.usda.gov/fnic/foodcomp/search; USDA Natl. Nutrient
Database for Standard Reference, Release 19). A 100-g serving
provides 1455 kJ. Polished white rice contains approximately
78% available carbohydrate, approximately 6.9% protein,
approximately 1.4% fiber, and < 1% lipid. A 100-g serving of
white rice provides the same amount of energy as brown rice;
however, polishing removes > 70% of the niacin, thiamin, and
riboflavin and reduces the iron content from approximately 2.5
g/100 g by a similar percentage to < 0.6 g/100 g. Beriberi (thi-
amin deficiency) can occur in Asian countries among people
whose diets consist primarily of white rice (FAO 2001). Iron defi-
ciency is common in populations for whom rice is the primary
staple food (FAO 2001). Enriched white rice is fortified with iron,
thiamin, and niacin (and with folic acid in the United States since
January 1998) to control beriberi and iron deficiencies. Enriched
rice, however, is of little nutritional benefit to the large numbers
of rice consumers who grow their own rice or eat locally pro-
duced rice. Polished white rice is not a significant source of the
fat-soluble vitamins A, D, E, and K. The OECD has published a
consensus document on key food and feed nutrients and antinu-
trients found in rice (OECD 2004).
5.2.3 Expected geographic distribution 
and nutritional impact
VAD is widespread in South and Southeast Asia (Figure A1-1),
which are the major rice-eating regions of the world. Sub-
Saharan Africa, Central America, and parts of the northern 
portions of South America also have significant VAD. Rice con-
tributes significantly to the diet in parts of these regions, includ-
ing people who are most at risk of VAD. If nutritionally viable and
acceptable to consumers, Golden Rice 2 could be introduced to
approximately 1.5 billion people in these regions by substituting
Golden Rice 2 varieties for conventional rice. More information
on VAD is in Appendix 1.
5.3 Crop Improvement and Molecular Characteristics
5.3.1 Breeding
No rice cultivars produce carotenoids in the endosperm, but
they are capable of producing the precursor, geranylgeranyl
diphosphate. Phytoene synthase converts this compound to phy-
toene, the immediate precursor of -carotene in plants, and








Rice intake (g/d)a 121.00 245.00 274.00 121.00 245.00 274.00
Current VA supply from all food sources (µg/d)a 234.30 597.10 404.10 234.30 597.10 404.10
RDA for VA (µg/d)b 500.00 800.00 1250.00 500.00 800.00 1250.00
VA deficit (µg/d) 265.70 202.90 845.90 265.70 202.90 845.90
Beta-carotene intake through GR (µg/d) 145.20 294.00 328.80 363.00 735.00 822.00
VA from GR after bioconversion (µg) 12.10 24.50 27.40 60.50 122.50 137.00
Improved VA supply (µg/d) 246.40 621.60 431.50 294.80 719.60 541.10
Contribution of GR to reduce VA deficit (%) 4.55 12.07 3.24 22.77 60.37 16.20
Efficacy (%) 11.54 24.64 9.65 47.97 86.08 40.30
Table 5-1—Theoretical effectiveness of Golden Rice as a dietary source of vitamin A.
aThese figures are based on FNRI (1993). bThese figures represent internationally used RDAs (IOM 2002).
From Zimmerman and Qaim (2004).
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requires phytoene desaturase, -carotene desaturase, and
lycopene -cyclase. Phytoene desaturase and -carotene desat-
urase are involved in catalyzing the introduction of 2 double
bonds, while lycopene -cyclase is encoded by the lcy  gene. In
Golden Rice 1, the former 2 enzymes were replaced by a bacter-
ial carotene desaturase capable of introducing all 4 double bonds.
Golden Rice 2 was transformed with homologues of the same
genes that were used in Golden Rice 1, and encode enzymes with
similar activities. The gene encoding phytoene synthase in Golden
Rice 2 was isolated from maize, while the synthase gene used in
the construction of Golden Rice 1 came from daffodil (Narcissus
pseudonareissus; Paine and others 2005).
The genetic elements present in the Golden Rice 2 construct
are shown in Figure 5-1 (Paine and others 2005). Agrobacterium
tumefaciens-mediated transformation was used to introduce the
DNA construct into Oryza sativa. The selectable marker used for
transformation was the E. coli phosphomannose isomerase selec-
tion (PMI) system (Negrotto and others 2000). A polymerase
chain reaction-based (PCR) method was used for preliminary
identification of events with single copies of the transferred DNA.
No additional molecular characterization of the transformants
was reported (Paine and others 2005).
5.3.2 Metabolic pathway for de novo
carotenoid biosynthesis
Carotenoid biosynthesis is well described at the biochemical
and molecular level (see Appendix 2). Figure A1-2 provides a
schematic overview of the pathway leading to biosynthesis of -
carotene and products derived from branches of the same path-
way. Carotenoids are one of many end products of isoprenoid
metabolism; however, they constitute a very small percentage of
the total cellular content (for example, approximately 20 to 
40 g/g dry weight, approximately 0.0002% to 0.0004% of dry
weight) in Golden Rice 2, and it is thus likely that very little meta-
bolic energy and only small amounts of precursors are invested
in their biosynthesis. Although the DNA construct present in
Golden Rice 2 would be expected to have little effect on overall
composition, it might be expected to alter the distribution of
metabolites that are ultimately derived from geranylgeranyl-
diphosphate (GGPP).
5.3.3 Possible undesirable effects
The most likely undesirable effect of the modification present in
Golden Rice 2 is a redistribution of metabolites that arise from
GGPP, such as within the carotenoid pool or among carotenoids,
tocopherols, and terpenoids (Misawa and others 1994).
Perturbations in isoprenoid metabolite concentrations subsequent
to pathway engineering have been reported (Misawa and others
1994). Such changes would have negligible nutritional impact on
humans because rice is not a good source of any required nutri-
ents that are formed from GGPP; however, they may have unin-
tended effects on the physiology or metabolism of the plant itself.
These changes could, in turn, indirectly affect the overall compo-
sition and nutritional value. In this regard, it is encouraging that
the phenotype of the transgenic rice plants seems to be indistin-
guishable from that of conventional counterparts (Paine and oth-
ers 2005). Keeping in mind that all plant breeding can lead to
unintended changes (Cellini and others 2004), compositional
analysis can reveal whether significant and meaningful changes
have occurred during gene transfer and subsequent breeding.
5.4 Stage of Product Development
Golden Rice 2 represents a significant enhancement of the
concept demonstrated by the construction of Golden Rice 1;
namely, that grains can be engineered to contain higher levels of
vitamin A precursors (see Figure 5-2). The project has resulted in
the production of rice plants that produce elevated levels of total
carotenoids (10 to 40 g/g dry weight) compared to convention-
al rice or Golden Rice 1, of which approximately 80% is present
as -carotene. The other 20% has been characterized as -
carotene and nonprovitamin-A carotenoids. The food safety
assessment of Golden Rice 1 is in progress (see http://www.gold-
enrice.org) and the initial transformation events are being 
Figure 5-1—DNA construct present in Golden Rice 2 (Paine and others 2005). Key to source of DNA elements: Glu: rice
glutelin Glut01 (Glu) promoter (nucleotides 1568--2406) SSUcrtl: functional fusion of the pea RUBISCO small subunit
plastid transit peptide with Erwinia uredovora crtI (D90087; Misawa and others 1993) Terminator regions of A. tumefa-
ciens nos (nucleotides 1848–2100, V00087). Zea mays phytoene synthase (psy) Zea Mays polyubiquitin Ubi–1 promoter
with intron E. coli phospho-mannose isomerase (PMI) selectable marker.
Figure 5-2—Comparison of rice (left),
Golden Rice 1 (middle), and Golden
Rice 2 (right). (Paine and others 2005;
used with permission).
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introgressed into cultivars that are used in South and Southeast
Asia so that agronomic and environmental impacts can be
assessed. The status of Golden Rice 2 is uncertain at this time; no
further reports have appeared since the initial publication (Paine
and others 2005).
5.5 Safety Assessment of Golden Rice 2
The prospective food safety assessment proposed subsequently
is based on the principles of scientific risk assessment of novel
foods as described by various international organizations (Codex
2003; ILSI 2004). In this assessment, the principles of risk-based
analysis are used to identify hazards and quantify and character-
ize risks. Plant breeders frequently alter the genetic composition
of crops through directed selection of mutations. Hundreds of rice
varieties are cultivated around the world. Although new varieties
may have altered agronomic properties and compositions, the
products of conventional plant breeding can be put into agricul-
tural production without regulatory review. This is because con-
ventional breeding is typically considered to be a safe process.
Scientific risk assessment supports the conclusion that newer
methods of modifying crops using the techniques of gene trans-
fer are no more likely than conventional breeding to produce
unintended outcomes (Cellini and others 2004). The safety
assessment should, thus, be focused on the safety of the crop
itself and not the technology used in its breeding. Changes can
be identified as differences between the content range of compo-
nents observed for conventional rice varieties and the new vari-
ety; that is to say, conventional rice is a suitable comparator for
Golden Rice 2. The principal questions to be answered are there-
fore: (1) Are the newly produced proteins safe to consume? (2)
Are the newly elevated levels of carotenoids safe to consume? (3)
Have there been unintended changes in composition? and (4)
Have other changes in phenotype occurred, and if so, do they
have any relevance to safety? (ILSI 2004). 
5.5.1 History of safe use
Rice has a long history of safe use, as does -carotene from
food. Selection was performed using the phosphomannose iso-
merase (PMI) selection (Negrotto and others 2000). The U.S. EPA
has affirmed the safety of the PMI marker system by granting an
exemption to a requirement for a tolerance to be set (EPA 2004).
The crtI gene isolated from Erwinia uredovora has also been used
to confer herbicide resistance to rice and other plants (Misawa
and others 1993, 1994). Resistance to bleaching herbicides
occurs because the product of crtI is insensitive to the herbicides
and, thus, bypasses the inhibition of carotenoid biosynthesis that
leads to bleaching. The constructs used to produce herbicide tol-
erance in this manner encode a transit peptide and a strong pro-
moter of high-level expression in green tissues. The constructs
are, thus, quite dissimilar to those described for Golden Rice 2
and are not relevant to the present case study.
Several of the DNA elements incorporated into the construc-
tion were isolated from crop plants that also have a long history
of safe use (that is, maize psy and Ubi–1 promoter with intron,
and rice Glu). The nos terminator from Agrobacterium tumefa-
ciens is frequently used in commercialized transgenic plants,
while the Erwinia uredovora crtI and the pmi from E. coli do not
have a long history of safe use in food per se, although humans
certainly ingest bacteria and foods that contain homologues of
these enzymes. Furthermore, pmi is found in strains of gastroin-
testinal bacteria that normally inhabit the human gut (Privalle
2003). The 3 biosynthetic enzymes, or their close homologues,
expressed in Golden Rice 2 are commonly consumed in the
human diet. Humans and animals consume many plant foods
that are rich in mixed carotenoids. Carotenoid-containing plants
also contain the enzymes of the same biosynthetic pathway that
has been enhanced in Golden Rice 2. It is therefore reasonable
to conclude that the introduced gene products, with the excep-
tion of carotene desaturase, have a long prior history of safe use
in human nutrition. The carotene desaturase gene (crtl) from E.
uredovora is almost certainly present in plant material consumed
by humans and animals; this prior level of exposure is, however,
uncharacterized to date.
The presence of increased levels of carotenoids in the rice
endosperm is evidence that the introduced enzymes are active;
however, the enzymes have not been directly characterized.
Sequence comparisons with DNA and protein databases
demonstrate that the inserted proteins bear no significant simi-
larity to known toxic proteins or allergens (Codex 2003;
Goodman and Wise 2006). Rice has low protein content
(approximately 7.5%). The enzymes encoded by the inserted
DNA are most likely expressed at very low levels. The level of
expression of carotene desaturase and PMI in the grain should
be determined, because that is the portion of the plant that
humans consume for which dietary exposure should be estimat-
ed. The similarity of these 2 enzymes to those isolated from the
donor organism should be established, particularly with regard
to the potential presence of posttranslational modifications.
Rice is cooked before consumption. Thermal processing (for
example, steaming of rice) denatures most proteins. It may be
informative to determine the effect of processing on carotene
desaturase; however, this information is not essential to the safety
assessment. The great majority of dietary proteins are digested rap-
idly in the stomach. Gastric digestibility can be evaluated in an in
vitro model (Thomas and others 2004). The in vitro digestibility of
carotene desaturase should be evaluated. In simulated gastric
fluid, PMI has been shown to be heat-labile and rapidly digestible
(Privalle 2002). If digestible proteins are present at low levels in
the consumed tissue and they bear no sequence similarity to
known allergens, antinutrients, or toxicants, they can be consid-
ered safe to consume (Lehrer and Bannon 2005). The great major-
ity of dietary proteins are not toxic, and almost without exception,
those few that are display acute toxicity (Sjoblad and others
1992). To address this issue, the lack of acute toxicity of PMI was
demonstrated in animal studies (Privalle 2002). Acute toxicity
studies with carotene desaturase have not been reported to date.
Because the vast majority of proteins consumed by humans are
not toxic, the enzyme from maize has no relationship to known
toxicants or allergens, and the protein is likely to be present at
exceedingly low concentrations in rice, it is reasonable to con-
clude that the enzyme is reasonably safe without need for further
experimentation. If the protein is readily digested in simulated
gastric fluid, it is worth asking if an oral acute toxicity study will
add materially to the overall safety assessment. Animal studies are
time-consuming, expensive, and of questionable ethical practice
when applied to a protein that has the characteristics just
described.
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Because rice allergy is uncommon, rice is classified as a non-
allergenic food (Lehrer and Bannon 2005). Nevertheless, patients
with cereal allergies, atopic dermatitis, and asthma display a
higher frequency of rice allergy than people without these con-
ditions (Lewis and Imber 1975; Tsai and others 1990). The major
rice protein allergens have been characterized and hypoaller-
genic rice strains have been developed (Nakamura and Matsuda
1996; Tada and others 1996).
5.5.2 Compositional changes
Golden Rice 2 varieties contain 10 to 40 g/g of carotenoids
(Paine and others 2005); this represents a negligible change in
the overall composition. The carotenoid pathway is a peripheral
biosynthetic pathway. It is anticipated, but not demonstrated, that
the inserted genes will have negligible effects on regulatory or
biosynthetic pathways in rice and should not markedly affect
overall composition. It is therefore recommended that the com-
positions (with respect to OECD consensus documents; OECD
2004) of Golden Rice 2 cultivars be compared with those of the
isogenic strains from which they are derived. The safety and
nutritional implications of any significant differences in compo-
sition should be further evaluated.
5.5.3 Metabolism of the target 
nutrient and potential for toxicity
In humans, -carotene undergoes enzymatic conversion in
vivo to retinal, which is reduced to retinol or vitamin A. Very high
intake levels of vitamin A are toxic and teratogenic.
Hypervitaminosis A has been reported at chronic intake levels of
vitamin A that are only 10-fold higher than the RDA. In contrast,
-carotene is typically accepted as being safe because it is not
toxic per se and is converted in vivo into retinol based on need.
Excessively high levels of -carotene can, however, lead to yel-
low pigmentation of the skin (Bender 2003). Golden Rice 2 vari-
eties contain lower amounts of carotenoids and their correspon-
ding biosynthetic elements than other foods that are commonly
and safely eaten (for example, sweet potato, carrot, maize)
(Holden and others 1999).
In recent years, 2 observations have shed new light on the long-
held belief that -carotene is safe to consume by all individuals
(Leo and Lieber 1999). Intervention studies, designed to evaluate
the potential protective effect of a -carotene supplement against
various types of cancer and heart disease based on its effective-
ness as an antioxidant, yielded the unexpected result that an
increased incidence of lung cancer was observed in persons who
smoked heavily and consumed supplemental -carotene (30
mg/d). Secondly, it has been demonstrated that -carotene inter-
acts with dietary ethanol to exacerbate, rather than ameliorate,
the effects of alcohol-induced vitamin A deficiency (Leo and
Lieber 1999). Thus, it appears prudent until further research is
completed to avoid excessively high intakes (for example, > 10
mg/d) of -carotene until an acceptable daily intake or tolerable
upper intake level has been set. The expected levels of approxi-
mately 31 g -carotene per gram fresh weight of Golden Rice 2
are orders of magnitude lower than the dietary supplement levels
and, therefore, are not of toxicological concern.
5.5.4 Unintended changes
As noted previously, unintended changes are a common
occurrence in conventional plant breeding (Cellini and others
2004). Composition analysis, according to OECD consensus
documents, should provide evidence of the presence or absence
of unintended changes. The safety and nutritional significance of
those changes can then be characterized. Change per se is not
necessarily undesirable. The phenotypic and agronomic proper-
ties of selected cultivars are also powerful indicators of the pres-
ence or absence of unintended changes; in the case of Golden
Rice 2, preliminary observation suggests that no changes have
occurred (Paine and others 2005). The changes introduced into
Golden Rice 2 are peripheral to central metabolism and should
divert very little cellular energy and metabolites to biosynthesis.
5.6 Nutritional Assessment
Cooked polished rice is essentially free of known antinutrients;
most of the antinutrients are removed with the bran and/or are
destroyed by heat (OECD 2004). The recommended list of rele-
vant analyses for food uses of polished rice is proximate analysis,
minerals, vitamins, total amino acids, total fatty acids, phytic
phosphorus, and amylose (OECD 2004).
Golden Rice 2, which is deep orange in color, was developed to
greatly increase the -carotene of rice (Paine and others 2005). It
contains as much as 37 g total carotenoids/g dry weight of grain,
of which 31 g/g is -carotene. Due to the higher level of -
carotene, the consumption of Golden Rice 2 in typical quantities
may provide adequate daily intake of vitamin A in countries in
which rice is a staple food, assuming cooking losses of -carotene
are not excessive. If proven effective, Golden Rice 2 could provide
adequate levels of vitamin A to large populations that are current-
ly at risk for VAD. Golden Rice 2 may also be effective even in pop-
ulations where rice is a smaller dietary component. Although not
safety related, stability, bioefficacy, and consumer acceptability
will need to be established as a practical matter.
As noted previously, a significant portion of global VAD occurs
in populations that consume rice as a major staple food.
Substitution of Golden Rice 2 for conventional rice may elimi-
nate a significant portion of VAD. In fact, since a typical serving
of 60 to 75 g of Golden Rice 2 can conservatively be estimated
to provide about half of the recommended daily intake of vitamin
A for an adult male, Golden Rice 2 could be introduced as a
dietary supplement rather than a direct total rice replacement.
This might reduce concerns about consumer acceptability in cul-
tures that highly value white rice as a traditional food, such as
South and Southeast Asia. Attitudinal survey studies performed in
2 rice-growing villages in the Philippines indicated that yellow
color was of minor concern to potential consumers of Golden
Rice 1, while taste and cost were important (Zimmerman and
Qaim 2004). Because it is necessary to consume only 50 to 100
g or 700 to 1400 kJ per day (1/4 to 
1/2 cup) of Golden Rice 2, it
represents a viable dietary approach to reducing VAD anywhere
in the world where this portion of rice can be supplied. Although
stability of storage and cooking is as yet undocumented, prelim-
inary results (2007 personal communication from R Russell,
unreferenced) suggest that -carotene in Golden Rice is highly
bioavailable.
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To be converted to nutritionally useful vitamin A, -carotene
must be absorbed and converted to retinol. The bioavailability of
-carotene varies with the species of carotenoid, molecular link-
age, amount of carotenoids in a meal, matrix in which the
carotenoid is incorporated, effectors of absorption and biocon-
version, nutrient status of the host, genetic factors, host-related
factors, and interactions (Castenmiller and West 1998). An exten-
sive discussion on bioavailability is included in Appendix 2. It
has been suggested (Yeum and Russell 2002) that -carotene may
be better absorbed from rice than from green leafy vegetables
because of its higher digestibility (Zimmerman and Qaim 2004).
It is also known that -carotene absorption is decreased in par-
ticipants whose diet is extremely low in lipid, although Jayarajan
and others (1980) have shown that as little as 5 g of fat per meal
is all that is needed for carotenoid absorption. Estimates of the
vitamin A bioavailability from -carotene delivered in a rice
matrix vary from a best-case estimate of 1:2 to a worst-case esti-
mate of 1:12 (Yeum and Russell 2002). The 12:1 conversion ratio
of -carotene to vitamin A is generally used as a representative
uptake from plant materials, although there is considerable vari-
ation in observed values (IOM 2001). As noted previously, pre-
liminary data indicate that a conversion factor of 4:1 may be
more appropriate (2007 personal communication from Russell,
unreferenced).
Based on published data, it can be estimated that to meet their
vitamin A requirements, a breastfed child and nonbreastfed child
during the 2nd year of life need an extra 1.92 to 2.4 mg and 3.6
mg of -carotene a day, respectively (Hess and others 2005).
Using Thai food intake data, it can be calculated that 1- to 2-y-
old breastfed children eating 160 g (standard deviation 29 g) of
Golden Rice 2 per day (which equates to approximately 67 g
uncooked rice providing approximately 2.1 mg -carotene
would consume approximately 5 times their RDA. This is a prom-
ising result because consumption of 65 to 70 g would prevent
most of the negative effects of VAD; however, the calculation
assumes a 12:1 conversion ratio for -carotene to vitamin A. If
the conversion is more efficient, even more vitamin A will be
available, and even if it is less efficient, Golden Rice 2 could still
be beneficial because absorption and/or bioconversion is better
among individuals with low vitamin A status (de Pee and West
1996; Castenmiller and West 1998). These 2 alternatives under-
score the need for human bioavailability and efficacy to be
assessed as soon as it is practicable.
Beta-carotene in fresh plant materials undergoes postharvest
degradation, especially when exposed to light and air. Degradation
and postharvest losses are less likely to occur in the dry rice matrix
(Zimmerman and Qaim 2004); however, this must be tested.
Heating at elevated temperature can slowly degrade -carotene,
but little degradation should occur at the temperatures at which
rice is steamed (Dietz and others 1988). No change in preparation
or use will be required for the introduction of Golden Rice 2.
5.7 Conclusions
Vitamin A deficiency is a major public health challenge. The
need and applications for Golden Rice 2 are identical to those for
Golden Rice 1. Golden Rice 2 is formally analogous to Golden
Rice 1; however, a gene isolated from daffodil has been replaced
by a more efficient gene analogue isolated from maize. When
compared to Golden Rice 1, the new rice variety represents a sig-
nificant enhancement of total carotenoid production in rice, with
-carotene being the predominant form.
Golden Rice 2 is in an early stage of development, establish-
ing the proof-of-concept. The relevant genes are now being
crossed into selected local cultivars in several Asian countries to
allow further evaluation of agronomic efficacy and safety studies
(see http://www.goldenrice.org/ for the latest information). The
safety considerations that apply to Golden Rice 1 and 2 are sim-
ilar. The components found in Golden Rice 2 have a history of
safe use. No novel proteins or metabolites not normally encoun-
tered in the human diet are known to be present; any novel pro-
teins present are at exceedingly low concentrations. The safety of
carotene desaturase stands out as the single component that war-
rants further characterization. It is recommended that the molec-
ular form of the protein and its in vitro digestibility be analyzed,
but it is considered unnecessary to assess its acute toxicity in ani-
mal studies if it is digestible—such studies would add little addi-
tional assurance of safety. The concentration of carotenoids is
similar to that encountered in other commonly eaten foods. Rice
allergy is not common and rice is not a significant source of tox-
icants or antinutrients. If no undesirable or adverse composition-
al changes are encountered upon analysis, Golden Rice 2 will
present insignificant food safety risks.
Effective risk management is based on the premise that the
stringency of analysis should be commensurate with risk, and 
the degree of risk that is acceptable must be weighed against the
benefits of approving a new crop variety along with the conse-
quences of nonadoption. In the case of Golden Rice 2, the most
significant concern is whether it will alleviate VAD as intended.
Ultimately, it is the role of risk managers to determine a priori
what balance of risk and benefits are acceptable (FAO/WHO
1997). Al-Babili and Beyer (2005) (see Appendix 5), however,
have argued strongly that Golden Rice should not become mired
in a regulatory review that seeks to evaluate and eliminate every
conceivable hazard.
Though not directly related to safety, there are matters of prac-
tical concern that should be addressed as part of a comprehen-
sive release strategy. While theoretically capable of supplying
nutritionally relevant levels of -carotene, the retention of -
carotene after processing, storage, and cooking needs to be
determined before efficacy is demonstrated. Moreover, some
have questioned if yellow rice will prove acceptable to people
who traditionally eat white polished rice. All of these points need
to be resolved if Golden Rice 2 is to become an important solu-
tion to VAD.
5.8 Recommendations
Recommendation 1. A safety assessment needs to be undertaken.
Specific analysis could include:
• Characterization of the DNA insert
• Characterization of the inserted proteins (posttranslational
modification)
• Digestibility (in vitro) of carotene desaturase
• Composition analysis
• Carotenoid metabolite pool analysis
Recommendation 2. In addition to the safety studies, the predic-
tion that Golden Rice 2 could greatly improve vitamin A 
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nutrition should be tested in premarket studies in free-living
humans, including palatability of rice with altered appearance to
conventional rice.
Recommendation 3. Any potential risks that may be identified
with Golden Rice 2 should be balanced against the potential to
ameliorate VAD and, thereby, reduce the loss of life and clinical
symptoms due to the nutritional deficiency. The magnitude of
this potential nutritional impact will only become known for
certain if Golden Rice 2 is adopted.
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6.1 Introduction
Animal production is often restricted because feed resources
are deficient in a specific nutrient or because the bioavailabili-
ty of a nutrient is low or is constrained by the presence of an
antinutritional factor. Several crops have been developed and
are currently in trials with modifications aimed at improving
nutritional characteristics in which the concentration of a spe-
cific nutrient, such as an essential amino acid, is increased. This
case study examines the safety and nutritional assessment of
maize grain in which modern biotechnology has been used to
increase the nutritional value by increasing the lysine content
of the grain.
6.1.1. The need for the enhanced nutrient
Poultry and swine diets based on maize and soybean meal
require supplemental lysine for optimal animal growth and pro-
duction (NRC 1994, 1998). Supplemental L-lysine is commer-
cially available and is typically produced via fermentation of
Corynebacterium glutamicum or Brevibacterium lactofermen-
tum (Eggeling 1994). As an alternative to supplementation, con-
ventional- and biotechnology-based strategies have been devel-
oped. Conventional breeding research resulted in the develop-
ment of Quality Protein Maize (QPM), which contains twice the
normal amount of lysine (CiMMYT). Lysine maize (LY038) was
developed through the use of recombinant DNA techniques to
integrate the cordapA gene into the maize genome, which results
in the production of maize grain with higher lysine content. This
grain with enhanced lysine concentration has an improved nutri-
tional value (similar to QPM) for use as a feed ingredient in diets
for broiler chickens, turkeys, and pigs.
6.2 The Crop and Its Role in Nutrition
6.2.1 The maize crop
Maize (Zea mays L.) is an annual, wind-pollinated, monoe-
cious species belonging to the subfamily Panicoideae of the grass
family Gramineae. It was probably domesticated in the highlands
of southern Mexico and grown as a food crop as early as 2700
BC. By the time Columbus arrived in the New World, maize was
being grown by the indigenous civilizations from Chile to south-
ern Canada. When on the north coast of Cuba, Columbus noted
in his log (November 6, 1492) that crew members reported “a
sort of grain called maize which was well tasted, baked, dried
and made into flour.” Within 2 generations of the introduction of
maize into the Old World by Columbus in 1494, it had spread as
far east as China and was widely grown in many areas of the
world.
6.2.2 How the maize crop is used for food and feed
Today, maize ranks third after wheat and rice as one of the
world’s 3 leading food grains, is grown on 140 million ha in 100
countries, and produced 700 million metric tons of grain in
2004. The major producers of maize are the United States,
China, Brazil, Mexico, France, and India and account for 75% of
world production (FAOSTAT 2004). However, unlike wheat and
rice, the majority of maize grain produced in the northern hemi-
sphere is fed to livestock, whereas maize is a major staple food
for humans in the tropics and the southern hemisphere.
While maize grain is often the preferred dietary energy source
for both ruminant and nonruminant livestock production 
systems, it is recognized that its low lysine content requires 
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Chapter 6: Maize with Increased Lysine 
(Lysine Maize—LY038)
ABSTRACT: Data and information provided in this case study relate to a crop derived by modern biotechnology, in
which a specific nutrient (lysine) has been increased in maize grain. Lysine maize is a feed ingredient with enhanced
nutritional characteristics for poultry and swine and provides an alternative to adding supplemental lysine to diets
for these animals. Lysine maize is in an advanced state of development; therefore, extensive unpublished data and
information are presented to demonstrate that (1) Lysine maize, and the feeds and foods derived from it, are as safe
as those derived from conventional maize, and (2) the increased lysine in Lysine maize grain produces the intended
nutritional benefit for broiler chickens when compared to a diet containing conventional maize grain and a crys-
talline lysine supplement. These conclusions are based on a detailed molecular characterization of Lysine maize, a
safety assessment of the introduced protein, a safety and nutritional assessment of the LY038 crop, and a compari-
son of the agronomic and phenotypic properties of maize hybrids with and without the Lysine maize trait. Although
Lysine maize is a specialty crop for use in animal feed, its safety for both animals and humans must be demonstrat-
ed. Free lysine is significantly increased in Lysine maize by the introduction of the dapA gene (cordapA) from
Corynebacterium glutamicum that encodes a form of dihydrodipicolinate synthase (cDHDPS) that is insensitive to
lysine feedback inhibition. Analysis of lysine anabolic and catabolic pathways in maize identified 6 metabolites that
might change as a consequence of the introduction of cDHDPS insensitive to lysine-feedback inhibition. The results
of compositional analysis demonstrated that Lysine maize grain is comparable to conventional maize, with the
exception of the intended increase in lysine and a corresponding increase in 2 products of lysine catabolism, saccha-
ropine and -aminoadipic acid. Therefore, the safety and/or nutritional implication of these 3 compounds under
the conditions of use were the focus of additional assessments and found to not present either a safety or nutrition-
al problem.
supplementation to optimize animal performance in pigs and 
poultry.
6.2.3 Expected geographic distribution 
of the nutritionally enhanced crop
Lysine maize will be a value-added specialty crop for use as an
animal feed ingredient. Lysine maize is expected to be used to
replace both the crystalline lysine and conventional maize in
many diets that are already nutritionally balanced for optimal
animal growth performance. It is anticipated that Lysine maize
will be produced in the United States and Argentina, with use of
the grain in both domestic and export markets.
6.2.4 Expected dietary impact and bioavailability
Lysine maize will simplify diet preparation by providing an
alternative to direct addition of supplemental lysine to poultry
and swine diets by increasing the amount of free lysine in the
grain. Furthermore, its production is faster than the development
of QPM via conventional breeding techniques. The lysine con-
tent of conventional maize grain ranges from 2500 to 2800
mg/kg on a dry matter (DM) basis and is largely incorporated into
storage proteins (free lysine is approximately 40 mg/kg). By com-
parison, the total lysine in Lysine maize grain is 3400 to 5200
mg/kg on a DM basis. This increased level of lysine is due to an
increased content of free lysine (approximately 1500 mg/kg).
Production and processing of feed from Lysine maize are not
expected to differ from those of conventional maize. To preserve
its enhanced nutritional value, appropriate commercial practices
are needed to minimize grain loss between harvesting and live-
stock producers. However, even if Lysine maize were inadver-
tently used in human food, it would be considered safe because
lysine is recognized as safe and the levels of lysine and related
metabolites would be similar to or lower than those present in
foods with a history of safe consumption. Thus the presence of
adventitious Lysine maize in the market should have no health or
nutritional effects different from those of conventionally derived
high lysine maize (QPM) already in commercial use.
6.3 Crop Improvement 
and Molecular Characterization
6.3.1 Crop transformation and breeding
To produce Lysine maize, a linear piece of DNA from a plas-
mid vector containing the cordapA and nptII coding sequences
was introduced into the maize inbred line H99. The nptII gene
encodes resistance to a category of aminoglycosides including
kanamycin, neomycin, and paromomycin. When cultured in the
presence of neomycin, only successfully transformed plant cells
continued to grow. Plants regenerated from these cells were
assayed for the presence of the cordapA gene by polymerase
chain reaction (PCR) and only positive plants continued being
propagated. A diagram showing the insertion of the LY038 insert
and nptII excision by cre/lox is presented in Figure 6-1. The nptII
cassette was flanked by 2 loxP sites to allow for its subsequent
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Figure 6-1—Diagram of LY038 insert 
and NptII excision by Cre/lox.
removal by Cre recombinase (Gilbertson 2003). An extensive
number of Southern blots, including generational stability analy-
ses over multiple generations, established that there were no
genetic elements from the cre and nptII coding sequences detect-
ed in Lysine maize.
The cordapA gene encodes a dihydrodipicolinate synthase
from Corynebacterium glutamicum (cDHDPS). The cordapA
gene is controlled by the Zea mays globulin 1 (Glb1) promoter
that directs cDHDPS protein expression and subsequent accu-
mulation of free lysine to the maize germ. The intron sequence
following the Glb1 promoter is derived from the rice actin-1 gene
and its purpose is to enhance DNA transcription (McElroy and
others 1990). Because cDHDPS is a bacterial enzyme, the
cordapA coding sequence is preceded by the Zea mays dihy-
drodipicolinate synthase chloroplast transit peptide (mDHDPS
CTP). The function of the mDHDPS chloroplast transit peptide is
to translocate cDHDPS to the plastid, where lysine biosynthesis
occurs via the aspartate pathway (Frisch and others 1991).
The cordapA gene is from Corynebacterium glutamicum, a
common soil microorganism that has been used for decades in
the industrial production of lysine (Eggeling and others 1998).
Dihydrodipicolinate synthase (DHDPS) is the first and major
rate-limiting enzyme for lysine biosynthesis in plants and bacte-
ria (Azevedo and Lea 2001) and is regulated by lysine feedback
inhibition (Galili 1995). However, compared to the DHDPS in
maize, this enzyme from C. glutamicum (cDHDPS) is relatively
insensitive to lysine inhibition (Vauterin and others 2000). The
LY038 plants expressing the cDHDPS protein are under the con-
trol of the Zea mays globulin 1 (Glb1) promoter and accumulate-
free lysine in the grain.
Analyses showed that LY038 contains 1 intact copy of the
cordapA gene cassette inserted at a single site in the maize
genome. Analysis of the genomic DNA flanking the inserted
DNA shows no concerns. No additional elements from the trans-
formation vector, linked or unlinked to the intact gene cassette,
were detected in LY038. LY038 does not contain either intact or
partial DNA fragments of the nptII cassette or the cre cassette and
also lacks detectable backbone sequence from the transforma-
tion plasmids. The presence of the cordapA gene cassette and the
absence of both cre and nptII gene cassettes in LY038 were fur-
ther confirmed by Southern blot generational stability analyses
over multiple generations representing each branch point of the
LY038 breeding tree. Analyses by PCR confirmed the organiza-
tion of the genetic elements of the inserted DNA in LY038 to be
identical to that in the transformation plasmid.
6.3.2 Possible undesirable effects
To be commercially successful, all crops derived from modern
biotechnology undergo extensive breeding with elite lines such
that > 90% of the germplasm of commercialized lines will be
derived from elite lines that have not experienced genetic trans-
formation. This should significantly reduce opportunities for
transformation-induced, random changes in the genome being in
the final product. Replicated field trials in multiple locations in
Argentina and the United States were conducted to assess
whether genetic modification resulted in unintentional pheno-
typic and agronomic changes in Lysine maize compared with
conventional hybrids. Phenotypic characteristics (for example,
seedling vigor, early stand count, days to 50% pollen shed, days
to 50% silking, stay green, ear height, plant height, dropped ears,
stalk lodged plants, root lodged plants, final stand count, grain
moisture, test weight, and yield) were statistically evaluated and
compared among Lysine maize, a control (near isogenic counter-
part), and reference maize hybrids within each field site and
across all field sites for a given geographical zone. The results
showed that the genetic modifications to generate Lysine maize
did not unintentionally alter the phenotype of Lysine maize
plants. Furthermore, dormancy and germination characteristics
of Lysine maize were unaltered compared to its control and no
differences in pollen characteristics, more specifically pollen
morphology and viability, were detected when comparing Lysine
maize to its control. It is, therefore, possible to conclude that
Lysine maize has shown similar agronomic behavior and pheno-
typic properties to conventional maize.
6.3.3. Metabolic pathways
In GM crops with improved nutritional characteristics, meta-
bolic pathways are often modified to achieve the desired nutri-
tional improvement, and a thorough understanding of the
changes that have occurred is important for both the safety and
nutritional evaluation of the GM crop. The metabolic pathways
altered in the development of Lysine maize are well characterized
and are shown in Figure 6-2 for lysine anabolism and in Figure 6-
3 for lysine catabolism in maize. Based on the analysis of these
pathways, the lysine-related metabolites described in section
6.5.2 were selected as specific targets for compositional analysis.
6.3.4. Stage of product development
The development of Lysine maize is well advanced and a full
safety and nutritional assessment has been conducted.
6.4 Safety Assessment
6.4.1 History of safe use
It is well recognized that absolute safety is not an achievable
goal in any human endeavor, and this is relevant with respect to
food and feed. The safe use of food or feed has typically been
established either through experience based on its common use
or by application of generally recognized scientific assessment
procedures. Since the 1990s, the standard for novel (especially
GM) food and feed crops has been that they should be as safe as
an appropriate counterpart with a history of safe use. This com-
parative assessment process identifies similarities and differences
between the newly developed food or feed crop and a conven-
tional counterpart with a history of safe use. The similarities
noted between the new and traditional crops are not subject to
further assessment because this provides evidence that those
aspects of the newly developed crop are as safe as crops with a
history of safe consumption. The identified differences are sub-
jected to further scientific procedures, as needed, to clarify
whether any safety issues or concerns exist.
6.4.2 Compositional changes
Compositional analysis is considered the cornerstone for the
safety and nutritional evaluation of GM crops. In the current case
ILSI: Assessments of foods and feeds . . .
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study, extensive compositional analyses of forage (whole plant at
early-dent stage) and grain have been performed on samples from
replicated, multisite field trials conducted in both Argentina (2001
to 2002) and the United States (2002) to compare the composi-
tion of Lysine maize to its control (a near isogenic counterpart)
and conventional maize. Lysine maize forage samples were sub-
jected to compositional analyses for proximates (protein, fat, ash,
and moisture), acid detergent fiber (ADF), neutral detergent fiber
(NDF), lysine, and minerals (calcium, phosphorus), as well as car-
bohydrates by calculation. Compositional analyses of Lysine
maize grain samples included proximates (protein, fat, ash, mois-
ture), ADF, NDF, total dietary fiber (TDF), amino acids, free lysine,
fatty acids (C8–C22), vitamins (thiamin, riboflavin, B6, E, niacin,
and folic acid), antinutrients (phytic acid and raffinose), minerals
(calcium, copper, iron, magnesium, manganese, phosphorus,
potassium, sodium, and zinc), carbohydrates by calculation, sec-
ondary maize metabolites per OECD (2003) consensus document
(furfural, ferulic acid, and -coumaric acid), and additional lysine-
related metabolites (cadaverine, -aminoadipic acid, saccha-
ropine, homoserine, L-pipecolic acid, and 2,6-diaminopimelic
acid). Homoserine and 2,6-diaminopimelic acid were chosen
from the lysine biosynthetic pathway because they are stable
metabolites and constitute either a key branch point or the penul-
timate synthetic step for making lysine, respectively. Cadaverine,
saccharopine, -aminoadipic acid, and pipecolic acid were
included because they represent the stable components of lysine
CRFSFS: Comprehensive Reviews in Food Science and Food Safety
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Figure 6-2—Lysine anabolism in maize.
Figure 6-3—Lysine catabolism in
maize.
catabolism known to accumulate in plants. In all, 85 different
analytical components (75 in grain, 10 in forage) were analyzed.
The compositional analyses of grain and forage of Lysine maize
showed them to be compositionally equivalent to that of conven-
tional maize, except for the intended increase in grain lysine con-
tent and an associated increase in the lysine-related catabolites,
saccharopine and -aminoadipic acid, supporting the absence of
unintended effects due to the genetic modification.
6.4.3 Protein safety assessment
Both Codex Alimentarius (Codex Alimentarius 2003) and the
European Food Safety Authority (EFSA 2004) have recognized 
the fact that a weight-of-evidence approach is appropriate for the
safety assessment of novel proteins, as numerous factors con-
tribute to whether they have the potential to be allergenic or
toxic. These factors include the source of the protein, sequence
homology to known allergens and/or toxins, and an assessment
of protein digestibility. The digestibility data are of value only in
the context of an overall “weight-of-the-evidence” assessment.
6.4.3.1 History of safe exposure to donor organism. Human
consumption of the cDHDPS protein from processed grain prod-
ucts is expected to be low because Lysine maize grain is not
intended to be used in food and because expression of cDHDPS
is primarily in the germ. The endosperm is the predominant frac-
tion humans consume. Nonetheless, several safety assessments
of cDHDPS were conducted.
C. glutamicum is a common soil bacterium. Humans and ani-
mals are regularly exposed to this organism and/or its compo-
nents (for example, cDHDPS) without adverse consequences. All
C. glutamicum cultures available from the American Type
Culture Collection are classified at Biosafety Level-1, the safest of
all cultures as defined by the U.S. Dept. of Health and Human
Services (CDC 1999). In addition, DHDPS proteins functionally
and structurally related to cDHDPS in Lysine maize are present
in plants and microbes that synthesize lysine, many of which are
consumed as feed and/or food such as maize.
Bioinformatic analyses revealed no biologically relevant
sequence similarities of the cDHDPS protein to known allergens,
toxins, or pharmacologically active proteins. Furthermore, no
short (8 amino acid) polypeptide matches are shared between
the cDHDPS protein sequence and known protein allergens.
These data demonstrated the lack of both structurally and
immunologically relevant similarities between allergens or toxins
and the cDHDPS protein sequence used in Lysine maize.
6.4.3.2 In vitro digestibility. In vitro digestibility and acute
mouse toxicity studies with cDHDPS utilized protein produced
and purified from E. coli. Before initiation of these studies,
cDHDPS protein produced in E. coli was compared to cDHDPS
expressed in Lysine maize by several methods, including enzy-
matic activity assays, determination that maize cDHDPS is not
glycosylated, sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE), immunoblot analysis, matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF MS), and N-terminal sequence analysis. From these
analyses, the cDHDPS protein purified from E. coli was shown to
be physicochemically and functionally equivalent to cDHDPS
produced in Lysine maize.
Previous studies assessed the susceptibility of proteins
expressed in genetically modified plants to in vitro proteolytic
digestion (Kimber and Dearman 2002) following a standard pro-
tocol (Pharmacopeia 1995). Recently, ILSI standardized the
pepsin digestibility assay protocol in a multilaboratory evaluation
(Thomas and others 2004). The in vitro digestibility of E. coli-pro-
duced cDHDPS protein was assessed in simulated gastric fluid
(SGF) containing the proteolytic enzyme pepsin following a time
course, and experimental parameters similar to conditions used
in the ILSI multilaboratory evaluation.
The digestibility of the cDHDPS protein was evaluated by visu-
al examination using stained SDS-PAGE gels and western blot
analysis. Visual examination of the stained gel showed that the
full-length (33 kDa) cDHDPS protein was rapidly digested after
incubation in SGF. Based on the limit of detection (LOD) for the
cDHDPS protein in SGF, it can be inferred that > 96% of the
cDHDPS protein was observed to be digested in SGF within 30
s. Western blot analysis confirmed that > 98% of the cDHDPS
protein was digested below the LOD of this immunoassay with-
in 30 s of incubation in SGF. No stable peptide fragments were
observed by either stained SDS-PAGE gels or by western blot
analysis. Therefore, the demonstrated rapid degradation of
cDHDPS in SGF, combined with the history of safe exposure to
the donor organism and the lack of sequence homology to
known allergens and toxins, supports a conclusion that the
cDHDPS protein has low allergenic and toxic potential.
6.4.3.3 Acute high-dose oral toxicity study of cDHDPS. An
acute high-dose oral toxicity study was considered appropriate
to assess the safety of E. coli-produced cDHDPS protein. In this
study, 2 groups of 10 male and 10 female mice were given a
single gavage dose of 800 mg/kg body weight cDHDPS protein.
Following administration of the cDHDPS protein, the mice
were observed daily and weighed weekly during a 14-d period.
There was no mortality and were no reports of adverse clinical
reactions. All cDHDPS-dosed mice gained weight during the
14-d postdosing period. Weight gain and food consumption
were comparable to those of controls. A gross necroscopy
examination was conducted on all animals at study termina-
tion. The macroscopic appearance of cDHDPS-dosed mice was
within normal limits for CD-1 mice and similar to the controls.
No toxicity was observed in any of the groups. Therefore, the
no observed effect level (NOEL) for the cDHDPS protein was
determined to be greater than 800 mg/kg body weight, the
highest dose tested.
6.4.3.4 Plant expression of cDHDPS in Lysine maize and
dietary risk assessment. The levels of cDHDPS in grain were
higher than those in other plant tissues (26, 0.081, and 0.94 g/g
dry weight in grain; whole plant at V2-V4 growth stage; and for-
age at the R5 growth stage, respectively) when measured by
enzyme-linked immunosorbent assay (ELISA). This is consistent
with the fact that cordapA gene expression is predominantly tar-
geted to the germ of the grain by the Glb1 promoter in LY038.
Based on cDHDPS levels in grain and the determined NOEL
from the mouse acute oral toxicity evaluation, large margins of
exposure were calculated for cDHDPS for livestock (> 500-fold
for broiler chickens and pigs) and humans (> 45000 for the high-
est consuming U.S. subpopulation and > 107 for the highest
European Union subpopulation, using conservative assumptions).
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This assessment leads to the conclusion that there is no meaning-
ful risk to animal or human health from dietary exposure to
cDHDPS from Lysine maize.
6.4.3.5 Lysine safety. Lysine is an essential amino acid and is
generally recognized as safe (GRAS) when added to animal diets
at nutritional levels (U.S. FDA 1982) and may be safely used as a
human food additive when used as a nutrient (U.S. FDA 1972).
Furthermore, excessive consumption of lysine by humans, pigs,
and rats over prolonged periods is well tolerated (Garlick 2004).
In plants and animals, lysine is primarily catabolized via the sac-
charopine pathway by 2 linked enzymes, lysine-ketoglutarate
reductase (LKR) and saccharopine dehydrogenase (SDH) (Miron
and others 2000).
Because ingested lysine is largely degraded through the sac-
charopine pathway in humans, animals, and plants, tissues
would be transiently exposed to higher than normal levels of sac-
charopine and -aminoadipic acid. However, it is anticipated
that farm animals consuming Lysine maize grain would readily
degrade saccharopine based on the liver capacity of SDH
(Fellows and Lewis 1973). Thus, the increased levels of saccha-
ropine and -aminoadipic acid in Lysine maize would not be
expected to pose a health risk for livestock, and would not be
expected to accumulate in livestock products any differently than
when lysine is included as a supplement in livestock diets.
Even though Lysine maize grain will be identity preserved to
facilitate recovery of its enhanced nutritional feed value, it can-
not be ruled out that a small portion of the grain might inadver-
tently be used for human food. If this occurred, humans would
experience only a short-term, limited dietary exposure to Lysine
maize grain as it would be diluted by other commodity maize
during harvest, transport, storage, and food processing. In addi-
tion, saccharopine and -aminoadipic acid are measurable com-
ponents of safely consumed foods, supporting a history of dietary
exposure and safe consumption of these 2 metabolites by
humans. Furthermore, confirmatory animal feeding studies in
broilers and rats provide supporting data regarding the safety of
Lysine maize grain for humans because maize grain exposure
levels were orders of magnitudes higher than potential human
consumption levels for corn grain-based products (see the fol-
lowing sections 6.4.3.6 and 6.5). Therefore, there is reasonable
certainty that the levels of saccharopine and -aminoadipic acid
in Lysine maize are not harmful to either animal or human
health.
6.4.3.6 A subchronic rat toxicology study of Lysine maize
grain. The safety of Lysine maize grain has been further assessed
by a 90-d feeding study in rats (FSANZ 2006). The study com-
pared the responses of rats fed diets containing grain from
Lysine maize at either 11% or 33% of the diet, its near isogenic
control, and 6 diets with traditional maize hybrids. Lysine
maize and control grain were produced at the same time and
under the same environmental conditions, and traditional refer-
ence grains were purchased from commercial sources.
Toxicological parameters such as survival, body weights, food
consumption, clinical pathology, organ weights, and macro-
scopic and microscopic pathology were evaluated in this study.
There were no test article-related changes in any of the toxico-
logical parameters. No adverse effects on growth, health, or
behavior were reported in rats fed Lysine maize grain at up to
33% of the diet for at least 90 d.
6.5 Nutritional Assessment
6.5.1 Lysine supplementation of broiler diets
Broiler chicken and swine diets based on maize and soybean
meal may require the addition of supplemental lysine for optimal
animal performance (NRC 1994, 1998). Supplemental lysine is
usually in the form of lysine monohydrochloride or lysine sulfate
(Leuchtenberger 1996) produced via fermentation by
Corynebacterium glutamicum or Brevibacterium lactofermen-
tum (Eggeling 1994). Both of these lysine sources are highly
bioavailable (Sibbald and Wolynetz 1985; Nelson and others
1986; Izquierdo and others 1988), and their addition to lysine-
deficient diets improves the growth rate and feed efficiency of
rapidly growing broiler chickens relative to birds fed similar diets
without supplemental lysine (Emmert and Baker 1997).
Relatively small changes in growth rate, feed efficiency, and/or
carcass measurements as a result of a change in nutritional (nutri-
ent or antinutrient) or health status can be detected in the fast
growing broiler (Hammond and others 1996; Taylor and others
2003a, 2003b, 2003c).
6.5.2 Performance
Studies using day-old broiler chicks, which are recognized as
being sensitive to small changes in nutritional composition, have
been widely used to compare nutritional performance obtained
from conventional and GM feeds with agronomic input traits
(NRC 1994; Taylor and others 2003a, 2003b, 2003c). While such
studies are not seen as a key component of the safety assessment,
EFSA (2004) has suggested that they may provide supplemental
information on the possible occurrence of unintended effects. In
the case of nutritionally enhanced crops, performance studies
with target species are essential to demonstrate the expected
nutritional enhancement occurs. In the case of Lysine maize, a
trial with fast growing broiler chickens was conducted to com-
pare the performance (growth rate, feed efficiency, and carcass
characteristics), bioefficacy, and bioavailability of lysine in Lysine
maize with a conventional maize grain of comparable genetics
and 4 reference maize varieties. Each of the control and refer-
ence maize diets were formulated with and without supplemen-
tal crystalline lysine so that the diets with the supplemental lysine
had a similar dietary lysine concentration to the Lysine maize
grain diet. Bird performance and health observations throughout
the study also provided a basis for assessing whether there were
any unexpected effects on broiler health and performance.
No unexpected effects on bird performance or health were
observed when feeding Lysine maize grain. The bioefficacy and
bioavailability of the lysine in Lysine maize grain were demon-
strated by the improved performance of birds receiving a diet with
Lysine maize compared to broilers fed a diet without supplemen-
tal crystalline lysine, but otherwise identical to the control and tra-
ditional reference maize varieties. Importantly, the performance
and carcass measurements of birds fed diets with Lysine maize
grain were comparable to those of birds fed diets supplemented
with crystalline lysine and either near isogenic control or conven-
tional reference maize at the same inclusion rate. Therefore,
Lysine maize grain can be considered as safe as traditional maize
when fed to poultry and more nutritious than traditional maize
because of the increased lysine levels in Lysine maize.
CRFSFS: Comprehensive Reviews in Food Science and Food Safety
104 COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY—Vol. 7, 2008
6.6 Conclusions
The data and information in this case study provide an exam-
ple of a GM crop in which a specific nutrient has been increased
and which is to be used as a feed ingredient. This case study has
demonstrated that, although each product must be considered on
a case-by-case basis, the comparative safety assessment process
successfully applied to agronomic trait GM crops is also appro-
priate and recommended for the safety and nutritional assess-
ment of nutritionally enhanced crops derived through modern
biotechnology. For the present case of Lysine maize, the available
data show that it is as safe as conventional maize while being
nutritionally enhanced for poultry diets.
For Lysine maize specifically, it is concluded that (1) Lysine
maize is as safe as conventional maize; and (2) the increased
lysine in Lysine maize grain produced the intended nutritional
benefit for broiler chickens when compared to conventional
maize grain with a crystalline lysine supplement.
These conclusions are based on several categories of assess-
ment that included:
1. Detailed molecular characterization.
2. Comparison of the phenotypic, agronomic, and composi-
tional properties of LY038 to conventional maize hybrids. The
results of the comparative safety assessment studies demonstrat-
ed that LY038 grain is substantially equivalent to conventional
maize with the exception of the intended increase in lysine and
the corresponding increase in 2 lysine catabolites.
3. Safety assessment of the cDHDPS protein with respect to
allergenicity and toxicity showed no major concerns.
6.7 Recommendations
Some of the possible key recommendations for the safety and
nutritional assessment of an animal feed product with improved
nutritional characteristics like Lysine maize are included below.
Recommendation 1. Comprehensive assessment of the safety
of the introduced protein, including an understanding of the his-
tory of safe consumption by humans and animals of this protein
and related proteins, a demonstration that the protein lacks
homology to known toxins and allergens, a demonstration that
the protein is rapidly degraded by digestive enzymes, and an
acute toxicity test in animals at levels that greatly exceed any
anticipated exposure from consumption of the product.
Recommendation 2. Consideration of the targeted metabolic
pathway to identify metabolites in the synthesis or degradation
pathways of the intended change that might accumulate, and
inclusion of these in the compositional analysis. In Lysine maize,
the well-understood metabolic pathways involved in lysine
metabolism in plants and animals identified the addition of 7
lysine-related metabolites (free lysine, cadaverine, a-aminoad-
ipic acid, saccharopine, homoserine, L-pipecolic acid, and 2,6-
diaminopimelic acid) to the OECD list of targeted analytes for
maize for the detection of alterations in the composition of grain
from Lysine maize compared to conventional maize.
Recommendation 3. Studies in laboratory animals are useful
in confirming the overall safety of the product established by the
other components of the safety assessment, thereby providing
added safety assurance.
Recommendation 4. Nutritional studies to demonstrate effica-
cy of the nutritional change in the target species. For Lysine
maize, broiler feeding studies were useful to demonstrate the
improved animal feed nutritional property associated with the
increased lysine in LY038 maize grain.
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Vitamin A deficiency (VAD) is a global public health chal-
lenge, particularly in infants, children, and pregnant and lactat-
ing women because of the extra requirements to support fetal,
infant, and child growth (Figure A1-1). Deficiency can result in
reduced resistance to infection, impaired cellular differentiation,
xerophthalmia, and ultimately blindness and death; it is also
associated with anemia. More than 100 million children and as
many as 7 million pregnant women living in over 100 countries
have VAD (West 2002; WHO 2003). It is estimated that between
1.3 and 2.5 million deaths of children aged 6 mo to 5 y could be
prevented each year by proper vitamin A nutrition (Figure A1-2).
Two million children have clinical or severe visual problems and
more than 250000 children become blind as a result of VAD
each year, one-half of whom die within a year of losing their
sight. (FAO 2002). The chances of death from measles or diar-
rheal disease are greatly increased by VAD (FAO/WHO 2002).
VAD also interacts with other nutrients; for example, iron metab-
olism is negatively affected and iron is not incorporated effective-
ly into hemoglobin (Hodges and others 1978).
Many countries with a high prevalence of VAD rely on rice as
a major source of energy. Rice does not contain -carotene, the
direct precursor of vitamin A. Attempts to provide biannual vita-
min A supplements to all children less than 6 y of age have been
difficult to sustain and are comparatively expensive (Bouis and
others 2003). More recently, fortification of foods such as sugar
and cereal flours with vitamin A has come to the fore. Lack of
dietary diversity causes VAD, and historically, emphasis has been
on increasing the intake of green leafy vegetables and yellow-
orange fruits and vegetables to improve vitamin A intake.
However, the -carotene in green leafy vegetable is less well
absorbed than that from yellow-orange fruits and roots or tubers,
although the method of preparation, including the presence of
dietary lipid, can improve bioefficacy (Yeum and Russell 2002;
Haskell and others 2004). The Inst. of Medicine (2001) has pro-
posed that 12 g of -carotene are required to provide 1 g of
vitamin A, while a conversion factor of 1 to 24 g has been set
for other provitamin A carotenoids, that is, -cryptoxanthin and
-carotene.
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Appendix 1: Vitamin A Deficiency: 
A Global Risk
Figure A1-1—Vitamin A deficien-
cy around the globe (FAO/WHO
2002).
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The details of the biosynthesis of -carotene and other
carotenoids in plants have been reviewed elsewhere
(Cunningham and Gantt 1998; Sandmann 2001; Taylor and
Ramsay 2005). The initial steps in the biosynthesis of -carotene
involve intermediates that are also precursors to other products
in plant cells. For example, the 5-carbon molecule (C5) isopen-
tenyl pyrophosphate (IPP) is the building unit for the synthesis of
various kinds of terpenoids, including -carotenes, plant hor-
mones, and other secondary metabolites and defense mole-
cules. IPP is formed both in the cytosol, through the mevalonate
pathway, and in plastids, through the deoxy-xylulose-phosphate
pathway. In plastids, IPP serves as substrate for carotenoid
biosynthesis, among others, and in the cytosol for some plant
hormones and steroids.
Because IPP isomerase is present in plant plastids and its activ-
ity is the limiting step of carotenoid synthesis in etioplasts, it has
been concluded that IPP is the major or only product of the 1-
deoxyxylulose-5-phosphate pathway–-the reaction sequence
leading to cyclic carotenoids (Albrecht and others 1994).
The 1st steps in the biosynthesis from IPP to -carotene entail
the formation of the C20 compound geranylgeranylphosphate
(GGPP) by condensation of 4 C5-precursors in total. First, 1 IPP
molecule is isomerized by the enzyme IPP isomerase into
dimethylallyl-pyrophosphate (DMAPP). This activated form of
IPP then reacts with 3 IPP molecules in 3 discrete reactions,
leading to the formation of GGPP catalyzed by the enzyme
GGPP synthase. Two molecules of GGPP are subsequently con-
densed to phytoene (C40) under the influence of the enzyme
phytoene synthase.
Phytoene enters a series of dehydrogenation and ring forma-
tion reactions, resulting in the formation of -carotene.
Phytoene desaturase (PDS) and zeta carotene desaturase (ZDS)
Figure A1-2—WHO estimates of childhood mortality
(FAO 1992).
Appendix 2: Biosynthesis of -Carotene
ILSI: Assessments of foods and feeds . . .
Vol. 7, 2008—COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY 109
catalyze 4 dehydrogenation reactions, while carotenoid iso-
merase (CRTISO) catalyzes the cis-trans isomerization of cis
double bonds, particularly the 15-cis-double bond between car-
bon atoms, so that ultimately all-trans-lycopene is formed. The
enzyme lycopene -cyclase (LCYB) converts lycopene into -
carotene through 2 cyclization reactions involving the formation
of C6-rings at both ends of the molecule. In addition, -carotene
itself may be converted to xanthophylls, which are carotenoid
molecules with hydroxylated rings. Further reactions of xantho-
phylls lead to, for example, formation of the plant growth regu-
lator, abscisic acid (Cunningham and Gantt 1998; Taylor and
Ramsay 2005).
Figure A2-1 provides a schematic overview of the pathway
leading to biosynthesis of -carotene and products derived from
branches of the same pathway. Increasing the flux through this
pathway toward -carotene or intermediates may alter the
biosynthesis of other metabolites. For example, Fray and others
(1995) found that levels of intermediates, including phytoene,
lycopene, and -carotene, had increased in tomato plants
expressing phytoene synthase. In addition, transgenic plants
showed stunted growth due to decreased production of gib-
berellic acid-based plant growth regulators. Chlorophyll biosyn-
thesis was decreased in these plants as well.
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Figure A2-1—Biosynthesis of -
carotene in plants and other products
originating from intermediates in the
same pathway. [Based on “Biochemical
Pathways” chart of Roche Applied
Sciences (www. expasy.org/ tools/path-
ways/) and Taylor and Ramsay (2005)].
Intake of -Carotene
Beta-carotene is an important provitamin A carotenoid, that is,
precursor of vitamin A, but is not an essential nutrient and has no
dietary reference value. Dietary intakes are expressed as total
micrograms of retinol equivalents (RE), in which 12 g 
-carotene is equivalent nutritionally to 1 g RE. The FAO/WHO
(2002) recommended safe dietary intake of vitamin A is 
375 g/d for infants, 400 to 450 g/d for children 1 to 6 y, 
800 g/d for pregnant women, and 850 g/d for lactating women.
Provitamin A carotenoids are generally ingested from plant
foods and can be biologically transformed to vitamin A.
Globally, about 60% of dietary vitamin A comes from provita-
mins A. Many factors influence the absorption and utilization of
provitamin A, such as the vitamin A status of the individual; the
amount, type, and physical form of the carotenoids in the diet;
the intake of fat, vitamin A, and fiber; the individual’s protein
and zinc status; and the presence of certain diseases and para-
sitic infections (de Pee and West 1996). Between 10% and 90%
of all dietary -carotene is absorbed, and absorption decreases
as intake increases. Bioavailability is reduced in very low-fat
diets.
Metabolism of -Carotene
The metabolism of -carotene in humans and animals is well
documented, with excellent reviews by Olson (1996), Parker
(1997), Burri and Clifford (2004), and Bendich (2004).
In humans, dietary fat and bile salts facilitate the absorption
of -carotene that occurs in the upper small intestine.
Absorption occurs via incorporation into multilamellar lipid
micelles, although a proportion of absorbed -carotene is con-
verted to retinol within intestinal mucosal cells. Unaltered -
carotene is transported via the lymph to the plasma where it is
associated with lipoproteins. Tissue uptake and distribution are
not well characterized. When the intake of -carotene is consis-
tently high, long-term accumulation occurs preferentially in adi-
pose tissues.
Experiments in rats have shown that the conversion of -
carotene to retinol is regulated by the levels of -carotene and
of preformed vitamin A. In vitro studies have shown that other
-carotene derivatives may also occur, but their biological activ-
ity, and whether they are synthesized in vivo, is unknown.
Carotenoid absorption and metabolism vary considerably
between animal species (Lee and others 1999). No single
species is a good model for studying biokinetics and metabolism
of -carotene in humans. The rat is unsuitable because it is high-
ly efficient at converting -carotene to vitamin A, and significant
levels of unaltered -carotene are absorbed only when very high
doses are given for a prolonged time. The preruminant calf, the
ferret, and the Mongolian gerbil are more useful models,
although there are many differences in carotenoid absorption,
distribution, and metabolism between these animals and
humans.
Toxicity of Carotene
Dietary -carotene has not been shown to be toxic in humans
(Expert Group on Vitamins and Minerals 2003).
Hypercarotenaemia (high plasma -carotene) has not been
associated with adverse effects other than reversible yellowing
of the skin, known as hypercarotenodermia. Long-term oral -
carotene therapy in doses up to 300 g/d showed no toxic
effects in individuals with erythropoietic protoporphyria.
Vitamin A toxicity does not occur because the metabolic con-
version is regulated by vitamin A status. Reproductive toxicity or
teratogenicity associated with high -carotene intake, either
before or during pregnancy, has not been reported. Two large-
scale supplementation trials testing the hypothesis that 
-carotene supplementation in smokers would reduce the inci-
dence of cancer have shown an association of high dose 
-carotene supplementation (20 to 30 mg/d) with increased
incidence of lung cancer in smokers and asbestos-exposed indi-
viduals (Alpha-Tocopherol Beta-Carotene Cancer Prevention
Study Group 1994; Omenn and others 1996). No statistically
significant differences in other cancer types were observed in
these studies.
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Appendix 3: Physiology of -Carotene
Malnutrition includes both under- and overnutrition.
Undernutrition is the general term for an inadequate intake of
energy or specific vitamins and minerals that are collectively
known as micronutrients. Overnutrition is the opposite. This
section focuses on undernutrition, specifically protein-energy
malnutrition (PEM). PEM syndrome results from inadequate
food intake and is characterized by energy deficits, due to a
reduced intake of all macronutrients and often many micronu-
trients as well. Clinically, PEM manifests as emaciation (maras-
mus), edema (kwashiorkor), or a combination of the two
(marasmic–kwashiorkor). The form depends on the balance of
nonprotein and protein sources of energy. Marasmus occurs
when energy intake is insufficient to meet requirements and the
body is forced to draw on its own stores: first glycogen, then
skeletal muscle and triglycerides in fat depots. Consequently,
the individual becomes thin from loss of muscle and body fat.
In kwashiorkor, dietary protein deficiency is usually more
marked than the energy deficiency, and this results in
decreased protein synthesis and edema. Children with maras-
mic–kwashiorkor have some edema and more body fat than
those with marasmus.
Marasmus is the predominant form of PEM in most develop-
ing countries and can affect all age groups. Kwashiorkor is less
common and is usually manifested as marasmic–kwashiorkor,
especially in young children. It tends to occur where the staple
foods are low in protein and excessively starchy (for example,
yam [Dioscorea], cassava, sweetpotato, taro, plantain, and
banana).
The assessment of PEM uses indices derived from measure-
ments of body stature or length, weight, age, and presence or
absence of edema that are compared with a reference popula-
tion considered to have normal growth characteristics---usually
the United States, although this has been questioned. The
indices are underweight (low weight for age), stunting (low
height for age), and wasting (low weight for height). National
and regional level data on nutritional status have been compiled
systematically for more than 20 y by the WHO Global Database
on Child Growth and Malnutrition, which represents most of the
children worldwide (de Onis and others 2004). Because 
the population in Asia is larger than elsewhere in the world, the
number of undernourished is greatest in Asia, followed by
Africa, although the proportion that are undernourished is great-
est in Africa (de Onis and others 2004).
Views on the causes of PEM have evolved over time. By the
1960s, for example, it was known that the supply of protein in
cereal-based diets was adequate (Hegsted and others 1946). The
FAO nevertheless considered protein deficiency to be serious
and widespread in developing countries. This was based on the
observations that kwashiorkor, which was common among 1- to
4-y-old children in developing countries, (1) responded to ther-
apy that included relatively high-protein supplements and (2)
caused liver damage. Because liver cirrhosis was common
among adults in Africa, the FAO thought this too indicated that
African diets remained protein-deficient throughout life and the
same might also be true in all developing countries. Milk and
milk powder were expensive and in short supply. Consequently,
much work was carried out to develop and test economical
alternatives to milk powder based on locally available cereals
and oilseed flours, fish protein concentrate, and single-cell pro-
tein from fermenting microorganisms. The work ended once it
was realized that most children with kwashiorkor had been
raised on diets that were as deficient in energy as they were in
protein. The diets were also too bulky, which meant children
could only eat a limited and inadequate amount (Whitehead
1973). Consensus was reached that the solution was to provide
more high-energy foods and correct electrolyte deficiencies
rather than concentrate just on protein (Waterlow 1961;
McLaren 1974; Carpenter 1994), although it was recognized
that diets based on staples such as cassava, bananas, and yams
(Dioscorea) that are both very bulky and in low in protein pres-
ent special challenges (Nicol 1971). In addition, initial treat-
ment for severe PEM requires comparatively low levels of pro-
tein with a high biological value to ensure optimal utilization of
protein for tissue maintenance and to prevent overloading the
impaired metabolic system with superfluous amino acids and
their nitrogenous metabolites. Following this initial treatment,
high-protein diets such as milk-based formula can be used to
stimulate growth and recovery (for example, Müller and
Krawinkel 2005).
The importance of good nutrition starts at conception
because fetal growth and development lay the foundation for
health at all later ages. A fetus depends on the mother’s abili-
ty to deliver nutrients, and this is greatly influenced by her
nutritional state at the time she becomes pregnant as well as
throughout pregnancy. Poor fetal growth and development
have major consequences for the offspring, and these also
have implications for health in the neonatal period, infancy,
childhood, adolescence, and later life. Undernutrition in
early childhood has serious consequences as these children
are not only more prone to illness, but they also tend to have
more severe illnesses than well-nourished children.
Undernourished children are also at greater risk of dying.
Undernutrition in school age children, much of which proba-
bly started in early childhood, adversely affects school atten-
dance, performance, and learning. A stunted girl is more like-
ly to become a stunted adolescent and later a stunted woman.
Apart from direct effects on her health and productivity,
undernutrition in an adult woman increases the chance that
her children will be born with low birth weight, and the cycle
begins again (United Nations Standing Committee on
Nutrition 2004). Interventions to control undernutrition are
therefore needed at different stages in the life cycle. These
include improved child care and feeding practices for infants
and young children; the provision of specific micronutrients
through food fortification, biofortification, and pharmaceuti-
cal supplementation; improved access to health care; household
ILSI: Assessments of foods and feeds . . .
Vol. 7, 2008—COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY 111
Appendix 4: Protein-Energy Malnutrition
food security; good hygiene and sanitation; and universal
female education.
The WHO global strategy for feeding infants and young
children highlights the importance of good feeding practices
during the transition period between exclusive breastfeeding
and full weaning, when breastfed children also need comple-
mentary food. In addition to being safe and timely, the diet
must be adequate—defined as providing sufficient energy,
protein, and micronutrients to meet a growing child’s nutri-
tional needs (WHO 2002). Children need a variety of foods to
ensure that nutrient needs are met. Diets that lack animal
source foods (meat, poultry, fish or eggs, plus milk products)
cannot meet the nutrient requirements for children ages 6 to
24 mo unless fortified foods or supplements are used. If milk
and other animal source foods are not taken in adequate
amounts, both grains and legumes should be consumed daily,
preferably within the same meal, to ensure adequate protein
quality (WHO 2004). In addition to the availability of these
foods, their accessibility to the population depending on, for
example, infrastructure and economic resources needs to be
considered.
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Deregulation is one term used for the process that eventually
leads to the registration of a product and the granting of its
unlimited commercial or noncommercial use. The national
authorities of the respective countries in which the product is
intended for use govern deregulation of GMO plants and the
foods derived from these. The process is driven by a science-
based risk assessment of the intended product and the environ-
ments into which it will be released. Current data requirements
can be extensive and are comprehensive, and require the sub-
mission of publication quality data reports. The development of
these materials can be time- consuming and costly. The studies
required to compile a regulatory dossier fall into 2 categories:
event-dependent and event-independent studies.
Event-independent studies can include biochemical analysis
(function, specificity and mode of action), studies on toxicity
and the allergenic potential of the newly expressed proteins. In
addition, dietary exposure modeling and bioavailability studies
can be conducted with the newly expressed proteins and, in the
case of enzymes, with the products produced by catalysis.
Event-dependent studies vary by country and can encompass
the characterization of the quality of integration, such as copy
number, the determination of the site of integration in the host
genome, demonstration of the absence of gene disruption, com-
pleteness of integrated DNA sequences, and the presence of the
marker gene at the same locus and absence of vector DNA
sequences. Phenotypic and biochemical evidence for trait stabil-
ity, including the monitoring of gene expression levels at key
growth stages and Mendelian inheritance over several genera-
tions, are usually components of these studies. Field performance
of typical agronomic traits, such as yield, and pest and disease
resistance, is an additional issue. The assessment is also based on
the comparison of the compositional analyses from materials
harvested at different locations with the equivalent nontransgenic
crop (and food) comparator. Event-dependent regulatory data are
usually not gathered until the developer is satisfied with the tech-
nical performance of the product and a few events (usually one)
have been chosen. Assessment of the potential risks of GM crops
is on a case-by-case basis within a scientific framework. A GMO
crop producing -carotene must be viewed differently than a
crop that produces an insecticide. Similarly, GR events express-
ing a phytoene synthase from maize, a widely consumed crop,
might be viewed differently than one using the enzyme from a
nonfood plant, such as daffodil.
From a scientific point of view it is often hard to understand
why randomly mutagenized crop plants can enter into breeding
lines easily, whereas GMOs, with considerably fewer genetic
modifications, have a much more rigorous assessment. To have
rational, science-based regulatory requirements it would be
necessary to realize the benefits (not only potential risks) that
GMO crops can provide (see lecture by Ingo Potrykus at
http://www.syngentafoundation.com/golden_rice/index.htm). It
is unhelpful to raise the regulatory requirements to the point
where anything that appears technically feasible is being
requested or is being offered to be applied (Kuiper and others
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2001), with the only justification that the genetically modified
organism involved is little understood. This strategy can raise
costs to unaffordable levels. We do not understand bred vari-
eties with their complex genomic changes much better at the
molecular level, but we tend to consider the traditional way of
producing new varieties safe in contrast to the novel way of pro-
ducing GMOs even though this is not based on any rational
evaluation. It is the final product and not the technology used to
produce it that should be scrutinized.
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Vitamin A deficiency (VAD) is a global public health chal-
lenge, particularly in infants, children, and pregnant and lactat-
ing women because of the extra requirements to support fetal,
infant, and child growth (Figure A1-1). Deficiency can result in
reduced resistance to infection, impaired cellular differentiation,
xerophthalmia, and ultimately blindness and death; it is also
associated with anemia. More than 100 million children and as
many as 7 million pregnant women living in over 100 countries
have VAD (West 2002; WHO 2003). It is estimated that between
1.3 and 2.5 million deaths of children aged 6 mo to 5 y could be
prevented each year by proper vitamin A nutrition (Figure A1-2).
Two million children have clinical or severe visual problems and
more than 250000 children become blind as a result of VAD
each year, one-half of whom die within a year of losing their
sight. (FAO 2002). The chances of death from measles or diar-
rheal disease are greatly increased by VAD (FAO/WHO 2002).
VAD also interacts with other nutrients; for example, iron metab-
olism is negatively affected and iron is not incorporated effective-
ly into hemoglobin (Hodges and others 1978).
Many countries with a high prevalence of VAD rely on rice as
a major source of energy. Rice does not contain -carotene, the
direct precursor of vitamin A. Attempts to provide biannual vita-
min A supplements to all children less than 6 y of age have been
difficult to sustain and are comparatively expensive (Bouis and
others 2003). More recently, fortification of foods such as sugar
and cereal flours with vitamin A has come to the fore. Lack of
dietary diversity causes VAD, and historically, emphasis has been
on increasing the intake of green leafy vegetables and yellow-
orange fruits and vegetables to improve vitamin A intake.
However, the -carotene in green leafy vegetable is less well
absorbed than that from yellow-orange fruits and roots or tubers,
although the method of preparation, including the presence of
dietary lipid, can improve bioefficacy (Yeum and Russell 2002;
Haskell and others 2004). The Inst. of Medicine (2001) has pro-
posed that 12 g of -carotene are required to provide 1 g of
vitamin A, while a conversion factor of 1 to 24 g has been set
for other provitamin A carotenoids, that is, -cryptoxanthin and
-carotene.
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Appendix 1: Vitamin A Deficiency: 
A Global Risk
Figure A1-1—Vitamin A deficien-
cy around the globe (FAO/WHO
2002).
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The details of the biosynthesis of -carotene and other
carotenoids in plants have been reviewed elsewhere
(Cunningham and Gantt 1998; Sandmann 2001; Taylor and
Ramsay 2005). The initial steps in the biosynthesis of -carotene
involve intermediates that are also precursors to other products
in plant cells. For example, the 5-carbon molecule (C5) isopen-
tenyl pyrophosphate (IPP) is the building unit for the synthesis of
various kinds of terpenoids, including -carotenes, plant hor-
mones, and other secondary metabolites and defense mole-
cules. IPP is formed both in the cytosol, through the mevalonate
pathway, and in plastids, through the deoxy-xylulose-phosphate
pathway. In plastids, IPP serves as substrate for carotenoid
biosynthesis, among others, and in the cytosol for some plant
hormones and steroids.
Because IPP isomerase is present in plant plastids and its activ-
ity is the limiting step of carotenoid synthesis in etioplasts, it has
been concluded that IPP is the major or only product of the 1-
deoxyxylulose-5-phosphate pathway–-the reaction sequence
leading to cyclic carotenoids (Albrecht and others 1994).
The 1st steps in the biosynthesis from IPP to -carotene entail
the formation of the C20 compound geranylgeranylphosphate
(GGPP) by condensation of 4 C5-precursors in total. First, 1 IPP
molecule is isomerized by the enzyme IPP isomerase into
dimethylallyl-pyrophosphate (DMAPP). This activated form of
IPP then reacts with 3 IPP molecules in 3 discrete reactions,
leading to the formation of GGPP catalyzed by the enzyme
GGPP synthase. Two molecules of GGPP are subsequently con-
densed to phytoene (C40) under the influence of the enzyme
phytoene synthase.
Phytoene enters a series of dehydrogenation and ring forma-
tion reactions, resulting in the formation of -carotene.
Phytoene desaturase (PDS) and zeta carotene desaturase (ZDS)
Figure A1-2—WHO estimates of childhood mortality
(FAO 1992).
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catalyze 4 dehydrogenation reactions, while carotenoid iso-
merase (CRTISO) catalyzes the cis-trans isomerization of cis
double bonds, particularly the 15-cis-double bond between car-
bon atoms, so that ultimately all-trans-lycopene is formed. The
enzyme lycopene -cyclase (LCYB) converts lycopene into -
carotene through 2 cyclization reactions involving the formation
of C6-rings at both ends of the molecule. In addition, -carotene
itself may be converted to xanthophylls, which are carotenoid
molecules with hydroxylated rings. Further reactions of xantho-
phylls lead to, for example, formation of the plant growth regu-
lator, abscisic acid (Cunningham and Gantt 1998; Taylor and
Ramsay 2005).
Figure A2-1 provides a schematic overview of the pathway
leading to biosynthesis of -carotene and products derived from
branches of the same pathway. Increasing the flux through this
pathway toward -carotene or intermediates may alter the
biosynthesis of other metabolites. For example, Fray and others
(1995) found that levels of intermediates, including phytoene,
lycopene, and -carotene, had increased in tomato plants
expressing phytoene synthase. In addition, transgenic plants
showed stunted growth due to decreased production of gib-
berellic acid-based plant growth regulators. Chlorophyll biosyn-
thesis was decreased in these plants as well.
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Figure A2-1—Biosynthesis of -
carotene in plants and other products
originating from intermediates in the
same pathway. [Based on “Biochemical
Pathways” chart of Roche Applied
Sciences (www. expasy.org/ tools/path-
ways/) and Taylor and Ramsay (2005)].
Intake of -Carotene
Beta-carotene is an important provitamin A carotenoid, that is,
precursor of vitamin A, but is not an essential nutrient and has no
dietary reference value. Dietary intakes are expressed as total
micrograms of retinol equivalents (RE), in which 12 g 
-carotene is equivalent nutritionally to 1 g RE. The FAO/WHO
(2002) recommended safe dietary intake of vitamin A is 
375 g/d for infants, 400 to 450 g/d for children 1 to 6 y, 
800 g/d for pregnant women, and 850 g/d for lactating women.
Provitamin A carotenoids are generally ingested from plant
foods and can be biologically transformed to vitamin A.
Globally, about 60% of dietary vitamin A comes from provita-
mins A. Many factors influence the absorption and utilization of
provitamin A, such as the vitamin A status of the individual; the
amount, type, and physical form of the carotenoids in the diet;
the intake of fat, vitamin A, and fiber; the individual’s protein
and zinc status; and the presence of certain diseases and para-
sitic infections (de Pee and West 1996). Between 10% and 90%
of all dietary -carotene is absorbed, and absorption decreases
as intake increases. Bioavailability is reduced in very low-fat
diets.
Metabolism of -Carotene
The metabolism of -carotene in humans and animals is well
documented, with excellent reviews by Olson (1996), Parker
(1997), Burri and Clifford (2004), and Bendich (2004).
In humans, dietary fat and bile salts facilitate the absorption
of -carotene that occurs in the upper small intestine.
Absorption occurs via incorporation into multilamellar lipid
micelles, although a proportion of absorbed -carotene is con-
verted to retinol within intestinal mucosal cells. Unaltered -
carotene is transported via the lymph to the plasma where it is
associated with lipoproteins. Tissue uptake and distribution are
not well characterized. When the intake of -carotene is consis-
tently high, long-term accumulation occurs preferentially in adi-
pose tissues.
Experiments in rats have shown that the conversion of -
carotene to retinol is regulated by the levels of -carotene and
of preformed vitamin A. In vitro studies have shown that other
-carotene derivatives may also occur, but their biological activ-
ity, and whether they are synthesized in vivo, is unknown.
Carotenoid absorption and metabolism vary considerably
between animal species (Lee and others 1999). No single
species is a good model for studying biokinetics and metabolism
of -carotene in humans. The rat is unsuitable because it is high-
ly efficient at converting -carotene to vitamin A, and significant
levels of unaltered -carotene are absorbed only when very high
doses are given for a prolonged time. The preruminant calf, the
ferret, and the Mongolian gerbil are more useful models,
although there are many differences in carotenoid absorption,
distribution, and metabolism between these animals and
humans.
Toxicity of Carotene
Dietary -carotene has not been shown to be toxic in humans
(Expert Group on Vitamins and Minerals 2003).
Hypercarotenaemia (high plasma -carotene) has not been
associated with adverse effects other than reversible yellowing
of the skin, known as hypercarotenodermia. Long-term oral -
carotene therapy in doses up to 300 g/d showed no toxic
effects in individuals with erythropoietic protoporphyria.
Vitamin A toxicity does not occur because the metabolic con-
version is regulated by vitamin A status. Reproductive toxicity or
teratogenicity associated with high -carotene intake, either
before or during pregnancy, has not been reported. Two large-
scale supplementation trials testing the hypothesis that 
-carotene supplementation in smokers would reduce the inci-
dence of cancer have shown an association of high dose 
-carotene supplementation (20 to 30 mg/d) with increased
incidence of lung cancer in smokers and asbestos-exposed indi-
viduals (Alpha-Tocopherol Beta-Carotene Cancer Prevention
Study Group 1994; Omenn and others 1996). No statistically
significant differences in other cancer types were observed in
these studies.
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Appendix 3: Physiology of -Carotene
Malnutrition includes both under- and overnutrition.
Undernutrition is the general term for an inadequate intake of
energy or specific vitamins and minerals that are collectively
known as micronutrients. Overnutrition is the opposite. This
section focuses on undernutrition, specifically protein-energy
malnutrition (PEM). PEM syndrome results from inadequate
food intake and is characterized by energy deficits, due to a
reduced intake of all macronutrients and often many micronu-
trients as well. Clinically, PEM manifests as emaciation (maras-
mus), edema (kwashiorkor), or a combination of the two
(marasmic–kwashiorkor). The form depends on the balance of
nonprotein and protein sources of energy. Marasmus occurs
when energy intake is insufficient to meet requirements and the
body is forced to draw on its own stores: first glycogen, then
skeletal muscle and triglycerides in fat depots. Consequently,
the individual becomes thin from loss of muscle and body fat.
In kwashiorkor, dietary protein deficiency is usually more
marked than the energy deficiency, and this results in
decreased protein synthesis and edema. Children with maras-
mic–kwashiorkor have some edema and more body fat than
those with marasmus.
Marasmus is the predominant form of PEM in most develop-
ing countries and can affect all age groups. Kwashiorkor is less
common and is usually manifested as marasmic–kwashiorkor,
especially in young children. It tends to occur where the staple
foods are low in protein and excessively starchy (for example,
yam [Dioscorea], cassava, sweetpotato, taro, plantain, and
banana).
The assessment of PEM uses indices derived from measure-
ments of body stature or length, weight, age, and presence or
absence of edema that are compared with a reference popula-
tion considered to have normal growth characteristics---usually
the United States, although this has been questioned. The
indices are underweight (low weight for age), stunting (low
height for age), and wasting (low weight for height). National
and regional level data on nutritional status have been compiled
systematically for more than 20 y by the WHO Global Database
on Child Growth and Malnutrition, which represents most of the
children worldwide (de Onis and others 2004). Because 
the population in Asia is larger than elsewhere in the world, the
number of undernourished is greatest in Asia, followed by
Africa, although the proportion that are undernourished is great-
est in Africa (de Onis and others 2004).
Views on the causes of PEM have evolved over time. By the
1960s, for example, it was known that the supply of protein in
cereal-based diets was adequate (Hegsted and others 1946). The
FAO nevertheless considered protein deficiency to be serious
and widespread in developing countries. This was based on the
observations that kwashiorkor, which was common among 1- to
4-y-old children in developing countries, (1) responded to ther-
apy that included relatively high-protein supplements and (2)
caused liver damage. Because liver cirrhosis was common
among adults in Africa, the FAO thought this too indicated that
African diets remained protein-deficient throughout life and the
same might also be true in all developing countries. Milk and
milk powder were expensive and in short supply. Consequently,
much work was carried out to develop and test economical
alternatives to milk powder based on locally available cereals
and oilseed flours, fish protein concentrate, and single-cell pro-
tein from fermenting microorganisms. The work ended once it
was realized that most children with kwashiorkor had been
raised on diets that were as deficient in energy as they were in
protein. The diets were also too bulky, which meant children
could only eat a limited and inadequate amount (Whitehead
1973). Consensus was reached that the solution was to provide
more high-energy foods and correct electrolyte deficiencies
rather than concentrate just on protein (Waterlow 1961;
McLaren 1974; Carpenter 1994), although it was recognized
that diets based on staples such as cassava, bananas, and yams
(Dioscorea) that are both very bulky and in low in protein pres-
ent special challenges (Nicol 1971). In addition, initial treat-
ment for severe PEM requires comparatively low levels of pro-
tein with a high biological value to ensure optimal utilization of
protein for tissue maintenance and to prevent overloading the
impaired metabolic system with superfluous amino acids and
their nitrogenous metabolites. Following this initial treatment,
high-protein diets such as milk-based formula can be used to
stimulate growth and recovery (for example, Müller and
Krawinkel 2005).
The importance of good nutrition starts at conception
because fetal growth and development lay the foundation for
health at all later ages. A fetus depends on the mother’s abili-
ty to deliver nutrients, and this is greatly influenced by her
nutritional state at the time she becomes pregnant as well as
throughout pregnancy. Poor fetal growth and development
have major consequences for the offspring, and these also
have implications for health in the neonatal period, infancy,
childhood, adolescence, and later life. Undernutrition in
early childhood has serious consequences as these children
are not only more prone to illness, but they also tend to have
more severe illnesses than well-nourished children.
Undernourished children are also at greater risk of dying.
Undernutrition in school age children, much of which proba-
bly started in early childhood, adversely affects school atten-
dance, performance, and learning. A stunted girl is more like-
ly to become a stunted adolescent and later a stunted woman.
Apart from direct effects on her health and productivity,
undernutrition in an adult woman increases the chance that
her children will be born with low birth weight, and the cycle
begins again (United Nations Standing Committee on
Nutrition 2004). Interventions to control undernutrition are
therefore needed at different stages in the life cycle. These
include improved child care and feeding practices for infants
and young children; the provision of specific micronutrients
through food fortification, biofortification, and pharmaceuti-
cal supplementation; improved access to health care; household
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food security; good hygiene and sanitation; and universal
female education.
The WHO global strategy for feeding infants and young
children highlights the importance of good feeding practices
during the transition period between exclusive breastfeeding
and full weaning, when breastfed children also need comple-
mentary food. In addition to being safe and timely, the diet
must be adequate—defined as providing sufficient energy,
protein, and micronutrients to meet a growing child’s nutri-
tional needs (WHO 2002). Children need a variety of foods to
ensure that nutrient needs are met. Diets that lack animal
source foods (meat, poultry, fish or eggs, plus milk products)
cannot meet the nutrient requirements for children ages 6 to
24 mo unless fortified foods or supplements are used. If milk
and other animal source foods are not taken in adequate
amounts, both grains and legumes should be consumed daily,
preferably within the same meal, to ensure adequate protein
quality (WHO 2004). In addition to the availability of these
foods, their accessibility to the population depending on, for
example, infrastructure and economic resources needs to be
considered.
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Deregulation is one term used for the process that eventually
leads to the registration of a product and the granting of its
unlimited commercial or noncommercial use. The national
authorities of the respective countries in which the product is
intended for use govern deregulation of GMO plants and the
foods derived from these. The process is driven by a science-
based risk assessment of the intended product and the environ-
ments into which it will be released. Current data requirements
can be extensive and are comprehensive, and require the sub-
mission of publication quality data reports. The development of
these materials can be time- consuming and costly. The studies
required to compile a regulatory dossier fall into 2 categories:
event-dependent and event-independent studies.
Event-independent studies can include biochemical analysis
(function, specificity and mode of action), studies on toxicity
and the allergenic potential of the newly expressed proteins. In
addition, dietary exposure modeling and bioavailability studies
can be conducted with the newly expressed proteins and, in the
case of enzymes, with the products produced by catalysis.
Event-dependent studies vary by country and can encompass
the characterization of the quality of integration, such as copy
number, the determination of the site of integration in the host
genome, demonstration of the absence of gene disruption, com-
pleteness of integrated DNA sequences, and the presence of the
marker gene at the same locus and absence of vector DNA
sequences. Phenotypic and biochemical evidence for trait stabil-
ity, including the monitoring of gene expression levels at key
growth stages and Mendelian inheritance over several genera-
tions, are usually components of these studies. Field performance
of typical agronomic traits, such as yield, and pest and disease
resistance, is an additional issue. The assessment is also based on
the comparison of the compositional analyses from materials
harvested at different locations with the equivalent nontransgenic
crop (and food) comparator. Event-dependent regulatory data are
usually not gathered until the developer is satisfied with the tech-
nical performance of the product and a few events (usually one)
have been chosen. Assessment of the potential risks of GM crops
is on a case-by-case basis within a scientific framework. A GMO
crop producing -carotene must be viewed differently than a
crop that produces an insecticide. Similarly, GR events express-
ing a phytoene synthase from maize, a widely consumed crop,
might be viewed differently than one using the enzyme from a
nonfood plant, such as daffodil.
From a scientific point of view it is often hard to understand
why randomly mutagenized crop plants can enter into breeding
lines easily, whereas GMOs, with considerably fewer genetic
modifications, have a much more rigorous assessment. To have
rational, science-based regulatory requirements it would be
necessary to realize the benefits (not only potential risks) that
GMO crops can provide (see lecture by Ingo Potrykus at
http://www.syngentafoundation.com/golden_rice/index.htm). It
is unhelpful to raise the regulatory requirements to the point
where anything that appears technically feasible is being
requested or is being offered to be applied (Kuiper and others
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2001), with the only justification that the genetically modified
organism involved is little understood. This strategy can raise
costs to unaffordable levels. We do not understand bred vari-
eties with their complex genomic changes much better at the
molecular level, but we tend to consider the traditional way of
producing new varieties safe in contrast to the novel way of pro-
ducing GMOs even though this is not based on any rational
evaluation. It is the final product and not the technology used to
produce it that should be scrutinized.
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Vitamin A deficiency (VAD) is a global public health chal-
lenge, particularly in infants, children, and pregnant and lactat-
ing women because of the extra requirements to support fetal,
infant, and child growth (Figure A1-1). Deficiency can result in
reduced resistance to infection, impaired cellular differentiation,
xerophthalmia, and ultimately blindness and death; it is also
associated with anemia. More than 100 million children and as
many as 7 million pregnant women living in over 100 countries
have VAD (West 2002; WHO 2003). It is estimated that between
1.3 and 2.5 million deaths of children aged 6 mo to 5 y could be
prevented each year by proper vitamin A nutrition (Figure A1-2).
Two million children have clinical or severe visual problems and
more than 250000 children become blind as a result of VAD
each year, one-half of whom die within a year of losing their
sight. (FAO 2002). The chances of death from measles or diar-
rheal disease are greatly increased by VAD (FAO/WHO 2002).
VAD also interacts with other nutrients; for example, iron metab-
olism is negatively affected and iron is not incorporated effective-
ly into hemoglobin (Hodges and others 1978).
Many countries with a high prevalence of VAD rely on rice as
a major source of energy. Rice does not contain -carotene, the
direct precursor of vitamin A. Attempts to provide biannual vita-
min A supplements to all children less than 6 y of age have been
difficult to sustain and are comparatively expensive (Bouis and
others 2003). More recently, fortification of foods such as sugar
and cereal flours with vitamin A has come to the fore. Lack of
dietary diversity causes VAD, and historically, emphasis has been
on increasing the intake of green leafy vegetables and yellow-
orange fruits and vegetables to improve vitamin A intake.
However, the -carotene in green leafy vegetable is less well
absorbed than that from yellow-orange fruits and roots or tubers,
although the method of preparation, including the presence of
dietary lipid, can improve bioefficacy (Yeum and Russell 2002;
Haskell and others 2004). The Inst. of Medicine (2001) has pro-
posed that 12 g of -carotene are required to provide 1 g of
vitamin A, while a conversion factor of 1 to 24 g has been set
for other provitamin A carotenoids, that is, -cryptoxanthin and
-carotene.
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Appendix 1: Vitamin A Deficiency: 
A Global Risk
Figure A1-1—Vitamin A deficien-
cy around the globe (FAO/WHO
2002).
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The details of the biosynthesis of -carotene and other
carotenoids in plants have been reviewed elsewhere
(Cunningham and Gantt 1998; Sandmann 2001; Taylor and
Ramsay 2005). The initial steps in the biosynthesis of -carotene
involve intermediates that are also precursors to other products
in plant cells. For example, the 5-carbon molecule (C5) isopen-
tenyl pyrophosphate (IPP) is the building unit for the synthesis of
various kinds of terpenoids, including -carotenes, plant hor-
mones, and other secondary metabolites and defense mole-
cules. IPP is formed both in the cytosol, through the mevalonate
pathway, and in plastids, through the deoxy-xylulose-phosphate
pathway. In plastids, IPP serves as substrate for carotenoid
biosynthesis, among others, and in the cytosol for some plant
hormones and steroids.
Because IPP isomerase is present in plant plastids and its activ-
ity is the limiting step of carotenoid synthesis in etioplasts, it has
been concluded that IPP is the major or only product of the 1-
deoxyxylulose-5-phosphate pathway–-the reaction sequence
leading to cyclic carotenoids (Albrecht and others 1994).
The 1st steps in the biosynthesis from IPP to -carotene entail
the formation of the C20 compound geranylgeranylphosphate
(GGPP) by condensation of 4 C5-precursors in total. First, 1 IPP
molecule is isomerized by the enzyme IPP isomerase into
dimethylallyl-pyrophosphate (DMAPP). This activated form of
IPP then reacts with 3 IPP molecules in 3 discrete reactions,
leading to the formation of GGPP catalyzed by the enzyme
GGPP synthase. Two molecules of GGPP are subsequently con-
densed to phytoene (C40) under the influence of the enzyme
phytoene synthase.
Phytoene enters a series of dehydrogenation and ring forma-
tion reactions, resulting in the formation of -carotene.
Phytoene desaturase (PDS) and zeta carotene desaturase (ZDS)
Figure A1-2—WHO estimates of childhood mortality
(FAO 1992).
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catalyze 4 dehydrogenation reactions, while carotenoid iso-
merase (CRTISO) catalyzes the cis-trans isomerization of cis
double bonds, particularly the 15-cis-double bond between car-
bon atoms, so that ultimately all-trans-lycopene is formed. The
enzyme lycopene -cyclase (LCYB) converts lycopene into -
carotene through 2 cyclization reactions involving the formation
of C6-rings at both ends of the molecule. In addition, -carotene
itself may be converted to xanthophylls, which are carotenoid
molecules with hydroxylated rings. Further reactions of xantho-
phylls lead to, for example, formation of the plant growth regu-
lator, abscisic acid (Cunningham and Gantt 1998; Taylor and
Ramsay 2005).
Figure A2-1 provides a schematic overview of the pathway
leading to biosynthesis of -carotene and products derived from
branches of the same pathway. Increasing the flux through this
pathway toward -carotene or intermediates may alter the
biosynthesis of other metabolites. For example, Fray and others
(1995) found that levels of intermediates, including phytoene,
lycopene, and -carotene, had increased in tomato plants
expressing phytoene synthase. In addition, transgenic plants
showed stunted growth due to decreased production of gib-
berellic acid-based plant growth regulators. Chlorophyll biosyn-
thesis was decreased in these plants as well.
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Figure A2-1—Biosynthesis of -
carotene in plants and other products
originating from intermediates in the
same pathway. [Based on “Biochemical
Pathways” chart of Roche Applied
Sciences (www. expasy.org/ tools/path-
ways/) and Taylor and Ramsay (2005)].
Intake of -Carotene
Beta-carotene is an important provitamin A carotenoid, that is,
precursor of vitamin A, but is not an essential nutrient and has no
dietary reference value. Dietary intakes are expressed as total
micrograms of retinol equivalents (RE), in which 12 g 
-carotene is equivalent nutritionally to 1 g RE. The FAO/WHO
(2002) recommended safe dietary intake of vitamin A is 
375 g/d for infants, 400 to 450 g/d for children 1 to 6 y, 
800 g/d for pregnant women, and 850 g/d for lactating women.
Provitamin A carotenoids are generally ingested from plant
foods and can be biologically transformed to vitamin A.
Globally, about 60% of dietary vitamin A comes from provita-
mins A. Many factors influence the absorption and utilization of
provitamin A, such as the vitamin A status of the individual; the
amount, type, and physical form of the carotenoids in the diet;
the intake of fat, vitamin A, and fiber; the individual’s protein
and zinc status; and the presence of certain diseases and para-
sitic infections (de Pee and West 1996). Between 10% and 90%
of all dietary -carotene is absorbed, and absorption decreases
as intake increases. Bioavailability is reduced in very low-fat
diets.
Metabolism of -Carotene
The metabolism of -carotene in humans and animals is well
documented, with excellent reviews by Olson (1996), Parker
(1997), Burri and Clifford (2004), and Bendich (2004).
In humans, dietary fat and bile salts facilitate the absorption
of -carotene that occurs in the upper small intestine.
Absorption occurs via incorporation into multilamellar lipid
micelles, although a proportion of absorbed -carotene is con-
verted to retinol within intestinal mucosal cells. Unaltered -
carotene is transported via the lymph to the plasma where it is
associated with lipoproteins. Tissue uptake and distribution are
not well characterized. When the intake of -carotene is consis-
tently high, long-term accumulation occurs preferentially in adi-
pose tissues.
Experiments in rats have shown that the conversion of -
carotene to retinol is regulated by the levels of -carotene and
of preformed vitamin A. In vitro studies have shown that other
-carotene derivatives may also occur, but their biological activ-
ity, and whether they are synthesized in vivo, is unknown.
Carotenoid absorption and metabolism vary considerably
between animal species (Lee and others 1999). No single
species is a good model for studying biokinetics and metabolism
of -carotene in humans. The rat is unsuitable because it is high-
ly efficient at converting -carotene to vitamin A, and significant
levels of unaltered -carotene are absorbed only when very high
doses are given for a prolonged time. The preruminant calf, the
ferret, and the Mongolian gerbil are more useful models,
although there are many differences in carotenoid absorption,
distribution, and metabolism between these animals and
humans.
Toxicity of Carotene
Dietary -carotene has not been shown to be toxic in humans
(Expert Group on Vitamins and Minerals 2003).
Hypercarotenaemia (high plasma -carotene) has not been
associated with adverse effects other than reversible yellowing
of the skin, known as hypercarotenodermia. Long-term oral -
carotene therapy in doses up to 300 g/d showed no toxic
effects in individuals with erythropoietic protoporphyria.
Vitamin A toxicity does not occur because the metabolic con-
version is regulated by vitamin A status. Reproductive toxicity or
teratogenicity associated with high -carotene intake, either
before or during pregnancy, has not been reported. Two large-
scale supplementation trials testing the hypothesis that 
-carotene supplementation in smokers would reduce the inci-
dence of cancer have shown an association of high dose 
-carotene supplementation (20 to 30 mg/d) with increased
incidence of lung cancer in smokers and asbestos-exposed indi-
viduals (Alpha-Tocopherol Beta-Carotene Cancer Prevention
Study Group 1994; Omenn and others 1996). No statistically
significant differences in other cancer types were observed in
these studies.
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Appendix 3: Physiology of -Carotene
Malnutrition includes both under- and overnutrition.
Undernutrition is the general term for an inadequate intake of
energy or specific vitamins and minerals that are collectively
known as micronutrients. Overnutrition is the opposite. This
section focuses on undernutrition, specifically protein-energy
malnutrition (PEM). PEM syndrome results from inadequate
food intake and is characterized by energy deficits, due to a
reduced intake of all macronutrients and often many micronu-
trients as well. Clinically, PEM manifests as emaciation (maras-
mus), edema (kwashiorkor), or a combination of the two
(marasmic–kwashiorkor). The form depends on the balance of
nonprotein and protein sources of energy. Marasmus occurs
when energy intake is insufficient to meet requirements and the
body is forced to draw on its own stores: first glycogen, then
skeletal muscle and triglycerides in fat depots. Consequently,
the individual becomes thin from loss of muscle and body fat.
In kwashiorkor, dietary protein deficiency is usually more
marked than the energy deficiency, and this results in
decreased protein synthesis and edema. Children with maras-
mic–kwashiorkor have some edema and more body fat than
those with marasmus.
Marasmus is the predominant form of PEM in most develop-
ing countries and can affect all age groups. Kwashiorkor is less
common and is usually manifested as marasmic–kwashiorkor,
especially in young children. It tends to occur where the staple
foods are low in protein and excessively starchy (for example,
yam [Dioscorea], cassava, sweetpotato, taro, plantain, and
banana).
The assessment of PEM uses indices derived from measure-
ments of body stature or length, weight, age, and presence or
absence of edema that are compared with a reference popula-
tion considered to have normal growth characteristics---usually
the United States, although this has been questioned. The
indices are underweight (low weight for age), stunting (low
height for age), and wasting (low weight for height). National
and regional level data on nutritional status have been compiled
systematically for more than 20 y by the WHO Global Database
on Child Growth and Malnutrition, which represents most of the
children worldwide (de Onis and others 2004). Because 
the population in Asia is larger than elsewhere in the world, the
number of undernourished is greatest in Asia, followed by
Africa, although the proportion that are undernourished is great-
est in Africa (de Onis and others 2004).
Views on the causes of PEM have evolved over time. By the
1960s, for example, it was known that the supply of protein in
cereal-based diets was adequate (Hegsted and others 1946). The
FAO nevertheless considered protein deficiency to be serious
and widespread in developing countries. This was based on the
observations that kwashiorkor, which was common among 1- to
4-y-old children in developing countries, (1) responded to ther-
apy that included relatively high-protein supplements and (2)
caused liver damage. Because liver cirrhosis was common
among adults in Africa, the FAO thought this too indicated that
African diets remained protein-deficient throughout life and the
same might also be true in all developing countries. Milk and
milk powder were expensive and in short supply. Consequently,
much work was carried out to develop and test economical
alternatives to milk powder based on locally available cereals
and oilseed flours, fish protein concentrate, and single-cell pro-
tein from fermenting microorganisms. The work ended once it
was realized that most children with kwashiorkor had been
raised on diets that were as deficient in energy as they were in
protein. The diets were also too bulky, which meant children
could only eat a limited and inadequate amount (Whitehead
1973). Consensus was reached that the solution was to provide
more high-energy foods and correct electrolyte deficiencies
rather than concentrate just on protein (Waterlow 1961;
McLaren 1974; Carpenter 1994), although it was recognized
that diets based on staples such as cassava, bananas, and yams
(Dioscorea) that are both very bulky and in low in protein pres-
ent special challenges (Nicol 1971). In addition, initial treat-
ment for severe PEM requires comparatively low levels of pro-
tein with a high biological value to ensure optimal utilization of
protein for tissue maintenance and to prevent overloading the
impaired metabolic system with superfluous amino acids and
their nitrogenous metabolites. Following this initial treatment,
high-protein diets such as milk-based formula can be used to
stimulate growth and recovery (for example, Müller and
Krawinkel 2005).
The importance of good nutrition starts at conception
because fetal growth and development lay the foundation for
health at all later ages. A fetus depends on the mother’s abili-
ty to deliver nutrients, and this is greatly influenced by her
nutritional state at the time she becomes pregnant as well as
throughout pregnancy. Poor fetal growth and development
have major consequences for the offspring, and these also
have implications for health in the neonatal period, infancy,
childhood, adolescence, and later life. Undernutrition in
early childhood has serious consequences as these children
are not only more prone to illness, but they also tend to have
more severe illnesses than well-nourished children.
Undernourished children are also at greater risk of dying.
Undernutrition in school age children, much of which proba-
bly started in early childhood, adversely affects school atten-
dance, performance, and learning. A stunted girl is more like-
ly to become a stunted adolescent and later a stunted woman.
Apart from direct effects on her health and productivity,
undernutrition in an adult woman increases the chance that
her children will be born with low birth weight, and the cycle
begins again (United Nations Standing Committee on
Nutrition 2004). Interventions to control undernutrition are
therefore needed at different stages in the life cycle. These
include improved child care and feeding practices for infants
and young children; the provision of specific micronutrients
through food fortification, biofortification, and pharmaceuti-
cal supplementation; improved access to health care; household
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food security; good hygiene and sanitation; and universal
female education.
The WHO global strategy for feeding infants and young
children highlights the importance of good feeding practices
during the transition period between exclusive breastfeeding
and full weaning, when breastfed children also need comple-
mentary food. In addition to being safe and timely, the diet
must be adequate—defined as providing sufficient energy,
protein, and micronutrients to meet a growing child’s nutri-
tional needs (WHO 2002). Children need a variety of foods to
ensure that nutrient needs are met. Diets that lack animal
source foods (meat, poultry, fish or eggs, plus milk products)
cannot meet the nutrient requirements for children ages 6 to
24 mo unless fortified foods or supplements are used. If milk
and other animal source foods are not taken in adequate
amounts, both grains and legumes should be consumed daily,
preferably within the same meal, to ensure adequate protein
quality (WHO 2004). In addition to the availability of these
foods, their accessibility to the population depending on, for
example, infrastructure and economic resources needs to be
considered.
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Deregulation is one term used for the process that eventually
leads to the registration of a product and the granting of its
unlimited commercial or noncommercial use. The national
authorities of the respective countries in which the product is
intended for use govern deregulation of GMO plants and the
foods derived from these. The process is driven by a science-
based risk assessment of the intended product and the environ-
ments into which it will be released. Current data requirements
can be extensive and are comprehensive, and require the sub-
mission of publication quality data reports. The development of
these materials can be time- consuming and costly. The studies
required to compile a regulatory dossier fall into 2 categories:
event-dependent and event-independent studies.
Event-independent studies can include biochemical analysis
(function, specificity and mode of action), studies on toxicity
and the allergenic potential of the newly expressed proteins. In
addition, dietary exposure modeling and bioavailability studies
can be conducted with the newly expressed proteins and, in the
case of enzymes, with the products produced by catalysis.
Event-dependent studies vary by country and can encompass
the characterization of the quality of integration, such as copy
number, the determination of the site of integration in the host
genome, demonstration of the absence of gene disruption, com-
pleteness of integrated DNA sequences, and the presence of the
marker gene at the same locus and absence of vector DNA
sequences. Phenotypic and biochemical evidence for trait stabil-
ity, including the monitoring of gene expression levels at key
growth stages and Mendelian inheritance over several genera-
tions, are usually components of these studies. Field performance
of typical agronomic traits, such as yield, and pest and disease
resistance, is an additional issue. The assessment is also based on
the comparison of the compositional analyses from materials
harvested at different locations with the equivalent nontransgenic
crop (and food) comparator. Event-dependent regulatory data are
usually not gathered until the developer is satisfied with the tech-
nical performance of the product and a few events (usually one)
have been chosen. Assessment of the potential risks of GM crops
is on a case-by-case basis within a scientific framework. A GMO
crop producing -carotene must be viewed differently than a
crop that produces an insecticide. Similarly, GR events express-
ing a phytoene synthase from maize, a widely consumed crop,
might be viewed differently than one using the enzyme from a
nonfood plant, such as daffodil.
From a scientific point of view it is often hard to understand
why randomly mutagenized crop plants can enter into breeding
lines easily, whereas GMOs, with considerably fewer genetic
modifications, have a much more rigorous assessment. To have
rational, science-based regulatory requirements it would be
necessary to realize the benefits (not only potential risks) that
GMO crops can provide (see lecture by Ingo Potrykus at
http://www.syngentafoundation.com/golden_rice/index.htm). It
is unhelpful to raise the regulatory requirements to the point
where anything that appears technically feasible is being
requested or is being offered to be applied (Kuiper and others
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2001), with the only justification that the genetically modified
organism involved is little understood. This strategy can raise
costs to unaffordable levels. We do not understand bred vari-
eties with their complex genomic changes much better at the
molecular level, but we tend to consider the traditional way of
producing new varieties safe in contrast to the novel way of pro-
ducing GMOs even though this is not based on any rational
evaluation. It is the final product and not the technology used to
produce it that should be scrutinized.
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Vitamin A deficiency (VAD) is a global public health chal-
lenge, particularly in infants, children, and pregnant and lactat-
ing women because of the extra requirements to support fetal,
infant, and child growth (Figure A1-1). Deficiency can result in
reduced resistance to infection, impaired cellular differentiation,
xerophthalmia, and ultimately blindness and death; it is also
associated with anemia. More than 100 million children and as
many as 7 million pregnant women living in over 100 countries
have VAD (West 2002; WHO 2003). It is estimated that between
1.3 and 2.5 million deaths of children aged 6 mo to 5 y could be
prevented each year by proper vitamin A nutrition (Figure A1-2).
Two million children have clinical or severe visual problems and
more than 250000 children become blind as a result of VAD
each year, one-half of whom die within a year of losing their
sight. (FAO 2002). The chances of death from measles or diar-
rheal disease are greatly increased by VAD (FAO/WHO 2002).
VAD also interacts with other nutrients; for example, iron metab-
olism is negatively affected and iron is not incorporated effective-
ly into hemoglobin (Hodges and others 1978).
Many countries with a high prevalence of VAD rely on rice as
a major source of energy. Rice does not contain -carotene, the
direct precursor of vitamin A. Attempts to provide biannual vita-
min A supplements to all children less than 6 y of age have been
difficult to sustain and are comparatively expensive (Bouis and
others 2003). More recently, fortification of foods such as sugar
and cereal flours with vitamin A has come to the fore. Lack of
dietary diversity causes VAD, and historically, emphasis has been
on increasing the intake of green leafy vegetables and yellow-
orange fruits and vegetables to improve vitamin A intake.
However, the -carotene in green leafy vegetable is less well
absorbed than that from yellow-orange fruits and roots or tubers,
although the method of preparation, including the presence of
dietary lipid, can improve bioefficacy (Yeum and Russell 2002;
Haskell and others 2004). The Inst. of Medicine (2001) has pro-
posed that 12 g of -carotene are required to provide 1 g of
vitamin A, while a conversion factor of 1 to 24 g has been set
for other provitamin A carotenoids, that is, -cryptoxanthin and
-carotene.
ILSI: Assessments of foods and feeds . . .
Vol. 7, 2008—COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY 107
Appendix 1: Vitamin A Deficiency: 
A Global Risk
Figure A1-1—Vitamin A deficien-
cy around the globe (FAO/WHO
2002).
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The details of the biosynthesis of -carotene and other
carotenoids in plants have been reviewed elsewhere
(Cunningham and Gantt 1998; Sandmann 2001; Taylor and
Ramsay 2005). The initial steps in the biosynthesis of -carotene
involve intermediates that are also precursors to other products
in plant cells. For example, the 5-carbon molecule (C5) isopen-
tenyl pyrophosphate (IPP) is the building unit for the synthesis of
various kinds of terpenoids, including -carotenes, plant hor-
mones, and other secondary metabolites and defense mole-
cules. IPP is formed both in the cytosol, through the mevalonate
pathway, and in plastids, through the deoxy-xylulose-phosphate
pathway. In plastids, IPP serves as substrate for carotenoid
biosynthesis, among others, and in the cytosol for some plant
hormones and steroids.
Because IPP isomerase is present in plant plastids and its activ-
ity is the limiting step of carotenoid synthesis in etioplasts, it has
been concluded that IPP is the major or only product of the 1-
deoxyxylulose-5-phosphate pathway–-the reaction sequence
leading to cyclic carotenoids (Albrecht and others 1994).
The 1st steps in the biosynthesis from IPP to -carotene entail
the formation of the C20 compound geranylgeranylphosphate
(GGPP) by condensation of 4 C5-precursors in total. First, 1 IPP
molecule is isomerized by the enzyme IPP isomerase into
dimethylallyl-pyrophosphate (DMAPP). This activated form of
IPP then reacts with 3 IPP molecules in 3 discrete reactions,
leading to the formation of GGPP catalyzed by the enzyme
GGPP synthase. Two molecules of GGPP are subsequently con-
densed to phytoene (C40) under the influence of the enzyme
phytoene synthase.
Phytoene enters a series of dehydrogenation and ring forma-
tion reactions, resulting in the formation of -carotene.
Phytoene desaturase (PDS) and zeta carotene desaturase (ZDS)
Figure A1-2—WHO estimates of childhood mortality
(FAO 1992).
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catalyze 4 dehydrogenation reactions, while carotenoid iso-
merase (CRTISO) catalyzes the cis-trans isomerization of cis
double bonds, particularly the 15-cis-double bond between car-
bon atoms, so that ultimately all-trans-lycopene is formed. The
enzyme lycopene -cyclase (LCYB) converts lycopene into -
carotene through 2 cyclization reactions involving the formation
of C6-rings at both ends of the molecule. In addition, -carotene
itself may be converted to xanthophylls, which are carotenoid
molecules with hydroxylated rings. Further reactions of xantho-
phylls lead to, for example, formation of the plant growth regu-
lator, abscisic acid (Cunningham and Gantt 1998; Taylor and
Ramsay 2005).
Figure A2-1 provides a schematic overview of the pathway
leading to biosynthesis of -carotene and products derived from
branches of the same pathway. Increasing the flux through this
pathway toward -carotene or intermediates may alter the
biosynthesis of other metabolites. For example, Fray and others
(1995) found that levels of intermediates, including phytoene,
lycopene, and -carotene, had increased in tomato plants
expressing phytoene synthase. In addition, transgenic plants
showed stunted growth due to decreased production of gib-
berellic acid-based plant growth regulators. Chlorophyll biosyn-
thesis was decreased in these plants as well.
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Figure A2-1—Biosynthesis of -
carotene in plants and other products
originating from intermediates in the
same pathway. [Based on “Biochemical
Pathways” chart of Roche Applied
Sciences (www. expasy.org/ tools/path-
ways/) and Taylor and Ramsay (2005)].
Intake of -Carotene
Beta-carotene is an important provitamin A carotenoid, that is,
precursor of vitamin A, but is not an essential nutrient and has no
dietary reference value. Dietary intakes are expressed as total
micrograms of retinol equivalents (RE), in which 12 g 
-carotene is equivalent nutritionally to 1 g RE. The FAO/WHO
(2002) recommended safe dietary intake of vitamin A is 
375 g/d for infants, 400 to 450 g/d for children 1 to 6 y, 
800 g/d for pregnant women, and 850 g/d for lactating women.
Provitamin A carotenoids are generally ingested from plant
foods and can be biologically transformed to vitamin A.
Globally, about 60% of dietary vitamin A comes from provita-
mins A. Many factors influence the absorption and utilization of
provitamin A, such as the vitamin A status of the individual; the
amount, type, and physical form of the carotenoids in the diet;
the intake of fat, vitamin A, and fiber; the individual’s protein
and zinc status; and the presence of certain diseases and para-
sitic infections (de Pee and West 1996). Between 10% and 90%
of all dietary -carotene is absorbed, and absorption decreases
as intake increases. Bioavailability is reduced in very low-fat
diets.
Metabolism of -Carotene
The metabolism of -carotene in humans and animals is well
documented, with excellent reviews by Olson (1996), Parker
(1997), Burri and Clifford (2004), and Bendich (2004).
In humans, dietary fat and bile salts facilitate the absorption
of -carotene that occurs in the upper small intestine.
Absorption occurs via incorporation into multilamellar lipid
micelles, although a proportion of absorbed -carotene is con-
verted to retinol within intestinal mucosal cells. Unaltered -
carotene is transported via the lymph to the plasma where it is
associated with lipoproteins. Tissue uptake and distribution are
not well characterized. When the intake of -carotene is consis-
tently high, long-term accumulation occurs preferentially in adi-
pose tissues.
Experiments in rats have shown that the conversion of -
carotene to retinol is regulated by the levels of -carotene and
of preformed vitamin A. In vitro studies have shown that other
-carotene derivatives may also occur, but their biological activ-
ity, and whether they are synthesized in vivo, is unknown.
Carotenoid absorption and metabolism vary considerably
between animal species (Lee and others 1999). No single
species is a good model for studying biokinetics and metabolism
of -carotene in humans. The rat is unsuitable because it is high-
ly efficient at converting -carotene to vitamin A, and significant
levels of unaltered -carotene are absorbed only when very high
doses are given for a prolonged time. The preruminant calf, the
ferret, and the Mongolian gerbil are more useful models,
although there are many differences in carotenoid absorption,
distribution, and metabolism between these animals and
humans.
Toxicity of Carotene
Dietary -carotene has not been shown to be toxic in humans
(Expert Group on Vitamins and Minerals 2003).
Hypercarotenaemia (high plasma -carotene) has not been
associated with adverse effects other than reversible yellowing
of the skin, known as hypercarotenodermia. Long-term oral -
carotene therapy in doses up to 300 g/d showed no toxic
effects in individuals with erythropoietic protoporphyria.
Vitamin A toxicity does not occur because the metabolic con-
version is regulated by vitamin A status. Reproductive toxicity or
teratogenicity associated with high -carotene intake, either
before or during pregnancy, has not been reported. Two large-
scale supplementation trials testing the hypothesis that 
-carotene supplementation in smokers would reduce the inci-
dence of cancer have shown an association of high dose 
-carotene supplementation (20 to 30 mg/d) with increased
incidence of lung cancer in smokers and asbestos-exposed indi-
viduals (Alpha-Tocopherol Beta-Carotene Cancer Prevention
Study Group 1994; Omenn and others 1996). No statistically
significant differences in other cancer types were observed in
these studies.
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Malnutrition includes both under- and overnutrition.
Undernutrition is the general term for an inadequate intake of
energy or specific vitamins and minerals that are collectively
known as micronutrients. Overnutrition is the opposite. This
section focuses on undernutrition, specifically protein-energy
malnutrition (PEM). PEM syndrome results from inadequate
food intake and is characterized by energy deficits, due to a
reduced intake of all macronutrients and often many micronu-
trients as well. Clinically, PEM manifests as emaciation (maras-
mus), edema (kwashiorkor), or a combination of the two
(marasmic–kwashiorkor). The form depends on the balance of
nonprotein and protein sources of energy. Marasmus occurs
when energy intake is insufficient to meet requirements and the
body is forced to draw on its own stores: first glycogen, then
skeletal muscle and triglycerides in fat depots. Consequently,
the individual becomes thin from loss of muscle and body fat.
In kwashiorkor, dietary protein deficiency is usually more
marked than the energy deficiency, and this results in
decreased protein synthesis and edema. Children with maras-
mic–kwashiorkor have some edema and more body fat than
those with marasmus.
Marasmus is the predominant form of PEM in most develop-
ing countries and can affect all age groups. Kwashiorkor is less
common and is usually manifested as marasmic–kwashiorkor,
especially in young children. It tends to occur where the staple
foods are low in protein and excessively starchy (for example,
yam [Dioscorea], cassava, sweetpotato, taro, plantain, and
banana).
The assessment of PEM uses indices derived from measure-
ments of body stature or length, weight, age, and presence or
absence of edema that are compared with a reference popula-
tion considered to have normal growth characteristics---usually
the United States, although this has been questioned. The
indices are underweight (low weight for age), stunting (low
height for age), and wasting (low weight for height). National
and regional level data on nutritional status have been compiled
systematically for more than 20 y by the WHO Global Database
on Child Growth and Malnutrition, which represents most of the
children worldwide (de Onis and others 2004). Because 
the population in Asia is larger than elsewhere in the world, the
number of undernourished is greatest in Asia, followed by
Africa, although the proportion that are undernourished is great-
est in Africa (de Onis and others 2004).
Views on the causes of PEM have evolved over time. By the
1960s, for example, it was known that the supply of protein in
cereal-based diets was adequate (Hegsted and others 1946). The
FAO nevertheless considered protein deficiency to be serious
and widespread in developing countries. This was based on the
observations that kwashiorkor, which was common among 1- to
4-y-old children in developing countries, (1) responded to ther-
apy that included relatively high-protein supplements and (2)
caused liver damage. Because liver cirrhosis was common
among adults in Africa, the FAO thought this too indicated that
African diets remained protein-deficient throughout life and the
same might also be true in all developing countries. Milk and
milk powder were expensive and in short supply. Consequently,
much work was carried out to develop and test economical
alternatives to milk powder based on locally available cereals
and oilseed flours, fish protein concentrate, and single-cell pro-
tein from fermenting microorganisms. The work ended once it
was realized that most children with kwashiorkor had been
raised on diets that were as deficient in energy as they were in
protein. The diets were also too bulky, which meant children
could only eat a limited and inadequate amount (Whitehead
1973). Consensus was reached that the solution was to provide
more high-energy foods and correct electrolyte deficiencies
rather than concentrate just on protein (Waterlow 1961;
McLaren 1974; Carpenter 1994), although it was recognized
that diets based on staples such as cassava, bananas, and yams
(Dioscorea) that are both very bulky and in low in protein pres-
ent special challenges (Nicol 1971). In addition, initial treat-
ment for severe PEM requires comparatively low levels of pro-
tein with a high biological value to ensure optimal utilization of
protein for tissue maintenance and to prevent overloading the
impaired metabolic system with superfluous amino acids and
their nitrogenous metabolites. Following this initial treatment,
high-protein diets such as milk-based formula can be used to
stimulate growth and recovery (for example, Müller and
Krawinkel 2005).
The importance of good nutrition starts at conception
because fetal growth and development lay the foundation for
health at all later ages. A fetus depends on the mother’s abili-
ty to deliver nutrients, and this is greatly influenced by her
nutritional state at the time she becomes pregnant as well as
throughout pregnancy. Poor fetal growth and development
have major consequences for the offspring, and these also
have implications for health in the neonatal period, infancy,
childhood, adolescence, and later life. Undernutrition in
early childhood has serious consequences as these children
are not only more prone to illness, but they also tend to have
more severe illnesses than well-nourished children.
Undernourished children are also at greater risk of dying.
Undernutrition in school age children, much of which proba-
bly started in early childhood, adversely affects school atten-
dance, performance, and learning. A stunted girl is more like-
ly to become a stunted adolescent and later a stunted woman.
Apart from direct effects on her health and productivity,
undernutrition in an adult woman increases the chance that
her children will be born with low birth weight, and the cycle
begins again (United Nations Standing Committee on
Nutrition 2004). Interventions to control undernutrition are
therefore needed at different stages in the life cycle. These
include improved child care and feeding practices for infants
and young children; the provision of specific micronutrients
through food fortification, biofortification, and pharmaceuti-
cal supplementation; improved access to health care; household
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food security; good hygiene and sanitation; and universal
female education.
The WHO global strategy for feeding infants and young
children highlights the importance of good feeding practices
during the transition period between exclusive breastfeeding
and full weaning, when breastfed children also need comple-
mentary food. In addition to being safe and timely, the diet
must be adequate—defined as providing sufficient energy,
protein, and micronutrients to meet a growing child’s nutri-
tional needs (WHO 2002). Children need a variety of foods to
ensure that nutrient needs are met. Diets that lack animal
source foods (meat, poultry, fish or eggs, plus milk products)
cannot meet the nutrient requirements for children ages 6 to
24 mo unless fortified foods or supplements are used. If milk
and other animal source foods are not taken in adequate
amounts, both grains and legumes should be consumed daily,
preferably within the same meal, to ensure adequate protein
quality (WHO 2004). In addition to the availability of these
foods, their accessibility to the population depending on, for
example, infrastructure and economic resources needs to be
considered.
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Deregulation is one term used for the process that eventually
leads to the registration of a product and the granting of its
unlimited commercial or noncommercial use. The national
authorities of the respective countries in which the product is
intended for use govern deregulation of GMO plants and the
foods derived from these. The process is driven by a science-
based risk assessment of the intended product and the environ-
ments into which it will be released. Current data requirements
can be extensive and are comprehensive, and require the sub-
mission of publication quality data reports. The development of
these materials can be time- consuming and costly. The studies
required to compile a regulatory dossier fall into 2 categories:
event-dependent and event-independent studies.
Event-independent studies can include biochemical analysis
(function, specificity and mode of action), studies on toxicity
and the allergenic potential of the newly expressed proteins. In
addition, dietary exposure modeling and bioavailability studies
can be conducted with the newly expressed proteins and, in the
case of enzymes, with the products produced by catalysis.
Event-dependent studies vary by country and can encompass
the characterization of the quality of integration, such as copy
number, the determination of the site of integration in the host
genome, demonstration of the absence of gene disruption, com-
pleteness of integrated DNA sequences, and the presence of the
marker gene at the same locus and absence of vector DNA
sequences. Phenotypic and biochemical evidence for trait stabil-
ity, including the monitoring of gene expression levels at key
growth stages and Mendelian inheritance over several genera-
tions, are usually components of these studies. Field performance
of typical agronomic traits, such as yield, and pest and disease
resistance, is an additional issue. The assessment is also based on
the comparison of the compositional analyses from materials
harvested at different locations with the equivalent nontransgenic
crop (and food) comparator. Event-dependent regulatory data are
usually not gathered until the developer is satisfied with the tech-
nical performance of the product and a few events (usually one)
have been chosen. Assessment of the potential risks of GM crops
is on a case-by-case basis within a scientific framework. A GMO
crop producing -carotene must be viewed differently than a
crop that produces an insecticide. Similarly, GR events express-
ing a phytoene synthase from maize, a widely consumed crop,
might be viewed differently than one using the enzyme from a
nonfood plant, such as daffodil.
From a scientific point of view it is often hard to understand
why randomly mutagenized crop plants can enter into breeding
lines easily, whereas GMOs, with considerably fewer genetic
modifications, have a much more rigorous assessment. To have
rational, science-based regulatory requirements it would be
necessary to realize the benefits (not only potential risks) that
GMO crops can provide (see lecture by Ingo Potrykus at
http://www.syngentafoundation.com/golden_rice/index.htm). It
is unhelpful to raise the regulatory requirements to the point
where anything that appears technically feasible is being
requested or is being offered to be applied (Kuiper and others
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2001), with the only justification that the genetically modified
organism involved is little understood. This strategy can raise
costs to unaffordable levels. We do not understand bred vari-
eties with their complex genomic changes much better at the
molecular level, but we tend to consider the traditional way of
producing new varieties safe in contrast to the novel way of pro-
ducing GMOs even though this is not based on any rational
evaluation. It is the final product and not the technology used to
produce it that should be scrutinized.
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Vitamin A deficiency (VAD) is a global public health chal-
lenge, particularly in infants, children, and pregnant and lactat-
ing women because of the extra requirements to support fetal,
infant, and child growth (Figure A1-1). Deficiency can result in
reduced resistance to infection, impaired cellular differentiation,
xerophthalmia, and ultimately blindness and death; it is also
associated with anemia. More than 100 million children and as
many as 7 million pregnant women living in over 100 countries
have VAD (West 2002; WHO 2003). It is estimated that between
1.3 and 2.5 million deaths of children aged 6 mo to 5 y could be
prevented each year by proper vitamin A nutrition (Figure A1-2).
Two million children have clinical or severe visual problems and
more than 250000 children become blind as a result of VAD
each year, one-half of whom die within a year of losing their
sight. (FAO 2002). The chances of death from measles or diar-
rheal disease are greatly increased by VAD (FAO/WHO 2002).
VAD also interacts with other nutrients; for example, iron metab-
olism is negatively affected and iron is not incorporated effective-
ly into hemoglobin (Hodges and others 1978).
Many countries with a high prevalence of VAD rely on rice as
a major source of energy. Rice does not contain -carotene, the
direct precursor of vitamin A. Attempts to provide biannual vita-
min A supplements to all children less than 6 y of age have been
difficult to sustain and are comparatively expensive (Bouis and
others 2003). More recently, fortification of foods such as sugar
and cereal flours with vitamin A has come to the fore. Lack of
dietary diversity causes VAD, and historically, emphasis has been
on increasing the intake of green leafy vegetables and yellow-
orange fruits and vegetables to improve vitamin A intake.
However, the -carotene in green leafy vegetable is less well
absorbed than that from yellow-orange fruits and roots or tubers,
although the method of preparation, including the presence of
dietary lipid, can improve bioefficacy (Yeum and Russell 2002;
Haskell and others 2004). The Inst. of Medicine (2001) has pro-
posed that 12 g of -carotene are required to provide 1 g of
vitamin A, while a conversion factor of 1 to 24 g has been set
for other provitamin A carotenoids, that is, -cryptoxanthin and
-carotene.
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A Global Risk
Figure A1-1—Vitamin A deficien-
cy around the globe (FAO/WHO
2002).
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The details of the biosynthesis of -carotene and other
carotenoids in plants have been reviewed elsewhere
(Cunningham and Gantt 1998; Sandmann 2001; Taylor and
Ramsay 2005). The initial steps in the biosynthesis of -carotene
involve intermediates that are also precursors to other products
in plant cells. For example, the 5-carbon molecule (C5) isopen-
tenyl pyrophosphate (IPP) is the building unit for the synthesis of
various kinds of terpenoids, including -carotenes, plant hor-
mones, and other secondary metabolites and defense mole-
cules. IPP is formed both in the cytosol, through the mevalonate
pathway, and in plastids, through the deoxy-xylulose-phosphate
pathway. In plastids, IPP serves as substrate for carotenoid
biosynthesis, among others, and in the cytosol for some plant
hormones and steroids.
Because IPP isomerase is present in plant plastids and its activ-
ity is the limiting step of carotenoid synthesis in etioplasts, it has
been concluded that IPP is the major or only product of the 1-
deoxyxylulose-5-phosphate pathway–-the reaction sequence
leading to cyclic carotenoids (Albrecht and others 1994).
The 1st steps in the biosynthesis from IPP to -carotene entail
the formation of the C20 compound geranylgeranylphosphate
(GGPP) by condensation of 4 C5-precursors in total. First, 1 IPP
molecule is isomerized by the enzyme IPP isomerase into
dimethylallyl-pyrophosphate (DMAPP). This activated form of
IPP then reacts with 3 IPP molecules in 3 discrete reactions,
leading to the formation of GGPP catalyzed by the enzyme
GGPP synthase. Two molecules of GGPP are subsequently con-
densed to phytoene (C40) under the influence of the enzyme
phytoene synthase.
Phytoene enters a series of dehydrogenation and ring forma-
tion reactions, resulting in the formation of -carotene.
Phytoene desaturase (PDS) and zeta carotene desaturase (ZDS)
Figure A1-2—WHO estimates of childhood mortality
(FAO 1992).
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catalyze 4 dehydrogenation reactions, while carotenoid iso-
merase (CRTISO) catalyzes the cis-trans isomerization of cis
double bonds, particularly the 15-cis-double bond between car-
bon atoms, so that ultimately all-trans-lycopene is formed. The
enzyme lycopene -cyclase (LCYB) converts lycopene into -
carotene through 2 cyclization reactions involving the formation
of C6-rings at both ends of the molecule. In addition, -carotene
itself may be converted to xanthophylls, which are carotenoid
molecules with hydroxylated rings. Further reactions of xantho-
phylls lead to, for example, formation of the plant growth regu-
lator, abscisic acid (Cunningham and Gantt 1998; Taylor and
Ramsay 2005).
Figure A2-1 provides a schematic overview of the pathway
leading to biosynthesis of -carotene and products derived from
branches of the same pathway. Increasing the flux through this
pathway toward -carotene or intermediates may alter the
biosynthesis of other metabolites. For example, Fray and others
(1995) found that levels of intermediates, including phytoene,
lycopene, and -carotene, had increased in tomato plants
expressing phytoene synthase. In addition, transgenic plants
showed stunted growth due to decreased production of gib-
berellic acid-based plant growth regulators. Chlorophyll biosyn-
thesis was decreased in these plants as well.
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Figure A2-1—Biosynthesis of -
carotene in plants and other products
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same pathway. [Based on “Biochemical
Pathways” chart of Roche Applied
Sciences (www. expasy.org/ tools/path-
ways/) and Taylor and Ramsay (2005)].
Intake of -Carotene
Beta-carotene is an important provitamin A carotenoid, that is,
precursor of vitamin A, but is not an essential nutrient and has no
dietary reference value. Dietary intakes are expressed as total
micrograms of retinol equivalents (RE), in which 12 g 
-carotene is equivalent nutritionally to 1 g RE. The FAO/WHO
(2002) recommended safe dietary intake of vitamin A is 
375 g/d for infants, 400 to 450 g/d for children 1 to 6 y, 
800 g/d for pregnant women, and 850 g/d for lactating women.
Provitamin A carotenoids are generally ingested from plant
foods and can be biologically transformed to vitamin A.
Globally, about 60% of dietary vitamin A comes from provita-
mins A. Many factors influence the absorption and utilization of
provitamin A, such as the vitamin A status of the individual; the
amount, type, and physical form of the carotenoids in the diet;
the intake of fat, vitamin A, and fiber; the individual’s protein
and zinc status; and the presence of certain diseases and para-
sitic infections (de Pee and West 1996). Between 10% and 90%
of all dietary -carotene is absorbed, and absorption decreases
as intake increases. Bioavailability is reduced in very low-fat
diets.
Metabolism of -Carotene
The metabolism of -carotene in humans and animals is well
documented, with excellent reviews by Olson (1996), Parker
(1997), Burri and Clifford (2004), and Bendich (2004).
In humans, dietary fat and bile salts facilitate the absorption
of -carotene that occurs in the upper small intestine.
Absorption occurs via incorporation into multilamellar lipid
micelles, although a proportion of absorbed -carotene is con-
verted to retinol within intestinal mucosal cells. Unaltered -
carotene is transported via the lymph to the plasma where it is
associated with lipoproteins. Tissue uptake and distribution are
not well characterized. When the intake of -carotene is consis-
tently high, long-term accumulation occurs preferentially in adi-
pose tissues.
Experiments in rats have shown that the conversion of -
carotene to retinol is regulated by the levels of -carotene and
of preformed vitamin A. In vitro studies have shown that other
-carotene derivatives may also occur, but their biological activ-
ity, and whether they are synthesized in vivo, is unknown.
Carotenoid absorption and metabolism vary considerably
between animal species (Lee and others 1999). No single
species is a good model for studying biokinetics and metabolism
of -carotene in humans. The rat is unsuitable because it is high-
ly efficient at converting -carotene to vitamin A, and significant
levels of unaltered -carotene are absorbed only when very high
doses are given for a prolonged time. The preruminant calf, the
ferret, and the Mongolian gerbil are more useful models,
although there are many differences in carotenoid absorption,
distribution, and metabolism between these animals and
humans.
Toxicity of Carotene
Dietary -carotene has not been shown to be toxic in humans
(Expert Group on Vitamins and Minerals 2003).
Hypercarotenaemia (high plasma -carotene) has not been
associated with adverse effects other than reversible yellowing
of the skin, known as hypercarotenodermia. Long-term oral -
carotene therapy in doses up to 300 g/d showed no toxic
effects in individuals with erythropoietic protoporphyria.
Vitamin A toxicity does not occur because the metabolic con-
version is regulated by vitamin A status. Reproductive toxicity or
teratogenicity associated with high -carotene intake, either
before or during pregnancy, has not been reported. Two large-
scale supplementation trials testing the hypothesis that 
-carotene supplementation in smokers would reduce the inci-
dence of cancer have shown an association of high dose 
-carotene supplementation (20 to 30 mg/d) with increased
incidence of lung cancer in smokers and asbestos-exposed indi-
viduals (Alpha-Tocopherol Beta-Carotene Cancer Prevention
Study Group 1994; Omenn and others 1996). No statistically
significant differences in other cancer types were observed in
these studies.
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Malnutrition includes both under- and overnutrition.
Undernutrition is the general term for an inadequate intake of
energy or specific vitamins and minerals that are collectively
known as micronutrients. Overnutrition is the opposite. This
section focuses on undernutrition, specifically protein-energy
malnutrition (PEM). PEM syndrome results from inadequate
food intake and is characterized by energy deficits, due to a
reduced intake of all macronutrients and often many micronu-
trients as well. Clinically, PEM manifests as emaciation (maras-
mus), edema (kwashiorkor), or a combination of the two
(marasmic–kwashiorkor). The form depends on the balance of
nonprotein and protein sources of energy. Marasmus occurs
when energy intake is insufficient to meet requirements and the
body is forced to draw on its own stores: first glycogen, then
skeletal muscle and triglycerides in fat depots. Consequently,
the individual becomes thin from loss of muscle and body fat.
In kwashiorkor, dietary protein deficiency is usually more
marked than the energy deficiency, and this results in
decreased protein synthesis and edema. Children with maras-
mic–kwashiorkor have some edema and more body fat than
those with marasmus.
Marasmus is the predominant form of PEM in most develop-
ing countries and can affect all age groups. Kwashiorkor is less
common and is usually manifested as marasmic–kwashiorkor,
especially in young children. It tends to occur where the staple
foods are low in protein and excessively starchy (for example,
yam [Dioscorea], cassava, sweetpotato, taro, plantain, and
banana).
The assessment of PEM uses indices derived from measure-
ments of body stature or length, weight, age, and presence or
absence of edema that are compared with a reference popula-
tion considered to have normal growth characteristics---usually
the United States, although this has been questioned. The
indices are underweight (low weight for age), stunting (low
height for age), and wasting (low weight for height). National
and regional level data on nutritional status have been compiled
systematically for more than 20 y by the WHO Global Database
on Child Growth and Malnutrition, which represents most of the
children worldwide (de Onis and others 2004). Because 
the population in Asia is larger than elsewhere in the world, the
number of undernourished is greatest in Asia, followed by
Africa, although the proportion that are undernourished is great-
est in Africa (de Onis and others 2004).
Views on the causes of PEM have evolved over time. By the
1960s, for example, it was known that the supply of protein in
cereal-based diets was adequate (Hegsted and others 1946). The
FAO nevertheless considered protein deficiency to be serious
and widespread in developing countries. This was based on the
observations that kwashiorkor, which was common among 1- to
4-y-old children in developing countries, (1) responded to ther-
apy that included relatively high-protein supplements and (2)
caused liver damage. Because liver cirrhosis was common
among adults in Africa, the FAO thought this too indicated that
African diets remained protein-deficient throughout life and the
same might also be true in all developing countries. Milk and
milk powder were expensive and in short supply. Consequently,
much work was carried out to develop and test economical
alternatives to milk powder based on locally available cereals
and oilseed flours, fish protein concentrate, and single-cell pro-
tein from fermenting microorganisms. The work ended once it
was realized that most children with kwashiorkor had been
raised on diets that were as deficient in energy as they were in
protein. The diets were also too bulky, which meant children
could only eat a limited and inadequate amount (Whitehead
1973). Consensus was reached that the solution was to provide
more high-energy foods and correct electrolyte deficiencies
rather than concentrate just on protein (Waterlow 1961;
McLaren 1974; Carpenter 1994), although it was recognized
that diets based on staples such as cassava, bananas, and yams
(Dioscorea) that are both very bulky and in low in protein pres-
ent special challenges (Nicol 1971). In addition, initial treat-
ment for severe PEM requires comparatively low levels of pro-
tein with a high biological value to ensure optimal utilization of
protein for tissue maintenance and to prevent overloading the
impaired metabolic system with superfluous amino acids and
their nitrogenous metabolites. Following this initial treatment,
high-protein diets such as milk-based formula can be used to
stimulate growth and recovery (for example, Müller and
Krawinkel 2005).
The importance of good nutrition starts at conception
because fetal growth and development lay the foundation for
health at all later ages. A fetus depends on the mother’s abili-
ty to deliver nutrients, and this is greatly influenced by her
nutritional state at the time she becomes pregnant as well as
throughout pregnancy. Poor fetal growth and development
have major consequences for the offspring, and these also
have implications for health in the neonatal period, infancy,
childhood, adolescence, and later life. Undernutrition in
early childhood has serious consequences as these children
are not only more prone to illness, but they also tend to have
more severe illnesses than well-nourished children.
Undernourished children are also at greater risk of dying.
Undernutrition in school age children, much of which proba-
bly started in early childhood, adversely affects school atten-
dance, performance, and learning. A stunted girl is more like-
ly to become a stunted adolescent and later a stunted woman.
Apart from direct effects on her health and productivity,
undernutrition in an adult woman increases the chance that
her children will be born with low birth weight, and the cycle
begins again (United Nations Standing Committee on
Nutrition 2004). Interventions to control undernutrition are
therefore needed at different stages in the life cycle. These
include improved child care and feeding practices for infants
and young children; the provision of specific micronutrients
through food fortification, biofortification, and pharmaceuti-
cal supplementation; improved access to health care; household
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food security; good hygiene and sanitation; and universal
female education.
The WHO global strategy for feeding infants and young
children highlights the importance of good feeding practices
during the transition period between exclusive breastfeeding
and full weaning, when breastfed children also need comple-
mentary food. In addition to being safe and timely, the diet
must be adequate—defined as providing sufficient energy,
protein, and micronutrients to meet a growing child’s nutri-
tional needs (WHO 2002). Children need a variety of foods to
ensure that nutrient needs are met. Diets that lack animal
source foods (meat, poultry, fish or eggs, plus milk products)
cannot meet the nutrient requirements for children ages 6 to
24 mo unless fortified foods or supplements are used. If milk
and other animal source foods are not taken in adequate
amounts, both grains and legumes should be consumed daily,
preferably within the same meal, to ensure adequate protein
quality (WHO 2004). In addition to the availability of these
foods, their accessibility to the population depending on, for
example, infrastructure and economic resources needs to be
considered.
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Deregulation is one term used for the process that eventually
leads to the registration of a product and the granting of its
unlimited commercial or noncommercial use. The national
authorities of the respective countries in which the product is
intended for use govern deregulation of GMO plants and the
foods derived from these. The process is driven by a science-
based risk assessment of the intended product and the environ-
ments into which it will be released. Current data requirements
can be extensive and are comprehensive, and require the sub-
mission of publication quality data reports. The development of
these materials can be time- consuming and costly. The studies
required to compile a regulatory dossier fall into 2 categories:
event-dependent and event-independent studies.
Event-independent studies can include biochemical analysis
(function, specificity and mode of action), studies on toxicity
and the allergenic potential of the newly expressed proteins. In
addition, dietary exposure modeling and bioavailability studies
can be conducted with the newly expressed proteins and, in the
case of enzymes, with the products produced by catalysis.
Event-dependent studies vary by country and can encompass
the characterization of the quality of integration, such as copy
number, the determination of the site of integration in the host
genome, demonstration of the absence of gene disruption, com-
pleteness of integrated DNA sequences, and the presence of the
marker gene at the same locus and absence of vector DNA
sequences. Phenotypic and biochemical evidence for trait stabil-
ity, including the monitoring of gene expression levels at key
growth stages and Mendelian inheritance over several genera-
tions, are usually components of these studies. Field performance
of typical agronomic traits, such as yield, and pest and disease
resistance, is an additional issue. The assessment is also based on
the comparison of the compositional analyses from materials
harvested at different locations with the equivalent nontransgenic
crop (and food) comparator. Event-dependent regulatory data are
usually not gathered until the developer is satisfied with the tech-
nical performance of the product and a few events (usually one)
have been chosen. Assessment of the potential risks of GM crops
is on a case-by-case basis within a scientific framework. A GMO
crop producing -carotene must be viewed differently than a
crop that produces an insecticide. Similarly, GR events express-
ing a phytoene synthase from maize, a widely consumed crop,
might be viewed differently than one using the enzyme from a
nonfood plant, such as daffodil.
From a scientific point of view it is often hard to understand
why randomly mutagenized crop plants can enter into breeding
lines easily, whereas GMOs, with considerably fewer genetic
modifications, have a much more rigorous assessment. To have
rational, science-based regulatory requirements it would be
necessary to realize the benefits (not only potential risks) that
GMO crops can provide (see lecture by Ingo Potrykus at
http://www.syngentafoundation.com/golden_rice/index.htm). It
is unhelpful to raise the regulatory requirements to the point
where anything that appears technically feasible is being
requested or is being offered to be applied (Kuiper and others
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2001), with the only justification that the genetically modified
organism involved is little understood. This strategy can raise
costs to unaffordable levels. We do not understand bred vari-
eties with their complex genomic changes much better at the
molecular level, but we tend to consider the traditional way of
producing new varieties safe in contrast to the novel way of pro-
ducing GMOs even though this is not based on any rational
evaluation. It is the final product and not the technology used to
produce it that should be scrutinized.
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